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Preterm birth is the leading cause of neonatal mortality and morbidity. The uterine 
cervix is key in maintaining a healthy pregnancy. Excisional procedures for the 
treatment of cervical intraepithelial neoplasia (CIN) are associated with preterm birth 
(PTB), but underlying mechanisms are yet to be described. Intrauterine infection is 
involved in 40% of PTB and cervical damage is likely to facilitate ascending infection 
with vaginal bacteria. The aim of this thesis was to establish and characterise an in 
vitro and in vivo model of cervical damage to study its interplay with ascending 
infection. For this, the surfactant N-9 was used as a damage agent.  
N-9 was found to reduce the endocervical epithelial cells’ viability and compromise 
their epithelial permeability in vitro. When vaginally administered in pregnant 
C57Bl/6 mice, N-9 disrupted the structural integrity of the cervical epithelium, caused 
an influx of neutrophils and resulted in increased cell proliferation in the basement 
membrane of the cervix. Similar where the findings in the vaginal epithelium. 
However, N-9-induced epithelial damage had no effect on timing of delivery or pup 
survival.  
Following vaginal infection with a luciferase-expressing Ureaplasma parvum, mice 
previously treated with N-9 exhibited higher rates of ascending infection, with 
increased bioluminescence signal in the upper reproductive tract. They also 
demonstrated higher bacterial titres in the amniotic fluid and higher bacterial product 
copy numbers in the reproductive tissues. This resulted in increased preterm birth rates 
among mice in this group compared to vehicle-treated controls. Infection with 
Ureaplasma parvum was characterised by an inflammatory response in the uterus, the 
placenta and the fetal membranes with increased expression of the proinflammatory 
cytokines TNFa, IL-1b, CXCL-1 and CXCL-2. This effect may be mediated by TLR2, 
the expression of which was also shown to increase accordingly.   
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Overall, these findings suggest that cervical epithelial damage facilitates ascending 
infection. This is a potential mechanism explaining the higher PTB incidence among 
women treated for CIN. The robust model of cervical epithelial damage during 
pregnancy described in this thesis can be used to study the barrier function of the cervix 
and its interplay with ascending infection in future studies. 
  




Preterm birth is any birth before 37 completed weeks of pregnancy and it occurs in 
about 10% of pregnancies. It is a very risky situation as babies born early are at 
increased risk of death and are also likely to face problems with any of their developing 
organs. The main reason why babies are born early is an infection with bacteria that 
takes place inside the womb. These bacteria travel there from the vagina, where they 
normally reside. The cervix is a little tube that stands between the vagina and the 
womb. When the cervix is damaged, then women are more likely to deliver preterm. 
Due to obvious ethical restrictions, experiments to find out why this happens cannot 
be done in women. The aim of this thesis was to mimic the above case in the laboratory 
setting using human cells and laboratory mice and to study whether damage in the 
cervix can increase the risk of infection in the womb. A substance called N-9 was used 
to cause cervical injury.  
When N-9 was applied to cells from the cervix in the laboratory, the cells started to 
die. It also disrupted their ability to filter what goes through them, a crucial feature for 
protecting against infection. When mice received N-9 in their vagina, the cells that 
form the lining of the cervix and the vagina, called the epithelium, started to die. In 
addition, specialised cells called neutrophils that participate in repair processes after 
injury were recruited on site. Finally, cells of the epithelium that survived started 
multiplying faster in order to replace the missing parts. These features were indicative 
of a successful mimicking of cervical damage. 
The interplay between cervical damage and infection was studied using N-9 and the 
most common bacteria in preterm birth, Ureaplasma parvum. In mice that had their 
cervix damaged by N-9, it was more likely for Ureaplasma parvum to manage to go 
from the vagina to the womb. This led to more mice in this group delivering preterm 
compared to the ones that had an intact cervix. It was also found that the presence of 
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Ureaplasma parvum causes the immune system of the mice to respond by producing 
specialised agents that cause inflammation.  
Overall, the work in this thesis suggests that damage to the cervix can increase preterm 
birth by allowing bacteria to pass through the cervix and infect the womb. 
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CO2 Carbon dioxide 
Ct Threshold cycle 
CXCL-1 C-X-C motif chemokine ligand 1 
CXCL-2 C-X-C motif chemokine ligand 2 
CXCL-8 C-X-C motif chemokine ligand 8 
CXCL-10 C-X-C motif chemokine ligand 10 
Cx-43 Connexin-43 
DAB 3,3’- diaminobenzidine 
DAMP Damage-associated molecular pattern 
DES Diethylstilbestrol 
DMEM Dulbeco’s modified Eagle medium 
DMF Dimethylformamide 
DMSO Dimethylsulfoxide 
DNA Deoxyribonucleic acid 
dNTPs Deoxyribonucleotide triphosphates 
EDTA Ethylenediaminetetraacetic acid 
EGF Epidermal growth factor 
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ELISA Enzyme-linked immunosorbent assay 
FBS Fetal bovine serum 
F. I. Fluorescence intensity 
FITC Fluorescein 
FOI Field of interest 
G-CSF Granulocyte-colony stimulating facror 
GM-CSF Granulocyte-macrophage colony-stimulating facror 
GROa Growth related oncogene-a 
HA Hyaluronic acid 
HBD-1 Human β-defensin 1 
HESC Human endometrial stromal cells 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HIER Heat-induced epitope retrieval 
HIV Human immunodeficiency virus 
HMGB1 High-mobility group box 1 
HPA Hypothalamus-Pituitary-Adrenal 
HPV16 Human Papilloma Virus type 16 
HRP Horseradish peroxidase 
Hz Hertz 
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H2O Water 
H2O2 Hydrogen peroxide 
H2SO4 Sulfuric acid 






IFNγ Interferon gamma 
IP-10 Interferon gamma-induced protein 10 
IRAK1 interleukin-1 receptor-associated kinase 1 
IRAK4 interleukin-1 receptor-associated kinase 4 
KO Knockout 
LDH Lactate dehydrogonase 
LEEP Loop electrosurgical excision procedure 
LLETZ Large loop excision of the transformation zone 
LMP Last menstrual period 
LTA Lipoteichoic acid 
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Ly6G Lymphocyte antigen 6 complex locus G6D  
MBA Multiple-banded antigen 
M-CSF Macrophage colony-stimulating factor 
MCP-1 Monocyte chemoattractant protein 1 
MIAC Microbial invasion of the amniotic cavity 
MIP-1a Macrophage inflammatory protein-1 alpha 
MIP-1b Macrophage inflammatory protein-1 beta 
MMPs Matrix metalloproteinases 




MyD88 Myeloid differentiation response element 88 
NaCl Sodium chloride 
NADH Nicotinamide adenine dinucleotide 
NFκB Nuclear factor kappa B 
NGS Normal goat serum 
NLRs Nod-like receptors 
NO Nitric oxide 
N-9 Nonoxynol-9 
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ON Overnight 
OR Odds ratio 
OTR Oxytocin receptor 
P Probability 
PBS Phosphate buffered saline 
PDE4 Phosphodiesterase 4 
PFA Polymeric formaldehyde 
PGDH Hydroxyprostaglandin dehydrogenase 
PGE2 Prostaglandin E2 
PGF2a Prostaglandin F2a 
PGs Prostaglandins 
PPROM Preterm premature rupture of membranes 
PRRs Pattern Recognition Receptors 
PTB Preterm birth 
PTL Preterm labour 
RANTES Regulated on activation, normal T cell expressed and 
secreted 
RCT Randomised clinical trial 
RIPA Radioimmunoprecipitation 
RNA Ribonucleic acid 
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ROI Region of interest 
RR Relative risk 
RT Room temperature 
RU486 Mifepristone 
SD Standard deviation 
SEM Standard error of the mean 
SLPI Secretory Leukocyte Protease Inhibitor 
STDs Sexually transmitted diseases 
SuRF Shared University Research Facilities 
TBS Tris-buffered saline 
TGF-β Transforming growth factor beta 
TIMPs Tissue inhibitors of metalloproteinases 
TLRs Toll-like Receptors 
TMB 3, 3’, 5, 5’- Tetramethylbenzidine 
TNFa Tumour necrosis factor A 
TRAF6 TNF receptor associated factor 6 
UK United Kingdom 
UP Ureaplasma parvum 
UreC Urease C 
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USA United States of America 
USM Ureaplasma selective medium 
WHO World Health Organisation 
WST 2-[4-iodophenyl]-3-[4-nitrophenyl]-5-[2,4-
disulfophenyl]-2H-tetrazolium, monosodium salt 
WT Wildtype 
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Chapter 1 Literature review 
1.1 Definition 
The definition of Preterm birth (PTB) was suggested by the World Health Organisation 
(WHO) in 1975 and refers to any delivery before 37 completed weeks of pregnancy 
(1). This is the equivalent of 259 days since the day of the last menstrual period (LMP). 
No global definition has been adopted for the lower limit, although this is generally 
set at 20 or 22 weeks of gestation (2). PTB can be further sub-classified into extremely 
preterm for babies born before 28 weeks, very preterm for babies born between 28 and 
32 weeks and moderate or late preterm for those born between 32 and 36 weeks (1). 
1.2 Epidemiology 
Preterm birth affects 11.1% of all live births worldwide with an prevalence that ranges 
from 5% to 18% (3). The incidence is between 5-10% in Europe, more than 10% in 
the United States and approaching 15% or more in Africa and South-East Asia (3). 
This results in about 15 million babies being delivered prematurely on an annual basis 
(4). About 80% of those are in Africa and Asia (5). 
Preterm birth can be iatrogenic due to medical indications or occur after spontaneous 
onset of preterm labour (PTL) or preterm premature rupture of membranes (PPROM). 
Despite this division, a spontaneous PTB increases the risk for a subsequent medically 
indicated PTB and vice versa (6). This indicates that common underlying mechanisms 
are likely to be shared in both conditions (7).  
Medical indications for a preterm delivery account for about 30% of PTBs and include 
conditions that put either the maternal (such as preeclampsia) or fetal (such as 
intrauterine growth restriction) health at risk (3). The number of medically indicated 
PTBs has been shown to have increased in industrialised countries over the past two 
decades (8). This is partly due to an increase in the use of assisted reproductive 
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technology (ART) which in itself increases the risk for preterm delivery, even in 
singleton pregnancies (9).  
1.3 Mortality and morbidity 
1.3.1 Mortality 
Over the past few decades, medical advances have improved mortality rates of babies 
born preterm. These include the use of assisted ventilation (10), surfactant 
administration (11) (12), widespread use of antenatal corticosteroids for preterm lung 
maturation (13) and the treatment of preterm babies in the intensive care unit (14). 
These advances have been pivotal for the striking improvement in preterm mortality 
rates, especially in the extremely preterm group (15). However, by 2013 preterm birth 
and its complications were still the leading cause of death during the neonatal period 
(16). These account for a total of approximately 1 million neonatal deaths annually 
(16).  
The mortality risk largely increases with smaller gestation age (17). Most studies 
report their data by birthweight (18) which can be used as an indication of gestational 
age (19). For example, survival to discharge ranges from less than 20% at 401-500g 
birthweight to more than 90% at 1401-1500g birthweight (20). The high mortality risk 
of this very small group has a vast effect on the overall mortality rates. In particular, 
babies below 1,000g birthweight account for almost half infant deaths in the US 
annually, despite them representing only 0.8% of the total number of births (21). The 
same pattern is also found for infants in the extremely preterm group of earlier than 28 
weeks gestation (21).  
1.3.2 Morbidity 
Surviving infants are potentially exposed to a wide spectrum of short-term 
complications that predispose and may lead to severe long-term outcomes.  
Shortly after delivery, preterm neonates are at increased risk of severe respiratory 
complications such as Acute Respiratory Distress Syndrome (ARDS) and 
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bronchopulmonary dysplasia. These conditions result in a poorer lung function later 
on in life (22) with a concurrent tendency for increased hospitalisation and more 
hospital re-admissions (23).  
Ocular complications such as retinopathy or prematurity are also common, especially 
in the extremely preterm group. This can lead to moderate morbidity such as myopia 
or hypermetropia (24). Importantly, it can lead to severe complications including 
retinal detachment (25), severe visual impairment or even blindness (26). 
Premature babies are also at increased risk of developing type 2 diabetes (27), renal 
(28) and cardiovascular disease (28) in their adulthood. These conditions further 
increase mortality and morbidity risks on their own. 
The most dramatic impact is arguably seen in the preterm infant’s brain. Preterm 
neonates are at increased risk of intraventricular haemorrhage (29). Given the brain’s 
immature status at this critical developmental window, this can lead to cerebral palsy 
(30) and neurosensory disabilities (31). These can evolve into permanent neurological 
disabilities with life-long morbidity (32). This becomes apparent as they face learning 
difficulties (33), cognitive deficit (34) and altered social behaviour (35).  
1.4 Financial implications 
Besides the detrimental effects on life, health and wellbeing of premature infants, PTB-
related morbidity also has important financial consequences on healthcare services 
both in the short and in the long-term. A cohort study from California reported that in 
the short-term, the cost of post-delivery hospitalisation of a premature baby at 24 
weeks has a median value of $216,814 for a median 92-day stay at the hospital (36). 
At 37 weeks however, the hospitalisation cost is at $591 for a 2-day stay (36). This 
highlights a remarkable cost reduction of more than 99%.. Similar results regarding 
hospitalisation length were also reported using a Swedish registry (37). This 
emphasizes the huge cost of PTB, even for those that manage to survive without any 
impairment.  
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Following hospital discharge, re-admissions related to prematurity complications are 
quite likely. Further costs related to social care and special education are also 
implicated as direct consequences of prematurity. In the UK, a fair total estimate of 
the financial burden of PTB to the public sector for 2006 was £2.946 billion which 
corresponds to $4.567 billion at the time the study was conducted (38). Predictably, 
the study found that the average cost for each preterm child increased as the gestational 
length got shorter as part of a direct inverse relationship (38). The respective financial 
burden for the US in 2005 was $26.2 billion, which is in line with the UK data, the 
difference being reflective of the population difference as well as the increased 
incidence (39).  
A recent study has estimated that a relative 5% reduction of preterm births in countries 
with a very high human development index would translate into 58,000 fewer preterm 
deliveries. This would result in global savings of $3 billion annually (40). Collectively, 
these data suggest that reducing preterm birth and/or alleviating its effects will have a 
huge financial benefit on healthcare systems.  
1.5 Key structures in the parturition process 
Parturition is a well-synchronised series of events that result in profound biological 
and clinical changes in three key reproductive tissues: the myometrium, the fetal 
membranes and the cervix. Synchronous activation of the 3 at term marks what has 
been described as “the common pathway of parturition” (41).   
1.5.1 The myometrium 
The reproductive tissue where the conceptus attaches, grows and develops during 
pregnancy is the uterus. The uterus consists of three distinct layers. The outer layer is 
called the perimetrium and the inner layer is called the endometrium. During gestation, 
the endometrium undergoes changes under the influence of the pregnancy-related 
hormones, such as progesterone, to become the decidua (42). The middle muscular 
layer is called the myometrium (42). The myometrium primarily consists of densely 
packed smooth muscle fibres (42). In addition is also has dense vasculature with many 
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blood and lymph vessels as well as connective tissue and immune cells (42). As 
gestation advances, the uterine smooth muscle cells undergo stretch-induced 
hypetrophy (43). The hallmark of myometrial transition to a labouring phenotype is 
initiation of co-ordinated contractions, resulting in the expulsion of the fetus and the 
placenta (44). This transition is termed “activation” (44). 
1.5.2 The fetal membranes 
The fetal membranes are comprised of the chorion and the amnion, the two of them 
being closely adherent (45). The thicker chorion is the exterior layer and mainly 
consists of a dense cellular population (46). The amnion is the thinner and inner-most 
layer and is rich in extracellular matrix formed of collagen fibrils (46). They surround 
the fetus which they manage to retain along with the amniotic fluid (47). 
Constitutively, they protect the fetus by forming a physical protective barrier (48). At 
the same time, they critically contribute to fetal nutrition by secreting nutritious 
substances (48). During parturition, the fetal membranes undergo extensive 
remodelling that leads to their weakening, rupture and finally separation from the fetus 
(49).    
1.5.3 The cervix 
The cervix is a tube-like tissue located between the uterus and the vagina. In the non-
pregnant state, it has an average length of 3-4 cm and it mainly consists of collagen-
rich extracellular matrix with only a minimal cellular component of fibroblasts, smooth 
muscle, epithelial and immune cells (50). It consists of two main areas: the ectocervix 
and the endocervix. The ectocervix is the cervical part protruding into the vagina. Like 
the vagina, it is lined with a non-keratinised stratified squamous epithelium (51). The 
endocervix or the endocervical canal is the tube part of the cervix that connects the 
uterine cavity to the ectocervical opening to the vagina, called the external os. The 
endocervical epithelium is a single layer of mucus-producing columnar cells (51). 
During pregnancy, the mucus produced by the endocervical cells forms the cervical 
plug or operculum (52). This is a physical and functional barrier that contributes to the 
protection of the fetus (53). For parturition to occur, the cervix undergoes effacement 
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and dilatation, which are mainly driven by the mechanical forces exerted by the 
myometrial contractions (54). This allows passage of the fetus through the cervical 
canal (55). 
Activation of one or more of the above-mentioned components of parturition - 
myometrium, fetal membranes, cervix - can lead to spontaneous onset of the 
parturition cascade. Untimely activation can lead to preterm birth.  
 
Figure 1.1 Basic anatomy of the reproductive tissues during pregnancy.  
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1.6 Risk factors  
The pathophysiology of preterm birth is still incompletely understood. This is further 
complicated by the fact that it does not represent a single clinical condition, but rather 
a syndrome. The notion that preterm birth is a syndrome is strongly supported by its 
diverse aetiology, with multiple pathologies involved (56).  
Several factors have been shown to increase the risk for preterm delivery. Among 
them, the most consistent is a previous history of preterm birth which results in a 2.5-
fold increase in the risk of preterm birth in the current pregnancy, the effect being 
stronger in extremely preterm deliveries (57). Moreover, recurrent PTB tends to occur 
around the same time as the previous event (58), with most women delivering within 
a couple of weeks of their first delivery (59). In addition, a large population-based 
study from Sweden found that sisters of women that delivered preterm have a 1.8-fold 
increased odds ratio (OR) of delivering preterm themselves (60). As environmental 
factors might be the reason for this association (61), another population-based study 
adjusted for known environmental risk factors only to find an even higher OR of 4.2 
in siblings of women that gave birth preterm (62). Collectively, these data highlight 
the importance of genetic predisposition as a risk factor for preterm birth. 
PTB tends to occur more often and earlier in gestation in black women (63). Racial 
disparities among population sub-groups have long been observed in the USA (64). A 
study in a low income population consisting of 69% black and 31% white women 
found that the higher incidence of PTB in black compared to white women was quite 
consistent even when controlled for other risk factors and cannot be explained based 
on separate maternal characteristics, such as smoking or alcohol consumption (65). 
Disparities in socioeconomic status are also involved, as substantial socioeconomic 
deprivation can increase the risk of very preterm births by a factor of 2 (66). 
Another factor implicated with preterm birth is the work environment. Although 
employment itself does not increase the risk for preterm delivery (67), long hours and 
physically or mentally demanding jobs are associated with increased risks (67) (68). 
These conditions increase the levels of maternal stress, which is an independent risk 
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factor in itself as it almost doubles the risk for preterm delivery (69). Extremes of these 
psychosocial factors, such as maternal depression have also been associated with PTB 
(70). 
The social factor that has been more firmly associated with preterm delivery is 
smoking. The association was first suggested in 1957 (71) and has since been 
confirmed in different cohorts (72) (73). The effect has been shown to be dose-
dependent and is more strongly associated with very preterm birth (74).  
Despite the fact that the above-mentioned conditions are observed risk factors for 
preterm delivery, there is no robust mechanistic evidence that fully explains the 
associations. Conditions that can predispose to preterm birth and for whom some 
mechanistic insights have been described are discussed right below. 
1.7 Causes of preterm birth 
1.7.1 Uterine overdistention  
An abnormal shape or size of the uterus confers an increased risk for preterm birth. In 
support of the former, patients having uterine malformations such as a bicornuate or 
septate uterus are at increased risk for preterm labour and subsequently preterm birth 
(75). This is also the case for patients with an increase in the size of the gravid uterus 
because of conditions such as polyhydramnios (76) (77) and multifetal pregnancies 
(78). This increase in size leads to overdistention of the uterus with a consequent 
stretching of the myometrium. Mechanistically, a stretching-induced increase in 
myometrial contractility that can predispose to preterm labour has long been described 
(79). In addition, myometrial stretching can induce the release of prostaglandins, 
which are key mediators of the activation of all three components of the parturition 
pathway (80). Stretching has also been shown to induce the mRNA levels of the 
contraction associated proteins Connexin-43 (Cx-43) (81) and Oxytocin Receptor 
(OTR) (82).  
However, uterine overdistention also results in the stretching of fetal membranes. 
Similar to what happens in the myometrium, stretching of amniotic epithelial cells in 
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vitro results in the release of prostaglandin E2 (PGE2) and interleukin-8 (IL-8) (83) 
(84). This indicates that stretching can induce an activation phenotype in the amnion 
that is compatible with membrane rupture.          
1.7.2 Vascularisation disorders 
Bleeding and vascularisation disorders have been linked with an increased risk for 
PTB. Intrauterine bleeding caused by conditions such as placental abruption 
significantly increase the risk for preterm delivery (85). Potential mechanistic insights 
have put the coagulation cascade in the centrepiece of the disease pathophysiology 
(86). In particular, the coagulation factor thrombin has been shown to be able to 
stimulate contractions of rat myometrial tissue both in vivo and ex vivo (86). Poor 
vascularisation can result in abnormal placentation and a consequent placental under-
perfusion (87). This unfavourable environment has been associated with PTB (88). A 
cross-sectional study found that patients delivering early after preterm labour with 
intact membranes exhibited higher rates of spiral arteries’ physiological 
transformation failure both in the myometrium and the decidua compared to normal 
term deliveries (88). In further support of the association between vascularization 
factors imbalance and PTB, it has been reported that a subset of women delivering 
prematurely demonstrate an anti-angiogenic profile in the maternal plasma that is 
apparent about 5 weeks prior to spontaneous onset of labour (89). This profile is 
characterised by both an increase in anti-angiogenic factors as well as an increase in 
factors that promote vascularisation (89). 
1.7.3 Insufficient tolerance to the fetus 
Both the fetus and placenta express tissue-specific maternal and paternal antigens. For 
a successful pregnancy to occur, immune tolerance mechanisms are in place both for 
the maternal (90) and the fetal side (91). These mechanisms induce the production of 
tolerogenic maternal and fetal regulatory T cells and safeguard the pregnancy by 
preventing the gestation equivalents of graft rejection and graft versus host disease 
respectively. Dysregulation of this tolerogenic state with maternal effector T cell 
infiltrations and cytokine secretion in the placenta, as in chronic chorioamnionitis, is 
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often observed especially in late preterm births (92). In addition, increased production 
of fetal antigens as is the case in antenatal fetal interventions significantly increase the 
risk for preterm delivery (93) (94). Potential mechanistic insights from mouse models 
have revealed that this increased production of fetal antigens triggers a breakdown of 
maternal-fetal tolerance, with a subsequent activation of maternal effector T cells (95). 
Even though potential mechanistic insights have been described for the above 
conditions, further studies are necessary in order for a causal relationship between 
them and PTB to be established. To date, the only cause of PTB with a well-established 
causality link and a properly described pathophysiology is an intrauterine infection.  
1.7.4 Cervical disorders 
Given the importance of the functions of the cervix for a healthy pregnancy, it is no 
surprise that cervical disorders could account for a number of pregnancy losses and 
preterm deliveries. Cervical insufficiency is a condition characterized by a painless 
dilation of the cervix in the absence of myometrial contractions that leads to a recurrent 
pregnancy loss during in the second trimester. It is reflective of the incompetence of 
the cervix to retain the uterine content within the uterus. 
Cervical insufficiency can be clinically diagnosed depending on specific cervical 
characteristics. Previous obstetric history of recurrent pregnancy loss after painless 
cervical dilation in the second trimester is indicative of cervical insufficiency. Clinical 
presentation with painless cervical dilation in the second trimester is also suggestive 
of cervical insufficiency. Finally, a short cervix as assessed by transvaginal ultrasound 
is associated with an increased risk for preterm delivery and can be a predictor of 
spontaneous PTB, although not necessarily due to cervical insufficiency (96). 
Congenital diseases such as a hypoplastic cervix (97) or exposure to diethylstilbestrol 
in utero (DES) (98) could result in cervical insufficiency (99). Genetic factors have 
also been implicated in the aetiology of cervical insufficiency (100). In particular, 
specific polymorphisms of the genes collagen 1A1 (COL 1A1) and transforming 
growth factor beta (TGF-β) are associated with cervical insufficiency (101). Both of 
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these genes are involved in diseases characterised by dysregulation of the extracellular 
matrix formation, such as osteoporosis (102) and tumour invasion (103). 
The relationship between an inflammatory state and cervical insufficiency is still 
unclear. A study reported that women with cervical insufficiency had higher levels of 
the proinflammatory cytokine IL-6 in the amniotic fluid compared to controls (104). 
From a genetics perspective, a specific polymorphism in the gene of the anti- 
inflammatory cytokine IL-10 appears to occur more frequently in women with cervical 
insufficiency compared to healthy controls (105). This could imply that variations in 
the inflammatory balance during pregnancy might have a role in the pathogenesis of 
cervical insufficiency. 
1.7.5 Infection/inflammation 
The first suggestion that infection is implicated in the pathogenesis of preterm birth by 
being able to cause membrane rupture and preterm labour was reported almost 70 years 
ago (106). For the next decades the focus was given on extrauterine and often systemic 
infections that could compromise the maternal health and thus predispose to preterm 
birth. Examples of such infections include malaria (107) and pyelonephritis (108), 
pneumonia (109), asymptomatic bacteriuria (110) and more recently periodontal 
disease (111). However, for the last 30 years the attention has been shifted towards an 
infection within the intrauterine tissues. This was driven by the finding that bacteria 
that have invaded the amniotic cavity can induce an inflammatory response in the fetal 
membranes and the choriodecidual space in patients presenting with preterm labour 
(112). Overall, infection is considered to account for a minimum of 25-40% of all 
preterm deliveries, making it the most common cause of preterm birth (113). 
Percentages vary significantly with gestational age. In particular, infection is 
implicated in about 10% of late preterm births. By contrast, the rate exceeds 80% in 
the extremely preterm population (114) (115).  The fact that these are the infants facing 
the greatest risks of neonatal morbidity and mortality showcases the importance of 
infection as a cause of preterm birth. 
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The fact that both intrauterine and extrauterine infections have been associated with 
PTB constitutes one line of support for the suggested causal relationship. Further 
evidence comes from the fact that preterm birth can be induced by administering live 
bacteria or bacterial products in different mouse models such as mice (116), rabbits 
(117) and rhesus macaques (118). This effect can be reversed by the use of antibiotics, 
as has been shown from both animal (119) and human studies (120). In humans 
however it has been shown that the only cases that are likely to benefit from antibiotic 
administration are those with evidence of clinical infection, this being consistent with 
the causation argument (121). In addition, the presence of cytokines such as IL-6 (122) 
and matrix degrading enzymes such as MMP-8 (123) in the amniotic fluid significantly 
increase the risk for PTB. These products are indicative of an inflammatory process 
secondary to an infectious trigger that is usually subclinical in nature (124).   
Mechanism of action 
1.7.5.1.1 Toll-like receptors 
Once the microorganisms invade the reproductive tissues, they first encounter the 
innate immune system. To sense the infection, the immune system uses specialised 
soluble, transmembrane or intracellular proteins that are expressed in immune and 
epithelial cells and are termed Pattern Recognition Receptors (PRRs). These receptors 
can recognise molecular structures that are unique to microbes and shared between 
them. Following ligation of such a structure to its receptor triggers the downstream 
activation of a non-specific immune response that helps clear the infection. Among the 
different families of PRRs, the most well-studied in the female reproductive tract that 
has an active role in the pathophysiology of PTB is the family of Toll-like receptors 
(TLRs). 
To date, ten different TLRs (TLR1-10) have been described in humans and thirteen in 
mice (TLR1-13) (125). TLR1, 2, 4, and 6 are expressed on the cellular membrane and 
they can recognize bacterial structures to mount an inflammatory response. By 
contrast, TLR3, 7, 8 and 9 are intracellular receptors expressed on specialized 
compartments that are mostly involved in antiviral immunity. The biological function 
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of TLR10 is not very well defined.In the human reproductive tissues TLR1, TLR2, 
TLR3, TLR4, TLR5 and TLR6 are expressed both in the lower and the upper 
reproductive tract. In particular, the vagina and the cervix express TLR1, 2, 3, 5 and 6 
(126). The upper reproductive tract is dominated by the expression of TLR2 and TLR4, 
although TLR1, 3, 5 and 6 are also expressed in the endometrium and the fallopian 
tubes (127). During pregnancy, the decidua has been shown to express all TLRs 
throughout the course of gestation (128). TLR2 and TLR4 are also expressed in the 
pregnant myometrium (129) and the fetal membranes (130) and the expression of both 
is significantly increased during labour, indicating a role in the parturition process. 
Important downstream molecules involved in the TLR pathway such as the Myeloid 
differentiation primary response element 88 (MyD88) protein and CD14 are also 
expressed in the reproductive tissues (127) (128).  
Overall, this body of literature suggests that the reproductive tissues during pregnancy 
are able to sense a microbial infection to mount an inflammatory response though the 
TLR family of PRRs, similar to what happens in other tissues. Crucial to this 
suggestion has been the finding that blocking the activity of TLR4 either by TLR4-
specific monoclonal antibodies (131) or by using a receptor antagonist (132) can stop 
preterm birth induced by live bacteria or bacterial products. Similarly, mice that 
express a mutant TLR4 receptor are resistant to PTB induced by the same substances 
(133). This has led to the theory that TLR4 signalling could be targeted as a potential 
a therapeutic strategy for PTB (134). 
Recently, it was reported that in the presence of chorioamnionitis, the most common 
infection preceding preterm birth, there is an increased upregulation of TLR-1 and 
TLR-2 in the amnion, the chorion and the decidua (135). In addition, another study 
found that that TLR-1 is also upregulated in pregnancies complicated by 
chorioamnionitis that eventually deliver prematurely (136).   
Upon ligation of specific microbial or viral molecular structures called PAMPs 
(Pathogen-associated molecular patterns), TLRs undergo conformational changes that 
lead to the recruitment of specialised adaptor molecules. These molecules drive the 
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signalling pathways downstream of TLRs. Four such adaptor molecules have been 
discovered to date: MyD88 (137), TIR- associated protein (TIRAP) (138), TIR-
domain-containing adaptor protein-inducing IFN-β (TRIF) (139) and TRIF-related 
adaptor molecule (TRAM) (140). Ligation of different PAMPs stimulates different 
TLRs leading to recruitment and activation of different adaptor molecules. 
Downstream signalling via MyD88 leads to the transcription of genes encoding 
proinflammatory cytokines whereas signalling through TRIF leads to the transcription 
of genes encoding interferons.  
Most TLRs signal through the adaptor molecule MyD88. This signal, via recruitment 
and activation of the intermediate molecules interleukin-1 receptor-associated kinase 
1 (IRAK1) (141) and IRAK4 (142) and then TNF receptor associated factor 6 
(TRAF6) (143) leads to phosphorylation and nuclear translocation of the transcription 
factor nuclear factor kappa B (NFκB). In addition, these pathway leads to the 
phosphorylation of MAP kinase kinase 6 (MKK6) which then subsequently 
phosphorylates further MAP kinases (144). The endopoint of the cascade is the 
production of inflammatory mediators such as cytokines and chemokines (145). 
1.7.5.1.2 Cytokines and chemokines 
Cytokines and chemokines have been central to the pathophysiology of preterm birth. 
The first cytokine to be associated with the mechanisms of infection-induced preterm 
birth was Interleukin 1 (IL-1). The study found that women in preterm labour with 
intra-amniotic infection had increased IL-1 activity in the amniotic fluid that correlated 
with an increase in prostaglandins E2 and F2a (146). The amnion itself can produce 
prostaglandins in response to IL-1 treatment in a dose-dependent manner (147). 
Another reproductive tissue capable of secreting IL-1 is the decidua (148). In addition, 
IL-1 family and IL-1b in particular has been shown to have the capacity to stimulate 
myometrial contractions during pregnancy in a non-human primate model using rhesus 
monkeys. Furthermore, it increased the production of other proinflammatory cytokines 
and prostaglandins in the amniotic fluid on the rhesus monkeys (149). In mice, a 
subcutaneous injection of IL-1 was used to establish the first mouse model of preterm 
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birth as all mice that were injected delivered prematurely (150). In further support of 
the role of IL-1 in this model, abrogating IL-1 activity by using an IL-1 receptor 
antagonist managed to stop preterm delivery in these mice (151). 
Production and release of IL-1b is done through a distinctively characteristic 
intracellular pathway (152). Initially, following gene transcription mediated by NFκB, 
an inactive precursor of IL-1b is produced, termed pro-IL-1b (153). This is then 
proteolytically cleaved by a protease called caspase-1 to acquire its active form, IL-1b 
(154). The activation of caspase-1 is mediated by a protein complex called the 
inflammasome. The different components that form the inflammasome complex are: 
a sensor molecule, an adaptor molecule called ASC and caspase-1 (155). A wide range 
of sensor molecules has been described to date (156). Most of them contain a NOD-
like receptor sensor, most notably, in the case of bacterial infections, NLRP3 (157). 
ASC then mediates the assembly of several pro-caspase 1 molecules, the self-cleavage 
of which leads to the formation of the active caspase-1 which then connects to NLRP3 
(155). 
The number of cytokines with a role in preterm birth expands beyond the IL-1 family. 
Interleukin-6 (IL-6) was the next cytokine to be associated with infection-induced 
preterm birth. It was found that women presenting with preterm labour that have an 
intra-amniotic infection exhibit significantly higher levels of IL-6 in the amniotic fluid 
(158). Higher IL-6 levels were also observed in women in preterm labour failing to 
respond to tocolytic therapy (158). IL-6 can also be used for detecting women at term 
with microbial invasion of the amniotic cavity (MIAC) as it demonstrates significantly 
increased levels in the amniotic fluid (159) (160).  
Similar were the findings for the proinflammatory chemokine Interleukin-8 (IL-8). 
The levels of IL-8 were found to be higher in the amniotic fluid of women in preterm 
labour with PPROM and positive amniotic fluid cultures (161) (162). 
Such is the case also for Tumor necrosis factor A (TNFα). Its levels were measurable 
in the amniotic fluid of women in preterm labour and with intra-amniotic infection as 
opposed to women without infection who had no detectable TNFα levels even in the 
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presence of preterm labour (163). Also bacterial products can stimulate reproductive 
tissues, such as the decidua to produce TNFα (164) (165).  
Other studies examined a series of proinflammatory cytokines rather individual ones. 
Similar to previously described studies, the levels of both IL-6 and IL-8, as well as the 
inflammatory cytokine Granulocyte-colony stimulating factor (G-CSF) were found to 
be increased in the amniotic fluid of women with intrauterine infection, more so for 
those in preterm labour (166). Another study reported that increased levels of IL-1a, 
IL-1b, IL-6, IL-8 and TNFα in the amniotic fluid were associated with histologic 
chorioamnionitis and the presence of bacteria in the amniotic fluid (167). The same 
study also found that elevated levels of the above cytokines can predict delivery with 
7 days of the measurements as well as delivery before 34 weeks (167). Early onset 
neonatal infection is a significant cause of neonatal morbidity and mortality. 
Responsible pathogens can often be acquired in utero. Infected newborns have 
elevated plasma levels of both IL-6 and TNFα (168). 
A very important finding supporting the concept that infection-induced preterm birth 
is mediated by cytokines came from mice. By using animals lacking both the IL-1 and 
TNF receptor, the group made the observation that these mice had significantly lower 
preterm birth rates compared to their wildtype counterparts after intrauterine 
administration of live Escherichia coli (169). This means that the IL-1 and TNF 
signalling pathways are necessary for E. coli-induced preterm delivery in mice, 
highlighting the importance of these cytokines (169). In addition, in mouse models of 
preterm birth that use bacterial products such as Lipopolysaccharide (LPS) (170) and 
Lipotechoic acid (LTA) (171) as a stimulus, there is significant upregulation of an 
array of cytokines and chemokines in the plasma and the amniotic fluid, notably IL-
1a, IL-6 and TNFα. 
Collectively, these data solidify the essential role of proinflammatory cytokines in 
infection-mediated preterm birth. Crucial for the pathophysiology of preterm 
parturition is the ability of these cytokines to regulate the production of the key 
proteins prostaglandins and matrix metalloproteinases.  
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1.7.5.1.3 Prostaglandins and Matrix metalloproteinases       
Both prostaglandins and matrix metalloproteinases (MMPs) are key to the 
inflammatory response and have a central role in the parturition process. 
Prostaglandins are lipid mediators that exert their actions in a paracrine and autocrine 
fashion. The function of prostaglandins is crucial to parturition as they promote 
myometrial contractility, membrane rupture, cervical dilatation, placental separation 
and finally uterine involution (172). MMPs are proteolytic enzymes that participate in 
extracellular matrix degradation processes. They are particularly involved in the 
remodelling and rupture of the fetal membranes and the remodelling and ripening of 
the cervix during parturition (173). 
An important aspect in the pathophysiology of infection-mediated preterm birth is the 
regulation of prostaglandins by proinflammatory cytokines. Both IL-1 and TNF 
stimulation has been shown to increase the expression of prostaglandins or the main 
prostaglandin synthesising enzyme Cyclooxygenase-2 (COX-2) both ex vivo (174) and 
in vitro (175). Such is the case for other tissues of the upper reproductive tract 
including the decidua (176), the amnion (177) and the chorion (178). Other cytokines, 
such as IL-6 (179) and macrophage inflammatory protein-1 alpha (MIP-1a) (180) in 
the amnion and the decidua and in both membranes respectively.  
As further indication of the link between infection, cytokines and prostaglandins, the 
bacterial product LPS has been shown to signal through the TNFα pathway to stimulate 
PGE2 production by human choriodecidual explants (181). In addition, the expression 
of COX-2 in the amnion depends on the NFκB activation, which is downstream of 
TLR signalling and can also be increased by IL-1b (182). Instead of promoting the 
expression of prostaglandin synthesising exzymes, cytokines such as IL-1b and TNFα 
(183), and bacterial products such as LPS (184) act to enhance prostaglandin activity 
by decreasing the catabolic activity of the enzyme Hydroxyprostaglandin 
dehydrogenase (PGDH) (185).    
The production of the extracellular matrix-degrading enzymes MMPs in the 
reproductive tissues can be stimulated both by cytokines and by prostaglandins. In the 
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upper reproductive tract, TNFα, IL-1b and Macrophage colony-stimulating factor (M-
CSF) can increase the secretion of MMP-9 by first trimester trophoblast cells with a 
subsequent increase in its collagenase activity (186). IL-1a can stimulate chorionic 
cells to produce MMP-1 in vitro (187). In vivo, IL-1b can increase the secretion of 
MMP-9 by the chorion and amnion resulting in increased MMP-9 concentrations in 
the amniotic fluid (188). Prostaglandins such as PGF2a  also increase the expression of 
MMP-2 and MMP-9 in decidual explants ex vivo (189).  
Similar is the effect of infectious agents and live bacteria in the production of MMPs. 
LPS can increase the production of both MMP-2 and MMP-9 by human 
amniochorionic membranes, an effect that can be ameliorated by the anti-
inflammatory cytokine Interleukin-10 (IL-10) (190). In non-human primate model 
using rhesus monkeys, the researchers found that group B streptococci bacterial 
infection of the choriodecidual space results in increased MMP-9 expression and 
activity in the amniotic fluid, an effect almost identical to that of IL-1b (188).  
In the lower reproductive tract, the production of MMPs is also stimulated by 
cytokines. In particular, TNFα has been shown to induce the expression of MMP-1, 
MMP-2 and MMP-9 by cervical smooth muscle cells in vitro (191). There is also a 
correlation between the expression levels of the chemokine IL-8 and those of MMP-8 
and MMP-9 in the lower uterine segment and the cervical stroma that is consistent 
between different studies (192) (193). The same association between IL-8 and MMP-
8 and -9 has also been observed in upper reproductive tissues including the 
myometrium, the decidua and the fetal membranes (194). Furthermore, on top of 
promoting the expression and activity of MMPs, cytokines like TNFα have the 
capacity to suppress the production of the MMP inhibitors called tissue inhibitors of 
metalloproteinases (TIMPs) (195).  
To summarise this section, current evidence describes a well-defined pathophysiology 
of how intrauterine infection can lead to preterm birth. Upon recognition of the 
microorganism by TLRs, an inflammatory process orchestrated by NFκB is initiated. 
This leads to a secretion of cytokines and chemokines by the reproductive tissues 
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involved, which in turn stimulate the production of prostaglandins and MMPs. The 
latter can then activate all three components of the parturition process, the onset of 
which can thus be dictated by the intrauterine infection.  
 
Figure 1.2 Proposed pathway leading from bacterial uterine colonization to 
preterm delivery. Adapted from (113). 
 
Routes of infection and pathogens  
Several hypotheses have been postulated regarding the route leading to an intrauterine 
infection. Potential routes include the following: i) Ascending infection from the 
vagina and through the cervix. ii) Haematogenous dissemination through the placenta. 
iii) Accidental introduction during invasive medical procedures such as amniocentesis 
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and chorionic villous sampling that could penetrate the reproductive tissues. iv) By 
retrograde spread from the abdominal cavity and through the fallopian tubes (113). 
 
Figure 1.3 Most common routes of intrauterine infection. Adapted from (196). 
 
Among the microorganisms that have been associated with preterm delivery are the 
following: Ureaplasma species (197) (198), Gardnerella vaginalis (199) (198), 
Mycoplasma hominis (197) (199), Bacteroides species (199) and Fusobacterium 
species (197). What these bacteria have in common is that they are of vaginal origin 
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and that most of them belong to the genital mycoplasma species. Much rarer is the case 
for bacteria that are commonly implicated in genital tract infections in non-pregnant 
women, such as Chlamydia trachomatis and Trichomonas vaginalis (160). The 
presence of non-genital bacteria has been reported but it is quite rare (200).  This means 
that the microorganisms most frequently isolated from the amniotic cavity of women 
that deliver preterm are of vaginal origin. This suggests the most common route of 
intrauterine infection is the ascending vaginal infection through the cervix. This 
concept is supported by a clinical study which found that microbial invasion of the 
amniotic cavity (MIAC) precedes the invasion of the chorioamniotic membranes in 
most cases of chorioamnionitis (201). The only route of infection consistent with this 
finding is the ascending infection through the cervix.  
Among the bacteria that have been associated with preterm delivery the most common 
ones belong to the Ureaplasma species (198) (202). They are also the bacteria most 
commonly isolated from the amniotic fluid of women with chorioamnionitis (203) and 
of women with chorioamnionits and preterm birth (204).  
1.8 The Ureaplasma species 
The Ureaplasma spp were first discovered in 1954 as a potential causative agent of 
non-gonococcal urethritis in males (205). They do not have a cell wall and thus cannot 
be stained by the Gram staining. Instead, they are surrounded by a plasma membrane 
and can therefore acquire a wide range of shapes and structures. This results in 
significant size variations (100 nm to 1 µm) even between Ureaplasmas of the same 
colony (206). This ranks them among the smallest microorganisms. The colonies 
themselves can range in size from 5 to 20 µm. An important distinguishing figure of 
Ureaplasmas is the fact that they produce a urease enzyme. This enzyme catalyses the 
hydrolysis of urea, in a reaction that allows the bacteria to produce virtually all of its 
energy requirements (207). 
There are two species of the human Ureaplasmas: Ureaplasma urealyticum and 
Ureaplasma parvum (208). Fourteen (14) strains or serovars have been recognised to 
date. Serovars 1, 3, 6 and 14 belong to U. parvum and the rest to U. urealyticum (208). 
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U. parvum is smaller than U. urealyticum (209) and they also have differences in their 
urease genes (210) as well as their main pathogenicity factor, the multiple-banded 
antigen (MBA) (211) (212).  
The potential of Ureaplasmas to adhere to mammalian cells has been described. 
Specifically, they have been shown to adhere to human erythrocytes (213) and 
epithelial cells (214). In addition, their ability to adhere to and stimulate placental 
endothelial cells has also been reported (215). However, little is known about the 
mechanisms utilised by the Ureplasma spp to facilitate this. Cell surface receptors 
terminating in sialic acid have been implicated in these mechanisms, since a marked 
reduction in bacterial adherence to HeLa cells and erythrocytes was noticed following 
pre-treatment with neuraminidase (214). 
With regards to cellular responses to Ureaplasma infection, mechanistic studies have 
provided insights towards stimulation of different pathways. In placental endothelial 
cells, Ureaplasmas can induce a stress response characterised by reduced expression 
of heat shock protein 70 (215). This renders host cells more susceptible to apoptosis 
and is mechanism commonly utilised by different bacteria (216) (217). They can also 
cause a significant significantly increase the levels of intracellular calcium and iron, 
in line with a stress response (215). Furthermore, in vitro studies have demonstrated 
the potential of Ureaplasma spp to induce apoptosis in human type II lung epithelial 
cells and macrophages (218). Both U. parvum and U. urealyticum can also deploy 
immune evasion mechanisms by downregulating the gene expression of antimicrobial 
peptides such as DEFB1, DEFA5, DEFA6 and CAMP in human THP-1 cells (219). 
The major virulence peptide of Ureaplasma spp is called Multiple-Banded Antigen 
(MBA) (220). This is a factor that can only be found in this species (221) and 
constitutes a potent cytokine inducer (222). It is thought to exert its actions by 
stimulating the toll-like receptors -1, -2, -6 and -9 (223) (224) (225). In addition, 
specific U. parvum (Serovar 3) and U. urealyticum (Serovars 4, 8) serovars express 
the enzymes Phospholipase A1, A2 and C (226) (227). These can cause phospholipid 
degradation by hydrolysing acyl ester and phosphodiester bonds respectively (228). 
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This has the potential to destabilise the cellular membrane leading to a reduced cell 
viability (228). 
Ureaplasmas are thought to be commensals of the lower reproductive tract in women. 
In support of this, they can quite often be found in the lower reproductive tract of 
sexually active women. The percentage has been shown to range between 40% (229) 
and 80% (230).  The more common of the two is U. parvum (231). Further evidence 
comes from the report that women presenting with symptoms of lower genital tract 
infections have similar colonization rates of Ureaplasma spp with women of the 
control group with no infection (231). However, this is not always the case as 
Ureaplasmas have been shown to be able to cause infections of the female 
reproductive system. In particular, there are reports associating them with infection of 
both the vagina (232) and the cervix (233), as well as urinary tract infections (234) 
(235) and bacterial vaginosis (236). What determines why this happens in some 
women and not in others has not been elucidated yet.  
Importantly, the presence of Ureaplasmas in the lower reproductive tract has been 
recognized as a potential risk factor for adverse pregnancy outcomes including preterm 
delivery. Vaginal colonization with U. parvum was found to be an independent risk 
factor for preterm birth or late abortion with an OR of 3 (237). The same study 
examined other genital Mycoplasmas but none of them was associated with the above 
outcomes (237). Although not in the same study, U. urealyticum has also been 
described as a risk factor for preterm delivery (238). Similar to the vagina, colonization 
of the endocervix with the Ureaplasma spp was also associated with preterm delivery 
in women presenting with preterm labour and intact membranes (239). As further 
support of this association, a quantitative approach has been also studied. The study 
found that women that had increased titres of U. urealyticum in the vagina were at 
increased risk of preterm birth (240). This was not the case for women colonized with 
low titres (240). Despite being a strong candidate as a risk factor for PTB, lower 
reproductive tract colonization with Ureaplasma spp cannot actually predict PTB 
(241). The reason for this is the high proportion of women than deliver normally at 
term despite having their vagina or cervix colonized with Ureaplasmas (242).  
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Despite normally colonizing the female lower reproductive tract, the Ureaplasma spp 
have also the potential to ascend to the upper reproductive tract as they have also been 
found in tissues such as the endometrium and the fallopian tubes (243) (244). In most 
cases they are not causing any inflammation, however they possess the capacity to 
cause an infection, which is more often subclinical in nature (245). 
Quite crucial to the association between Ureaplasma spp and PTB is the fact that these 
bacteria are also considered to be causing chorioamnionitis, the infection implicated 
to 40-70% of all preterm births (246). The first study that described the potential link 
was back in 1975 and used culture methods on swabs from the infants’ ears, throat, 
umbilicus, external genitalia and the perineum. They found a significant association 
between fetal colonization with Ureaplasma spp and histological lesions in the 
placenta that were consistent with chorioamnionitis (247). Later, the presence of 
Ureaplasma spp in the fetal serum and the fetal cerebrospinal fluid were also 
associated with chorioamnionitis (248). Their isolation in these compartments could 
potentially imply a role in cases of intraventricular haemorrhage as well. The results 
are also similar when examining the presence of Ureaplasmas in the cord blood, as an 
association with chorioamnionitis, PROM and earlier gestation has been noticed (249). 
Most studies that have addressed this question have chosen to examine the presence of 
Ureaplasma spp either in the amniotic fluid or the placenta. High titres of Ureaplasma 
spp in the amniotic fluid have been found to be associated with higher incidence of 
both intra-amniotic inflammation (250) and histological chorioamnionitis (251). 
Consistent with the findings in the other tissues and body fluids, placental colonization 
with Ureaplasma spp is associated with histological chorioamnionitis and low birth 
weight (252). This has been described in different gestational ages. The presence of 
Ureaplasma spp was found to increase the risk for histologically confirmed 
chorioamnionitis and intra-amniotic inflammation in moderate and late preterm births 
(253). This is also the case for extremely preterm deliveries (254). In these instances, 
chorioamnionitis is also increased risk of intraventricular haemorrhage and subsequent 
brain lesions (254) as well as chronic lung disease (255). 
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From a pathophysiological perspective, studies in animal models have shown that 
Ureaplasmas can stimulate the mechanistic pathways that are implicated in 
infection/inflammation-induced preterm birth. Specifically, intrauterine infection with 
U. urealyticum has been shown to increase the protein expression of TLR2 and the 
important TLR co-factor CD14 (256), which is also found upregulated in the amniotic 
fluid of women infected with Ureaplasma spp (257). In a sheep model of intra-
amniotic infection, administration of U. parvum can mount an inflammatory response 
that is characterised by increased expression of the proinflammatory cytokines IL-1b, 
IL-6 and IL-8 in the chorion and the amnion (258) as well as the fetal lung (259).  
Studies in non-human primates further are also consistent with the above findings. IL-
6 and IL-8 were increased in the amniotic fluid and the fetal lung of pregnant baboons 
2-3 days post-intra-amniotic inoculation with U. urealyticum (260). After 
administration of U. parvum to rhesus monkeys, a mild inflammatory response is 
observed with upregulation of TNFα, CXCL-8 and CCL-8 (261). In another study on 
non-human primates, intra-amniotic administration of U. parvum to pregnant rhesus 
monkeys was found to elicit an inflammatory response that resulted in a significant 
increase of IL-1a, IL-1b, IL-6, IL-8 and TNFα in the amniotic fluid after 2-3 days 
(262). This study also reported increased amniotic fluid levels of the prostaglandins E2 
and F2a and increased activity of MMP-9 (262). These resulted in increased uterine 
contractions as measured by the intrauterine pressure changes and ultimately led to 
preterm delivery (262).   
Overall, these data highlight the importance of Ureaplasma spp as microorganisms 
commonly associated with preterm delivery. This is in large due to their role as 
causative agents of chorioamnionitis, the most common antecedent of preterm birth. 
Furthermore, the Ureaplasma-induced pathophysiology during pregnancy is 
compatible with the mechanisms involved in inflammation-induced PTB. Therefore, 
the Ureaplasma spp are clinically relevant bacteria for preterm birth.       
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1.9 The role of the cervix 
As discussed before, the cervix constitutes one of the three components of the 
parturition process. However, its role during pregnancy extends well beyond 
parturition itself.  
1.9.1 The cervix during pregnancy 
During the course of gestation, the cervix remains closed and firm in order to support 
and keep the conceptus within the uterus. At the same time, it undergoes progressive 
remodelling that ultimately leads to parturition related changes, effacement and 
dilatation. 
Remodelling of the cervix is divided into four phases. These phases overlap with one 
another and are termed softening, ripening, dilation and postpartum repair. Cervical 
softening is a long procedure that spans across the whole of gestation and is 
characterised by a progressive increase in tissue distensibility that can be clinically 
assessed in the first trimester of pregnancy. The main feature of cervical softening is 
the change in the structure of collagen, the most abundant protein of the cervical 
extracellular matrix. This is characterised by a decrease in the formation of cross-links 
between collagen fibres (263). An important reason for this is the decrease in the 
expression of the key enzymes thrombospondin 2 and tenascin C, which are involved 
in the cross-link formation (264). The end result is a gradual increase in collagen 
solubility and a subsequent loss in tensile tissue strength in the absence of an increase 
in tissue hydration. 
In contrast with the long and progressive nature of cervical softening, ripening and 
dilation occur very rapidly at the end of pregnancy. They thus overlap to a great extent 
as the ripening process allows maximum compliance of the cervical tissue, something 
that facilitates dilation to allow the fetus to pass through. This maximum compliance 
is achieved by an increase in the diameter of the collagen fibres and their in-between 
spacing (265). 
 Cervical epithelial damage and preterm birth 
Literature review 55 
Finally, timely recovery of the cervix postpartum is essential to maintain protection 
from potential environmental threats. The tissue repair process initiated results in 
increased cross-linking of collagen fibrils to promote return of the cervix to the pre-
pregnancy state (266).  
1.9.2 Barrier function against infection 
By being located between the uterus and the vagina, the cervix is what separates the 
uterine content from the bacteria-rich vaginal environment. To exert its role in 
safeguarding pregnancy, the cervix forms both a physical and a functional barrier 
against infections that could potentially be detrimental to pregnancy by leading to 
preterm birth and other complications. Central to these, is the role of the cervical 
epithelium.  
Physical barrier 
The cervical epithelium is divided into two parts: the columnar endocervical and the 
stratified squamous ectocervical epithelium. The physical part of the barrier to 
infections is achieved by a precise regulation of the expression of specific proteins that 
participate in inter- and intra-cellular adhesions. Among these proteins are tight 
junction proteins, adherens junction proteins and desmosomes (267) (268). In 
particular, the mouse cervix expresses the tight junction proteins claudin 1 and claudin 
2. During pregnancy, the expression of the tight junction protein claudin 1 in the mouse 
cervical epithelium progressively increases (269). At the same time, the expression of 
claudin 2 decreases in a similar fashion (269). This phenotype is characterised by a 
much more efficient barrier function with increased tightness between the adjacent 
cells (270). Loss of claudin function has been shown to compromise the epithelial 
barrier (271).  
Other junction proteins expressed in the cervix include occludin (272) (273), zona 
occludens (274) and junctional adhesion molecule-A (JAM-A) (275). Specific 
microRNAs that target the expression of these proteins can be expressed during 
pregnancy (276) (277). Importantly, a study on cervical smears found that women that 
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went on to deliver preterm had an increased expression of miR-43 and miR-45 earlier 
during gestation (278). These microRNAs target JAM-A and could thus compromise 
the epithelial barrier function of the cervix to increase susceptibility to PTB (279). It 
has also been found that inappropriate differentiation of the cervical epithelial cells of 
the mouse results in loss of the barrier function and increased preterm birth rates after 
vaginal administration of E.coli (280). 
Functional barrier 
The epithelium also plays a major part in the functional barrier of the cervix during 
pregnancy. Cervical epithelial cells can sense a bacterial infection, as they have been 
shown to express TLRs, in particular TLR2 and TLR4 (281). They can also secrete 
proinflammatory cytokines and chemokines to stimulate the immune response (282). 
In addition, the epithelial cells participate in the effector mechanisms of innate 
immunity by secreting antimicrobial peptides. In particular, they can secrete Secretory 
Leukocyte Protease Inhibitor (SLPI) (283), Elafin (284) (283), and LL-37 (285). A 
study in mice reported that the expression of TLRs and the expression and function of 
antimicrobial peptides can be diminished by a viral infection (286). This could lead to 
a disruption of the functional arm of the cervical barrier function and increase 
susceptibility to infection-induced preterm birth. Overall, these data suggest that 
cervical epithelial cells have an important role in the innate immunity of the cervix and 
therefore the whole pregnancy.  
Cervical mucus and plug 
Cervical epithelial cells also have a pivotal role on the formation of the mucosal barrier 
of the cervix by secreting significant amounts of mucus. During pregnancy, the 
epithelial cells secrete a much thicker mucus that forms a plug. This thick layer of 
mucus ends up filling the cervical canal and sealing off the uterine cavity. Thus, 
another important layer of physical protection is added by the cervix during pregnancy.  
In addition, the mucus plug has some unique immunological properties that are crucial 
to the functional barrier function of the cervix during pregnancy. Innate immune 
mechanisms are in place in the cervical mucus plug. Various antimicrobial factors can 
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be found into the mucus including SLPI, lysozyme, calprotectrin, lactoferrin and 
human β-defensin 1 (HBD-1) (287) (288). Furthermore, the proinflammatory 
cytokines IL-1b, IL-6, IL-8 and TNFα have been found to be present in the cervical 
mucus (289) (290). Levels of proinflammatory cytokines like IL-18 in the mucus plug 
are not associated with the levels in the amniotic fluid (291). This is indicative of the 
fact that the cervix is a separate compartment that has to respond to infectious 
challenges distinctively. Among these cytokines, IL-6 in particular has shown 
potential as a biomarker for pregnancy complications. Increased levels of IL-6 on 
cervical secretions are associated with chorioamnionitis. In addition, they have been 
associated with PPROM (292). Finally, several studies have found an association 
between IL-6 and preterm delivery (292) (293) (294). As its levels are only moderately 
predictive of preterm birth, it has limited use as biomarker (295). However, this is still 
reflective of the role of the cervix as an immunological barrier to infection.  
Factors of the highly-specialized adaptive immune response are also present in the 
mucus plug. The immunoglobulins IgA, IgG and IgM can be found in abundance 
within the mucus plug (296). This is a specific adaptation to pregnancy as the levels 
of IgA and IgG are actually much higher in the mucus plug compared to the mucus 
from non-pregnant women (296). Also, the IgA levels in the cervical mucus plug are 
much higher than their respective serum levels in pregnant women (297).  
These antimicrobial properties of the mucus plug have been proven in vitro. Cervical 
mucus plugs from healthy pregnant women can completely inhibit the growth of 
bacteria such as Staphylococcus saprophyticus, E.coli, Pseudomonas aeruginosa and 
Group B Streptococcus (298).    
1.9.3 Cervical epithelial injury 
Iatrogenic cervical injury has also been associated with preterm birth and as a potential 
cause of cervical insufficiency. Procedures that damage the cervix are commonly 
performed for the treatment of cervical intraepithelial neoplasia. This is a pre-
cancerous state of the cervical epithelium that in some cases evolves into invasive 
cervical cancer. Excisional procedures like cold knife conisation, laser conisation and 
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large loop excision of the transformation zone (LLETZ) (also termed loop 
electrosurgical excision procedure-LEEP) are used to remove the lesions once the 
diagnosis is confirmed (299). 
All excisional procedures have been consistently associated with a subsequent preterm 
delivery. Laser conisation and LLETZ were reported to increase the risk for PPROM 
in a retrospective cohort study from a colposcopy clinic in New Zealand by 2.7- (95% 
CI, 1.3-5.6) and 1.9-fold (95% CI, 1.0-3.8) respectively (300). A population based 
cohort study from Norway found that cervical conisation treatments  had a relative risk 
of 4.4 for extremely preterm delivery, a risk of 3.4 for very preterm delivery and a risk 
of 2.5 for late preterm delivery (301). A smaller but still significant risk of preterm 
birth after conisation treatments was also reported in a cohort study from England, 
where the relative risk was 1.19 (95%CI, 1.01-1.41)  Similar were the findings for 
LLETZ from another population based cohort study from Denmark, which identified 
a relative risk of 2.07 (95% CI, 1.88-2.27) among women that were treated with the 
procedure (302).   
Secondary analyses that took place confirmed the above findings. A secondary 
analysis on pregnant women participating in multicentre studies and randomized for 
treatment interventions in London found an increased risk for preterm delivery both 
before and after 34 weeks gestation in women previously treated with LLETZ (303). 
The relative risk was 2.71 (95% CI, 1.63-4.52) (303). A systematic review and meta-
analysis found that both cold knife conisation and LLETZ are significantly associated 
with a subsequent preterm birth (304). The relative risks were 2.59 (95% CI, 1.80-
3.70) and 1.70 (95% CI, 1.24-2.35) respectively (304). These findings were in 
agreement with a later systematic review and meta-analysis that reported an increased 
risk of preterm delivery in women previously treated with excisional procedures 
compared to the control group (RR 1.96, 95% CI 1.46-2.64) (305). 
What these procedures have in common is the fact that they remove a part of the 
epithelium along with the underlying stroma. As described earlier, the importance of 
the cervical epithelium in the barrier function of the cervix against infection is 
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paramount. However, no satisfactory explanation has been provided for the association 
between excisional procedures and preterm birth. 
1.10 Animal models of Preterm Birth 
Despite the growing body of literature that provides new insights into the 
pathophysiology of preterm birth, the incidence of the syndrome has not changed 
substantially over the past decades. This may reflect the fact that our current 
understanding of the mechanisms implicated in preterm birth is incomplete. Due to a 
series of ethical and practical restrictions, mechanistic studies in humans are difficult.  
From an ethical perspective, human samples cannot be collected at predefined time 
points to ensure optimal experimental design. Also, experiments can only be 
performed ex vivo or in vitro, making it hard to link any intervention with the 
pregnancy outcome. Practical restrictions include the limited number of human tissues 
that can be readily available for research purposes. With the exception of the placenta 
and the fetal membranes, the other reproductive and fetal tissues cannot be collected 
as a whole from humans. More tissues become available in the case of caesarean 
sections, but still not as a whole.  For example, decidual samples are usually collected 
only from the superficial layers and myometrial samples are usually collected from the 
upper flap of the lower transverse incision through the uterine wall (306). This makes 
the effort to extrapolate the findings very difficult. Overall, these limitations have 
necessitated the use of animal models for an in-depth study of the preterm birth 
pathophysiology. Different species have been used in preterm birth research and, 
despite their limitations, each has significantly contributed to our current 
understanding. 
1.10.1 Sheep 
Historically, sheep has been the first animal model to contribute to the basic 
understanding of the mechanisms of parturition. The size of sheep is closer to humans 
compared with most other animal models. Importantly, the fetal weight of the sheep at 
birth is very similar to the fetal weight of humans (307). Such is also the size of the 
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litter as the sheep usually have 1-2 fetuses per pregnancy. The gestational length at an 
average of 147 days is also closer to the human average of 280 days than any other 
model that has been studies, with the exception of non-human primates (308). The 
development of surgical techniques that enabled catheterization of intrauterine 
compartments was crucial for the widespread use of this model (308). 
The use of sheep has been pivotal for the current understanding of the endocrinology 
of parturition. The studies that identified the role of the fetal Hypothalamus-Pituitary-
Adrenal (HPA) axis were first conducted in sheep. In particular, it was first reported 
50 years ago that a continuous and prolonged administration of Adrenocorticotropic 
hormone (ACTH) to fetal lambs mid- to late- gestation induces preterm delivery within 
one week (309). Administration of cortisol to the fetus yielded similar results (309). 
The same group also found that glucocorticoids administered to the fetus can induce 
preterm birth in sheep (310). 
From the maternal side, it was found in sheep that a single administration of estradiol 
benzoate induces delivery within 48 hours (311). Studies in sheep also helped establish 
the role of prostaglandin F2a as a potential agent to stimulate myometrial contractions 
(312). This prostaglandin was also shown to be able to induce preterm birth, albeit at 
lower rates compared to glucocorticoids such as flumethasone (FLU) (313). An 
increased in the levels of prostaglandin F2a is achieved by a shift in the hormonal 
balance with towards a decrease in progesterone activity with a concurrent increase in 
estradiol levels, which initiates labour (314). When continuously administered 
prostaglandin E2 can cause preterm birth in sheep as well, by activating the fetal HPA 
axis (315). Collectively, these data were crucial helped to clarify the series of hormonal 
events leading to the onset of labour. Briefly, increased ACTH secretion from a mature 
fetal HPA axis stimulates corticosteroid secretion from the fetal adrenal gland. The 
increased cortisol secretion, along with promoting maturation of the fetal lung it 
stimulates the placental conversion of progesterone to estrogen. This increases the 
levels of prostaglandins in the process of a pro-labour phenotype acquisition (316). 
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When studying the mechanisms of infection-mediated preterm birth, the sheep model 
has also been valuable. The big gestational length allows for samples to be collected 
at various time points and it also potentiates the study of the effect of chronic exposure 
to infectious stimuli. However, creating a sheep model of infection-induce preterm 
birth has been very challenging. Intravenous infusion of LPS derived from Salmonella 
typhimurium can has been shown to cause birth within 28 hours (317). Still, this model 
does not satisfactorily recapitulate the most clinically relevant case of intrauterine 
infection. Intra-amniotic administration of E. coli-derived LPS has also been reported 
to induce preterm delivery, in this case within 72 hours (318). Yet, this is not the case 
in most studies that have been performed so far. In fact, despite the initiation of a 
potent inflammatory response at the gestational tissues, preterm birth was not achieved 
after administration of either intra-amniotic (319) (320) or extra-amniotic LPS (319) 
(321) or live U. parvum (322).    
On the positive side, this allows for the study of the effects of infectious agents to the 
fetus to be examined in utero and at different time points, since preterm delivery does 
not occur. However, the very fact that bacterial products and live bacteria cannot 
consistently induce preterm birth restricts the use of sheep as a clinically relevant 
model to study infection-mediated preterm delivery. In addition, the sheep’s immune 
system is not very well characterised and there is a shortage of available molecular 
tools to develop proper mechanistic studies (308). Lastly, practical reasons such as the 
requirement for large landholdings and specialized storage facilities further limits the 
use of this model.       
1.10.2 Non-human primates 
The species more closely related to humans, is the nonhuman primates. Pregnancy in 
this species resembles human pregnancy much closer compared to sheep or rodents 
(323). The gestational length of around 170 days which is longer than any other PTB 
model and the singleton pregnancies which are usually the case, are two features of 
the species alignment (324). They also possess a unicornuate uterus like humans (323). 
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As in sheep, the biotechnology tools necessary for catheterisation of the intrauterine 
compartments have been fully developed (325) (326) (118). 
Nonhuman primates have been an invaluable model for the in vivo study of uterine 
electrophysiology during pregnancy. It was first found that cynomolgus monkeys have 
synchronous uterine contractions at the third trimester that could resemble those 
observed in humans (327). Based on this knowledge of the uterine contraction 
pathways, potential tocolytic drugs have been tested in nonhuman primates. As in 
humans, oxytocin induces preterm labour in cynomolgus monkeys (328). The oxytocin 
receptor antagonists Barusiban and Atosiban are highly efficient in reducing oxytocin-
induced uterine contractions and can delay the onset of labour and therefore prolong 
the pregnancy (328). However, they were ineffective in stopping normal labour (329). 
The pathways of infection-induced preterm birth have also been studied in non-human 
primates. The first model was described in the rhesus monkeys where an intra-amniotic 
administration of live Group B Streptococci resulted in significant increases in the 
levels of the proinflammatory cytokines TNFα, IL-1a and IL-6 in the amniotic fluid 
(330). This was then followed by an increase in the levels of prostaglandins E2 and F2a 
which resulted in an increase in myometrial contractility (330). The end result was 
delivery within 28 hours of the inoculation (330). The same research group then took 
this model one step closer to recapitulating the more clinically relevant scenario of 
ascending infection by administering the Group B Streptococci in the choriodecidual 
space instead (331). This resulted in intra-amniotic inflammation with the same 
features that were described before (331). When high bacterial doses were 
administered, this was followed by microbial invasion of the amniotic fluid and an 
even more robust inflammatory response that led to preterm labour (331). In a 
following study, the administration of the antibiotic ambicillin could not reverse the 
intra-amniotic proinflammatory phenotype induced by Group B Streptococci despite 
eradicating the infection (332). This is in line with observations in humans rendering 
the antibiotics incapable of delaying preterm birth. However, when they targeted the 
inflammatory response by using the COX inhibitor indomethacin plus dexamethasone 
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at the same time as targeting the bacteria by ampicillin, they managed to delay the 
onset of labour (332). 
The same series of events can also be induced by the cytokines IL-1b and TNFα (333) 
(334). On the other hand, IL-6 and IL-8 could not stimulate the same pathway, 
indicating that they most likely have a bystander role in triggering inflammation-
mediated preterm birth (334). Similar to the live bacterial infection, the IL-1b-
mediated uterine contractions could be prevented by pre-treatment with indomethacin. 
This further confirms the validity of the perceived pathway of infection-associated 
preterm delivery in this model (335).  
LPS administered intra-amniotically can also induce the cytokine and prostaglandin 
milieu that has been associated with preterm birth in rhesus monkeys (336). This effect 
has been shown to be alleviated by the use of a TLR-4 antagonist, indicating the central 
role of TLRs in this process (336).  
Overall, nonhuman primates have some outstanding features that make them suitable 
for investigating preterm birth mechanisms. On top of anatomical resemblance and the 
common pregnancy characteristics with humans, they also appear to share the same 
pathophysiological pathways that lead to infection-mediated preterm birth. However, 
their use in parturition research has been limited. The main reason is the high financial 
costs associated with their research use, as they require specialized facilities and care. 
In addition, they sometimes exhibit aggressive behaviour and can thus only be handled 
by specialized personnel. This results in only a few selected centres worldwide being 
able to meet the above requirements. Consequently, the vast majority of researchers 
has focused on the use of the much more pragmatic alternative of rodent models.    
1.10.3 Rodents  
Despite their drawbacks as a model, rodents are overall the most extensively used 
species in parturition research. These drawbacks include massive anatomical 
differences such as the size difference and the presence of a bicornuate uterus (337). 
Their very small size in particular is a huge barrier in trying to study individual 
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intrauterine compartments as can be done in sheep and nonhuman primates. This is 
further intensified by the much bigger litter size compared to humans. The size varies 
depending on the strain and can range from 7 to 20 pups per dam (338). In addition, 
different mouse strains can respond differently to the same stimuli, something that 
makes the attempt to extrapolate relatively hard even for the same species. Also, the 
very short gestational length of approximately 20 days is both very far from the human 
length and does not allow for the study of chronic conditions and effects in a rigorous 
manner (306). Nevertheless, the very short rodent gestation can also pose a significant 
advantage as it allows for a much bigger number of experiments to be conducted within 
the timeframe. It also allows for quicker acquisition of sufficient numbers to ensure 
validity of the results obtained.  
Perhaps the most substantial difference between the rodent and human parturition 
relates to its hormonal regulation. In rodents, the main source of progesterone during 
pregnancy is the corpus luteum (339), whereas in humans the placenta takes over from 
the corpus luteum at around 8 to 10 weeks of gestation (340). Importantly, a systemic 
progesterone withdrawal precedes and is necessary for the onset of term parturition in 
rodents (341). In humans, progesterone levels do not drop at the end of pregnancy and 
rather a functional withdrawal of progesterone has been described (342) (343). 
However, in infection-induced preterm birth using E. coli in mice, progesterone 
withdrawal is not necessary for preterm delivery to occur (344). Furthermore, 
exogenous progesterone supplementation cannot rescue preterm delivery induced by 
either bacterial products (345) or live bacteria (344). Thus, the fundamental difference 
of absolute versus functional progesterone withdrawal appears to be less relevant in 
the context of infection-mediated preterm birth.  
Rats 
The use of rodent models and especially mice has been particularly important on the 
field of infection-related preterm birth. Rats have been useful for establishing the role 
of prostaglandins in labour processes as it was first found in a rat model that the 
administration of prostaglandin F2a can stimulate myometrial contractions in vivo 
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(346). The main disadvantage of the use of rats is the absence of a consistent model of 
infection/inflammation-induced preterm birth. There are reports that both systemic, 
after intraperitoneal injection (347), and intrauterine, after catheterisation (348), 
administration of LPS can significantly shorten the timing of delivery. However, other 
studies either reported much lower preterm birth rates (349) or even failure to induce 
preterm birth at all (350). In line with these findings, intrauterine administration of live 
E. coli bacteria also failed to cause preterm delivery in rats (351). Therefore, the use 
of the much more consistent mouse models of preterm birth has been widely adopted. 
Mice 
In this context, mice have the significant advantage of having a well-studied immune 
system that is very similar to the human (323). The mouse immune system can be 
genetically manipulated, something that offers the ability to dissect specific pathways 
involved in the parturition mechanisms (323). For example, it was found that mice 
lacking the prostaglandin F2a receptor cannot go into labour, highlighting the 
importance of this mediator for the parturition process (352). These findings were also 
confirmed by knocking out the prostaglandin synthase COX-1, which accounts for 
much of PGF2a production (353) (354). The COX-1 deficient mice exhibited delayed 
parturition (353). Studies in KO mice helped elucidating mechanisms involved in the 
hormonal and biochemical events that stimulate labour. For instance, KO of the 
cannabinoid receptor 1 (CB1) disrupts the progesterone/estrogen balance leading to a 
pro-labour phenotype that results in preterm birth (355). Also, a K+ channel with an 
important function in parturition was identified (small conductance calcium activated 
K+ channel isoform 3) in by genetic manipulation. Mice overexpressing this channel 
demonstrated failed parturition (356) and were also resistant to preterm birth induction 
by LPS and mifepristone (RU486) (357), suggesting its down-regulation is necessary 
for labour to occur. Finally, chemical ablation of the myometrial gap junction Cx-43 
resulted in pregnancy prolongation, indicating the crucial role of this protein for the 
parturition process (358). 
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Mouse KO models were also crucial for studying the mechanisms underlying 
infection/inflammation-induced preterm birth. KO of the TLR signalling downstream 
adaptor molecule MyD88 protected mice from preterm delivery caused by intrauterine 
injection of E.coli, while their wildtype (WT) delivered prematurely (359). This 
finding suggested that PTB induced by E.coli or its products depends upon TLR 
signalling. This was not the case for the IL-1b receptor, as mice deficient in it were 
vulnerable to preterm labour induction by an intrauterine E. coli administration (360). 
Such a finding is likely to reflect the redundancy of the cytokine network in 
intrauterine infection. 
Specific pathways through which the inflammatory response secondary to bacterial 
infection could stimulate myometrial contractions were identified using mouse KO 
models. The phosphodiesterase PDE4 is involved in regulation of inflammation and 
smooth muscle contractility and the inhibition of its action in mice prevents LPS-
induced preterm labour (361). Furthermore, inhibition of the Rho/Rho-kinase pathway 
which is involved in myometrial contractions also managed to stop preterm LPS-
stimulated preterm delivery (362). Both of these finding support a role for the 
respective pathway in the pathophysiology of infection-mediated preterm birth and 
suggest potential therapeutic targets. 
1.10.3.1.1 Mouse models of infection/inflammation-induced preterm birth 
These many advantages that the mouse has as a model led many groups to the effort 
of creating mouse models of preterm birth. The first one was described back in 1991 
and involved the subcutaneous administration of IL-1b which resulted in preterm 
delivery in all treated mice (116). Since then, different bacteria and bacterial products 
have been utilised. The use of LPS is perhaps the most widespread in mouse models 
of preterm birth. The first study managed to induce PTB via intraperitoneal 
administration of LPS (363). Later studies also managed to induce preterm birth by 
administering LPS in the intrauterine compartment, either by open laparotomy (364) 
or using ultrasound guidance to guide the injection (170). There is also a study 
reporting induction of preterm labour after intravaginal inoculation of LPS (365). 
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Other bacterial products have also been used in mouse models of PTB. LTA, a product 
of gram-positive bacteria was shown to induce preterm delivery after intraperitoneal 
injection, although not as effectively as LPS (366). In addition, co-administration of 
the TLR2 agonist peptidoglycan (PGN) and the TLR3 agonist polyinosinic:cytidilic 
acid [poly(I:C)] in the uterus also stimulated preterm birth in a mouse model (367). 
Another study managed to induce preterm delivery by stimulating another family of 
PRRs, the intracellular Nod-like receptors (NLRs) (368). In particular, they reported 
that an intraperitoneal injection of the Nod1 agonist γ-D-glutamyl-meso-
diaminopimelic acid (iE-DAP) results in preterm birth within 24 hours (368).  
Different bacterial have also been used in preterm mouse birth models. Firstly, an 
intrauterine injection of E.coli after open laparotomy resulted in delivery within 48 
hours (306). Later studies used other bacteria as well. Intravaginal administration of 
Chlamydia trachomatis on day 5 during mouse gestation resulted in preterm delivery 
on days 15 to 16 (369). However, none of the above bacteria have been strongly 
associated with preterm birth in humans. Another study reported the induction of 
preterm birth in mice after intravenous administration of Fusobacterium nucleatum 
(370). This is an oropulmonary pathogen that has been associated with preterm birth 
in humans (371). This model tries to recapitulate the concept of preterm birth caused 
by periodontitis that leads to intrauterine infection via hematogenous dissemination. 
Although, clinically relevant, it does not mimic the most clinically relevant scenario 
of ascending infection of vaginal bacteria through the cervix. 
1.10.3.1.2 Other models of preterm birth 
Several mouse models of preterm birth that used non-infectious stimuli have also been 
described. The most widely used among them involves the subcutaneous injection of 
the progesterone receptor antagonist RU486 (372). Systemic progesterone withdrawal 
is essential for parturition to occur in mice, albeit not in humans. The effect of alcohol 
was also examined. A study found that repeated alcohol administration via oral 
gavages resulted in increased rates of preterm delivery (373). This was achieved 
through the upregulation of prostaglandins E and F2a (373). Intraperitoneal injection of 
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prostaglandin F2a alone was shown to induce preterm birth in a different study (374). 
The uterine smooth muscle relaxation function of nitric oxide (NO) was also 
investigated in a study which reported that a subcutaneous injection with the NO 
inhibitor NG-nitro-L-arginine methyl esther (L-NAME) caused preterm birth (375). 
Similarly, the peptide neuromedin B which is thought to stimulate smooth muscle 
contraction in the urogenital and gastrointestinal tract, could cause preterm birth after 
intraperitoneal administration (376). Another model used an intra-amniotic injection 
of the lung surfactant SP-A, which is produced only by a mature fetal lung, to induce 
preterm delivery identifying its crucial role in the endocrinology of parturition (377).  
Sterile inflammation models have also been established in the context of preterm birth. 
In particular, both intrauterine administration of fetal fibronectin (378) and intra-
amniotic injection of the damage-associated molecular pattern (DAMP) high-mobility 
group box 1 (HMGB1) (379) can cause preterm delivery in mice. 
1.10.4 The need for a new model 
The above-mentioned models and their successors have substantially contributed to 
our current understanding of preterm birth and its underlying mechanisms. However, 
as discussed earlier, the preterm birth rates have not significantly reduced and the 
current therapeutic options are very limited. This is an indication of the fact that our 
current knowledge is not sufficient to effectively tackle the problem. To this end, the 
development of new and more clinically relevant models is of paramount importance. 
Most current models use either bacterial products but not live bacteria, or bacteria that 
are not clinically relevant, or an administration route that is not reflective of the current 
consensus of ascending infection.  
In addition, the role of the cervix in the mouse models of preterm birth has been 
underappreciated. To our knowledge, no mouse model of cervical damage during 
pregnancy has been described. To this end, an aim of this thesis was to create and 
characterise a mouse model of cervical damage during pregnancy. For this purpose, 
the surfactant Nonoxynol-9 (N-9) was identified as potent damage inducer candidate. 
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1.11 Nonoxynol-9 
Nonyl-phenoxy-polyethoxy-ethanol or Nonoxynol-9 (N-9) belongs to the family of 
isononyl-phenyl-polyoxyethylene ethers. It is a non-ionic surfactant, meaning that its 
chemical structure consists of a hydrophobic and a hydrophilic group, the latter having 
no electrical charge. It has been extensively used as a spermicidal agent in various 
contraceptive methods, such as condoms or cervical barrier methods.  
 
Figure 1.4 Chemical structure of Nonoxynol-9. 
Its spermicidal function is based on the molecule’s structural affinity to the cell 
membranes’ lipids (380). When N-9 comes in contact with sperm, its molecules start 
to lyse the cell membranes of spermatozoa, resulting in their detachment, 
immobilization and ultimately cell death (381). This leads to a complete cessation of 
sperm motility within 4-6 minutes (382). Eventually, the membranes lose their 
integrity resulting in sperm death (382). However, the Centres for Disease Control and 
Prevention (CDC), have recommended against the use of N-9-containing condoms in 
the absence of evidence from clinical trials that they confer superior protection (383). 
The use of N-9 is significantly declining and is now banned from most European 
counties. This was decided based on the several concerns that have been raised 
regarding cytotoxicity, especially against epithelial surfaces. Although initially 
considered to be the safest among spermicides (384), this perception changed when a 
study in rabbits found that N-9 vaginal application resulted in significant ulceration of 
the vaginal epithelium (385). Similar findings were also reported in rats, in this case 
as inflammation in both the vagina and the cervix as acute cervicovaginitis (386). 
Another study in the same species found that N-9 application results in increased 
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vaginal epithelial permeability in vivo (387). This could potentially imply a decreased 
epithelial protection against infection. 
Studies in nonhuman primates further confirmed the above findings. A single N-9 
vaginal application on pigtailed macaques caused irritation of the lower reproductive 
tract with erythematous lesions as observed by colposcopy (388). A different study 
found that a single application can cause significant epithelial damage with whole 
sheets of vaginal epithelia identified in the vaginal lavage fluid (389). The same study 
also reported large infiltrations of neutrophils and macrophages in the vaginal lumen 
(389). The cervical epithelium was found to be even more susceptible to epithelial 
disruption, especially after repeated exposures to N-9 (390). 
More recently, mouse studies have reported similar results. The first one found that a 
single vaginal application of N-9 results in significant disruption of the cervical 
epithelium that is apparent at 2 hours post-administration and reaches the maximum 
toxicity levels at 8 hours post-administration (391). The vaginal epithelium had only 
minor disruptions (391). A later study reported identical findings and also found that 
N-9 application resulted in significant infiltration of monocytes and tissue resident 
macrophages in the cervical stroma (392). 
Overall, these data confirm that N-9 is an agent of high cytotoxicity against epithelial 
cells in vivo and is also a potent stimulator of an inflammatory response. Importantly, 
a higher selectivity if these effects towards the cervix as opposed to the vagina has 
been suggested. However, all these studies have been conducted in non-pregnant 
animals. This means that the effects of N-9 during pregnancy, particularly with regards 
to its potential interplay with an ascending infection, have not been studied. 
1.12 Summary 
Preterm birth is a worldwide healthcare problem as it represents the leading cause of 
neonatal mortality and morbidity. Despite extensive research in the field, the incidence 
of preterm birth remains steady over the past decades. At the same time, no proper 
etiological treatment for preterm birth has been found. This is reflective of the fact that 
 Cervical epithelial damage and preterm birth 
Literature review 71 
our current understanding of the disease mechanisms is not sufficient and makes the 
need for new approaches using clinically relevant models all the more necessary.  
The most common cause of spontaneous preterm birth is an intrauterine infection with 
bacteria that reside in the vagina, the most common of which is the Ureaplasma 
species. The cervix stands between the vagina and the uterus to form a physical and 
functional barrier that protects the uterine content from ascending infection with 
vaginal bacteria. This protective function largely depends on the presence of a healthy 
cervical epithelium. Human data have shown cervical epithelial damage after 
excisional procedures to be associated with an increased risk for preterm delivery but 
without any satisfactory mechanistic explanation. The surfactant N-9 has also been 
shown to cause cervical epithelial damage in various models but its effects during 
pregnancy remain unknown.    
1.13 Hypothesis 
The hypothesis of the study presented in this thesis is that Nonoxynol-9:  
i) damages the cervical epithelium   
ii) facilitates ascending infection and  
iii) predisposes to preterm birth. 
1.14 Aims 
To address this hypothesis, the aims that were set were: 
- To investigate the effect of N-9 on cervical epithelial cells in vitro. 
- To create and characterise a mouse model of cervical epithelial damage during 
pregnancy using N-9. 
- To examine whether N-9-induced cervical epithelial damage during pregnancy 
facilitates ascending infection with Ureaplasma parvum. 
- To determine whether Ureaplasma parvum can mount an inflammatory 
response in maternal and fetal tissues and that could lead to preterm birth.
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Chapter 2 Materials and Methods 
2.1 Cell culture 
2.1.1 End1/E6E7 cells 
End1/E6E7 ATCC CRL-2615TM (ATCC, Manassas, VI, USA) are immortalized 
human endocervical cells, isolated from a 43-year-old premenopausal woman that had 
undergone hysterectomy for endometriosis (393). Immortalisation was made possible 
by transducing a retroviral vector expressing the HPV16 oncogenes E6 and E7 (LXSN-
16E6E7) (393). These proteins have been shown to help human epithelial cells 
increase their proliferative capacity and avoid cell senescence (394) (395) (396). 
End1/E6E7 cells were cultured in Keratinocyte Serum-free Medium (Gibco, 
ThermoFischer Scientific, Paisley, UK) supplemented with CaCl2 (1:5000), Epidermal 
Growth Factor (EGF) (0.1 ng/ml; Gibco, ThermoFischer Scientific) and Bovine 
Pituitary Extract (BPE) (0.05 mg/ml; Gibco, ThermoFischer Scientific). Cells were 
incubated at 37oC in a humid incubator with 5% CO2 in the air and grown in T75 flasks 
with media changing every 2-3 days until they reached 80-90% confluence. 
2.1.2 HeLa cells 
HeLa are human malignant epithelial cells derived from an epidermoid carcinoma of 
the cervix (397). HeLa cells (ATCC) were cultured in Dulbeco’s Modified Eagle 
Medium (DMEM) supplemented with 10% v/v heat-inactivated Fetal Bovine Serum 
(FBS), 0.1 mM non-essential amino acids, 1.0 mM sodium pyruvate, 10 mM (4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid or HEPES and 100 U/mL 
penicillin/streptomycin (ThermoFisher Scientific, Waltham, MA, USA). Cells were 
incubated at 37oC in a humid incubator with 5% CO2 in the air and grown in T75 flasks 
with media changing every 2-3 days until they reached 80-90% confluence. 
2.1.3 HESC cells 
HESC are immortalized human fibroblast stromal cells obtained from an adult female 
with myomas (398). HESC cells were cultured in DMEM supplemented with 15% v/v 
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heat-inactivated FBS, 0.1 mM non-essential amino acids, 1.0 mM sodium pyruvate, 
10 mM (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid or HEPES and 100 U/mL 
penicillin/streptomycin. Cells were incubated at 37o in a humid incubator with 5% CO2 
in the air and grown in T75 flasks with media changing every 2-3 days until they 
reached 80-90% confluence. 
2.1.4 Swan 71 cells 
Swan 71 cells are immortalized human first trimester trophoblast cells (399). Swan 71 
cells were cultured in Dulbeco’s Modified Eagle Medium: Nutrient Mixture F-12 
(DMEM/F12) supplemented with 10% v/v FBS, 0.1 mM non-essential amino acids, 
1.0 mM sodium pyruvate, 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
or HEPES and 100 U/mL penicillin/streptomycin. Cells were incubated at 37o in a 
humid incubator with 5% CO2 in the air and grown in T75 flasks with media changing 
every 2-3 days until they reached 80-90% confluence. 
2.1.5 Mycoplasma testing 
All cell lines were routinely monitored for the presence of mycoplasma using the 
MycoAlert™ Mycoplasma Detection Kit (Lonza, Basel, Switzerland). This assay is 
used to detect the presence of enzymes that are released from lysed mycoplasmas. 
Addition of the enzymes’ MycoAlert™ substrate results in the conversion of 
adenosine diphosphate (ADP) to adenosine triphosphate (ATP). The ATP level can be 
measured before and after MycoAlert™ is added. ATP levels are proportionate to the 
presence of mycoplasmal enzymes.  
The assay was performed by Dr Forbes Howie, following the protocol described below 
(Specialised Assay Service, University of Edinburgh). 
Cells were seeded at 1.5x105 cells/ml (3x105 cells in 2 ml) in 6-well plates and cultured 
in 10% FBS DMEM, omitting P/S and G418, for 48 h. An aliquot of medium was 
removed and centrifuged at 200g for 5 min to remove cell debris and 100 μl of 
supernatant was collected for analysis. The MycoAlert™ reagent was then added in an 
equal volume of 100 μl and the samples were incubated for 5 min at room temperature. 
The first luminescence reading was then taken on a FLUOstar OPTIMA (BMG 
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Labtech, Ortenberg, Germany). Then, 100μl MycoAlert™ substrate was added to the 
sample, followed by a 10-min incubation at room temperature. The luminescence was 
then read again and the ratio between the two readings was calculated. Ratios greater 
than 1.2 suggested mycoplasma contamination. 
 
2.2 Ureaplasma spp culture 
2.2.1 Ureaplasma urealyticum 
Ureaplasma urealyticum ATCC 27618 (ATCC, Manassas, VA, USA) was cultured in 
SP4 Broth with urea (Hardy Diagnostics, Santa Monica, CA, USA). The key aspect of 
Ureaplasma growth in medium is the conversion of urea to ammonium ions, which 
increases the pH of the growth medium from pH=6.2 to pH>9, resulting in a colour 
change from yellow to dark pink. The SP4 Broth with urea contains 1.0 g/L urea. 
Culture of the bacteria was performed at the Reproductive Immunology Unit, Yale 
University School of Medicine. 
Using a 96-well plate, 20μl of Ureaplasma urealyticum ATCC 27618 were added to 
180μl of SP4 Broth in the top well of a given column. The rest of the wells in that 
column were filled with 180μl of SP4 Broth each. 10-fold serial dilutions of the 1st 
well’s bacterial concentration were created across the column by transferring 20μl 
from the 1st well to the 2nd, from the 2nd to the 3rd etc. Depending on the volume of 
Ureaplasma urealyticum needed, several columns could be used in each 96-well plate. 
Plates were sealed with adhesive tape and incubated at 37°C in a humidified cell 
culture incubator with ambient CO2 overnight. The following morning, the last 2 wells 
from each column showing pH change consistent with the threshold of detection based 
on colour change (dark pink) were pooled with the 2 subsequent wells that did not 
reach this threshold (yellow). The pooled aliquots were returned to a humidified cell 
culture incubator with ambient CO2 and left to incubate for 3-4 h in order to form a 
homogeneous population in log phase growth. Following this incubation period, 
aliquots were frozen and stored in -80oC. 
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2.2.2 Ureaplasma parvum 
Luciferase expressing HPA5 Ureaplasma parvum serovar 3 was donated by Dr Brad 
Spiller from Cardiff University. The bacteria expresses NanoLuc, a luciferase 
engineered by Promega (Madison, WI, USA), coming from the deep sea shrimp 
Oplophorus gracilirostris (400). Upon administration of the NanoLuc 
imidazopyrazinone substrate called furimazine, glow-type luminescence is produced 
(400).  
The same culture method as for U. urealyticum was used. Ureaplasma parvum was 
cultured in Ureaplasma Selective Medium (USM) (Mycoplasma Experience ltc, 
Surrey, UK). Bacteria were shipped to Edinburgh as individual aliquots in dry ice and 
were stored in -80oC until use. 
2.2.3 Determination of Ureaplasma concentration 
Determination of Ureaplasma concentration is based on the culture method and 
utilizes the colour change visual detection resulting from the pH change. It is expressed 
in Colour Changing Units per ml (CCU/ml).    
Using a 96-well plate, 20μl of Ureaplasma urealyticum of unknown concentration 
were added to 180μl of SP4 Broth in the top well of a given column. The rest of the 
wells in that column were filled with 180μl of SP4 Broth each. 10-fold serial dilutions 
of the 1st well’s bacterial concentration were created across the column by transferring 
20μl from the 1st well to the 2nd, from the 2nd to the 3rd etc. Plates were sealed with 
adhesive tape and incubated at 37°C in a humidified cell culture incubator with 
ambient CO2 overnight. After 48 h, the last well from each column showing pH change 
consistent with the threshold of detection based on colour change (dark pink) 
represented 1 Colour Changing Unit (CCU). As this well was a 10-fold dilution of the 
previous one, the previous well represented 10 CCU. Consequently, if n number of 
wells in the column showed pH change consistent with the threshold of detection based 
on colour change (dark pink) and the last well represented 1 CCU, the top well 
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containing 20μl of the Ureaplasma of unknown concentration represents 10n-1 CCU. 
In this case, the initial concentration is 5x10n CCU/ml.      
 
2.3 MTT metabolic activity assay 
To assess the effect of N-9 on End1/E6E7 cells’ viability, a metabolic activity assay 
was performed. The assay uses the yellow tetrazolium dye 3-(4,5-dimethylthiazol-2-
yl)-2,5-dyphenyltetrazolium or MTT, which is being processed in the mitochondria of 
metabolically active cells into an insoluble purple formazan by the enzyme succinate 
dehydrogenase. In this case, the metabolic activity of a cell population is directly 
proportionate to the cell viability of the population. 
80-90% confluent End1/E6E7 cells were transferred to 96-well plates (2 x105 cells/ml) 
and allowed to set for 48 h in Growth medium (200 μl/well). After 48 h supernatant 
was discarded and N-9 or vehicle control was added to the wells (200 μl; 2, 4, 8, 16, 
32, 64, 128, 256, 512 μg/ml in Growth medium; AbCam, Cambridge, UK). Cells were 
incubated in N-9 for various time points (30 min, 1, 2, 4, 24 h). After that, supernatant 
was discarded and 200 μl of Growth medium was added to each well. This was then 
followed by adding 10 μl of MTT (5 mg/ml; ThermoFisher Scientific, Waltham, MA, 
USA) in each well and left to incubate for 4 h. Supernatant was then discarded and 100 
μl of Acidified Isopropanol (4M HCl 1:100 in Isopropanol; Sigma-Aldrich, Poole, 
UK) was added in each well as a solubilizing agent. Solution was mixed in a shaking 
platform for 20 min and absorbance was read at 540mm. Four independent 
experiments were conducted. 
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2.4 In vitro cell permeability assay 
 
Figure 2.1 In vitro permeability assay principle. Adapted from (401). 
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The semi-permeable membranes of specialised inserts (MilliporeSigma, Burlington, 
MA, USA) were first hydrated at RT for 15 min with 250 μl of Growth medium. Then, 
200 μl of medium was removed and 200 μl of End1/E6E7 cell suspension was added 
to each insert (2.5 x106 cells/ml in Growth medium). They were left to incubate for 72 
h. Supernatant was discarded and N-9 or vehicle control was added to the wells (200 
μl; 3, 10, 30, 100 μg/ml) and left to incubate for 2 h. Supernatant was discarded and 
500 μl of Growth medium was added to the receiver wells. A Fluorescein-tagged 
dextran solution was added to the inserts (150 μl; 1:40 in Growth medium; 
MilliporeSigma) for 1 h, protected from light, at RT. Following this, dextran 
permeation was stopped by removing the inserts from the receiver wells. Medium in 
the receiver wells was thoroughly mixed and 100μl out of each well was transferred to 
a 96-well opaque plate. Five independent experiments were conducted. Fluorescence 
intensity of the medium in the receiver wells was measured in a CLARIOstar 
multimode microplate reader at 485 mm excitation/535 mm emission wavelengths 
(BMG Labtech, Ortenberg, Germany). 
Inserts that were removed to stop permeation were placed in a new receiver wells. A 
cell stain solution (Part # 20294; MilliporeSigma) was added to the inserts (100 μl) for 
20 min at RT. Following this, the cell stain solution was removed and inserts and 
receiver wells were washed x2 with PBS. 
Images were taken on a Leitz Labovert inverted brightfield microscope (Leitz, 
Wetzlar, Germany) using an AxioCam ICc 1 camera (Carl Zeiss AG, Oberkochen, 
Germany). 
2.5 Human cytokine proteomic array 
2.5.1 Principle 
The assay uses selected capture antibodies against human cytokines that have been 
spotted in duplicate on nitrocellulose membranes. Samples are mixed with a cocktail 
of biotinylated detection antibodies and then incubated with the membranes. 
Streptavidin- Horseradish peroxidase (HRP) and a chemiluminescence-based 
 Cervical epithelial damage and preterm birth 
Materials and Methods 79 
detection system are used resulting in light production that can be quantified using 
light detectors. 
2.5.2 Kit reagents 
Table 2-1 Human cytokine proteomic array kit reagents (R&D Systems) 
Array Buffer 4 (Part #895022) Buffered protein base with preservatives 
Array Buffer 5 (Part #895876) Buffered protein base with preservatives 
Wash Buffer Concentrate (Part 
#895003) 
Concentrated solution of buffered surfactant 
with preservatives 
Detection Antibody Cocktail (Part 
#898261) 
 
Streptavidin-HRP (Part #893019)  
Chemi Reagent 1 (Part #894287) Stabilised hydrogen peroxide with 
preservative 
Chemi Reagent 2 (Part #894288) Stabilised luminol with preservative 
 
2.5.3 Assay procedure 
Supernatants (200 µl each) from 4 different experiments were pooled after 
centrifugation to get rid of the debris. Each membrane was blocked with 2 ml of Array 
Buffer 4 for 1 h on a rocking platform shaker making sure the membrane is rocking 
end to end. 
To prepare the sample/detection antibody mix, samples were first diluted by adding up 
to 1 ml of each sample to 0.5 ml of Array Buffer 4 in separate tubes. Final volume was 
adjusted to 1.5 ml with Array Buffer 5. Then, 15 μl of reconstituted Human Cytokine 
Array Detection Antibody Cocktail was added to each prepared sample. Mix was left 
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to incubate at room temperature for 1 h. Array Buffer 4 was then aspirated and 
sample/antibody mix was added. Mix was left to incubate with the membrane 
overnight at 2-8 °C on a rocking platform. After overnight incubation, membranes 
were carefully removed and placed in individual plastic containers with 20 ml of 1X 
Wash Buffer. Each membrane was washed with 1X Wash Buffer for 10 min on a 
rocking platform shaker for a total of three washes. 
Streptavidin-HRP was prepared in Array Buffer 5 according to the dilution factor on 
the vial label. Membranes were incubated in Streptavidin-HRP for 30 minutes at room 
temperature on a rocking platform shaker. Each membrane was then washed with 1X 
Wash Buffer for 10 min on a rocking platform shaker for a total of three washes. Each 
membrane was then placed on the bottom sheet of the plastic sheet protector with the 
identification number facing up. 1 ml of the prepared Chemi Reagent Mix (1:1 Chemi 
Reagent 1: Chemi Reagent 2) was added on top of each membrane and allowed to 
spread evenly. Membranes were left to incubate for 1 min. Chemiluminescence signal 
was read in a LI-COR Odyssey Fc (LI-COR Biotechnology, Lincoln, NE, USA). 
 
 
2.6 DuoSet Enzyme-linked immunosorbent assay 
(ELISA) 
2.6.1 ELISA solutions preparation 
Table 2-2 Generic ELISA reagents 
Preservatives Methylisothiazolone (20%, 2 g) 
Bromonitrodioxane (20%, 2 g) 
Dimethylsulfoxide (DMSO, 5 ml) 
Dimethylformamide (DMF, 5 ml) 
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Dry coat solution Polyvinyl pyrollidone (20%, 2 g) 
Bovine serum albumin (BSA, 0.5%; 5 g) 
Ethylenediaminetetraacetic acid (EDTA, 5 mM; 1.68 g) 
Tris base (50 mM; 6.05 g) 
Preservatives (0.1%; 1 ml)         
ELISA Buffer Tris base (100 mM; 12.11 g) 
Sodium chloride (NaCl, 0.9%; 9 g) 
EDTA (2 mM; 0.744 g) 
BSA (0.5%; 5 g) 
Phenol red solution (0.03%; 300 µl) 
TWEEN 20 (0.03%; 300 µl) 
Preservatives (1ml) 
Deionized H2O (800 ml)  
Wash Buffer (x20)  NaCl (0.9%; 360 g) 
Tris base (10 mM; 48.4 g) 
TWEEN 20 (0.05%; 20 ml) 
dH2O (1.7 L) 
pH adjusted to 7.5 
Buffer made to 2 L            
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Substrate Buffer Sodium acetate anhydrous (100 nM; 4.1 g) 
Preservatives (0.1%; 0.5 ml) 
dH2O (405 ml)   
pH adjusted to 6 
Buffer made to 500 ml                     
Solution A 3, 3’, 5, 5’- Tetramethylbenzidine (TMB; 0.3%; 0.3 g) 
DMF (100 ml) 
Solution B Urea hydrogen peroxide (0.5%; 0.5 g) 
Sodium acetate buffer (50 mM; 100 ml) 
Stop solution Sulfuric acid (2N H2SO4) 
 
2.6.2 DuoSet ELISA reagents 
Table 2-3 DuoSet IL-6 and IL-8 ELISA reagents (R&D Systems) 
Capture Antibodies  
Mouse anti-human IL-6 (R&D 
Systems, Abington, UK) 
1:120 in PBS 
Mouse anti-human IL-8 (R&D 
Systems) 
1:120 in PBS 
Detection Antibodies  
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Biotinylated goat anti-human IL-
6 (R&D Systems) 
1:60 in ELISA buffer 
Biotinylated goat anti-human IL-
8 (R&D Systems) 
1:60 in ELISA buffer 
Streptavidin HRP 1:40 in ELISA buffer 
 
2.6.3 Assay procedure 
96-well plates werecoated with the following capture antibodies: anti-human IL-6 and 
anti-human IL-8 (100μl/well; 1:120 in PBS). Plates were seal-covered and incubated 
overnight at 5o. The following day, plate contents were discarded and the plate was 
blot-dried on tissue. 100μl of Dry Coat Solution was added to each well and left to 
incubate for 1 h. After this, contents were discarded, plates were blot-dried and left to 
air-dry at RT for 3-4 hours. Plates were then washed x4 in Wash Buffer and blotted 
dry in tissue. A 7-point standard curve was created by adding 100μl/well of a solution 
with known cytokine concentration and diluting it 2-fold across the plate’s column 
(top standard 600pg/ml for IL-6 and 2000pg/ml for IL-8 serially diluted 2-fold in 
ELISA Buffer). All samples were in duplicates. The plate was sealed and incubated 
overnight at 5oC. The following day, contents were discarded and plates were washed 
x4 in Wash Buffer and blotted dry. 100μl of detection antibody (1:60 in ELISA Buffer 
for all 3 cytokines) was added to each well and the plates incubated for 1o at RT under 
gentle agitation. After this, well contents were discarded and plates were washed x4 in 
Wash Buffer and blotted dry. 100μl of a Streptavidin-HRP solution was added to each 
well (1:40 in ELISA Buffer) and plates incubated for 20 min at RT under gentle 
agitation and protected from direct sunlight. Well contents were then discarded and 
plates were washed x4 in Wash Buffer and blotted dry. 100μl of the substrate solution 
(for a full plate: 10 ml Substrate buffer + 1 ml Solution A + 1 ml Solution B) was then 
added to each well and incubated for 20 min at RT. The reaction was stopped and 
colour development was quenched by adding 50μl of the Stop solution to each well. 
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The colour absorbance was then immediately read at 450 nm using the Softmax Pro 
software and plate reader (Molecular Devices, Sunnyvale, CA, USA). 
2.7 Protein quantification assay 
Total secreted protein is directly proportionate to the total number of cells. To quantify 
total protein, a colorimetric microplate assay was performed. 
All samples were cell culture supernatants collected from the experiment described in 
section 2.1.4. Using a 96-well plate, 5 μl of each sample or Radioimmunoprecipitation 
Assay Buffer (RIPA Buffer) (Bio Rad, Hercules, CA, USA) used as blank were added 
per well. A 7-point standard curve was created by adding 100μl/well of a solution with 
known protein concentration (1.37mg/ml serially diluted in RIPA Buffer) (Bio Rad). 
25 μl of “Working Reagent A” were added to each well (20 μl of Reagent S to each 
1ml of Reagent A needed for the assay, Bio Rad). After this, 200 μl or Reagent B (Bio 
Rad) were added to each well and plates were left to incubate on bench for 15 min. 
The colour absorbance was then read at 650 nm using the Softmax Pro software and 
plate reader (Molecular Devices, Sunnyvale, CA, USA). 
2.8 LDH cytotoxicity assay 
LDH is present in all cell membranes and, upon damage, it is released by the damaged 
cells in the Growth medium. This assay utilizes the ability of LDH to oxidize lactate 
and generate NADH, which then reacts with WST resulting in yellow colour 
production. Colour intensity is directly correlated with the cell number lysed.   
All samples were cell culture supernatants collected from the experiment described in 
section 2.1.4. Using a 96-well plate, 10 μl of each sample or Growth medium used as 
negative control were added per well. 100 μl of LDH Reaction Mix (200 μl of WST 
Substrate Mix in 10 ml of LDH Assay Buffer for every 100 reactions) (BioVision, 
Milpitas, CA, USA) was then added to each well and incubated for 30 min at room 
temperature. To stop colour development, 10 μl of Stop Solution (BioVision) were 
added in each well and mixed thoroughly. The colour absorbance was then read at 450 
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nm using the Softmax Pro software and plate reader (Molecular Devices, Sunnyvale, 
CA, USA). 
 
2.9 Bio-Plex cytokine assay 
To measure secreted cytokines in cell culture supernatant, the Bio-Plex ProTM Human 
Cytokine, Chemokine and Growth Factor Magnetic Bead-Based Assay was used (Bio 
Rad, Hercules, CA, USA). This assay utilizes 6.5μm magnetic beads to capture the 
cytokines of interest. Biotinylated detection antibodies are then added to the mix. The 
addition of Streptavidin-Phycoerythrin (PE) results in light emission after sample 
excitation that allows for cytokine quantification against a standard curve. The 
experiment was performed by Mrs Paulomi Aldo at Yale University School of 
Medicine. 
A standard flat-bottom 96-well plate was first pre-wet with 100 μl/well Bio-Plex Assay 
Buffer (Bio Rad) and then vacuum-filtered. The vacuum pressure was set to 2 inches 
Hg. The bottom of the plate was then blotted on tissue.  
50 μl of Working Bead Solution (25-fold dilution of the Anti-cytokine Bead Stock 
Solution in Bio-Plex Assay Buffer A, Bio Rad) was then added to each well. Before 
being added, the Working Bead Solution was vortexed for 20 sec. The plate was then 
vacuum-filtered and blotted on tissue. Plate was then washed x2 with 100 μl of Bio-
Plex Wash Buffer/per well (Bio Rad). 
A 7-point standard curve was created by adding 50μl/well of a standard solution 
reconstituted in tissue culture media and diluting it 4-fold across a plate’s column (top 
standard 32,000 pg/ml, low standard 0.2 pg/ml). 50 μl from each sample was then 
added in appropriate wells (each sample was tested in duplicate). The plate was 
covered with foil and samples and standards were incubated at room temperature for 
30 min in a shaking platform. Initially, the shaking frequency was slowly ramped up 
to 1,100 rpm and the plate was then shaken for 30 sec. After this, the speed was reduced 
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to 300 rpm for the remainder of the incubation time. Plate sealer was then removed 
and the plate was washed x3 with 100 μl of Bio-Plex Wash Buffer/per well.  
25 μl of the Detection Antibody Mixture was then added to each well (10-fold dilution 
of the Detection Antibody Mix Stock Solution in Bio-Plex Detection Antibody 
Diluent, Bio Rad). The plate was covered with foil and samples and standards were 
incubated at room temperature for 30 min in a shaking platform. Initially, the shaking 
frequency was slowly ramped up to 1,100 rpm and the plate was then shaken for 30 
sec. After this, the speed was reduced to 300 rpm for the remainder of the incubation 
time. Plate sealer was then removed and the plate was washed x3 with 100 μl of Bio-
Plex Wash Buffer/per well.  
50 μl of Streptavidin-PE Working Solution was then added to each well (100-fold 
dilution of the Streptavidin-PE Stock Solution in Bio-Plex Assay Buffer, Bio Rad). 
The plate was covered with foil and samples and standards were incubated at room 
temperature for 30 min in a shaking platform. Initially, the shaking frequency was 
slowly ramped up to 1,100 rpm and the plate was then shaken for 30 sec. After this, 
the speed was reduced to 300 rpm for the remainder of the incubation time. Plate sealer 
was then removed and the plate was washed x3 with 100 μl of Bio-Plex Wash 
Buffer/per well. 
To resuspend the beads, 125 μl of Bio-Plex Assay Buffer was then added to each well. 
Plate was covered with an adhesive plate sealer and the bottom of the plate was 
thoroughly blotted. The plate was then shaken on a platform shaker. The shaking 
frequency was slowly ramped up to 1,100 rpm and the plate was then shaken for 30 
sec. Plate sealer was then removed and the plate was read in a Bio-Plex Reader ((100 
beads/region in a volume of 50 μl in the low Photomultiplier Tube (PMT)) (Bio Rad).   
2.10 RNA extraction 
2.10.1 RNA extraction from cells 
Cells were lysed using Buffer RLT (Qiagen Ltd., Maryland, USA) with beta-
mercaptoethanol (β-ME; Sigma-Aldrich). They were then further lysed by being 
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repeatedly passed through a blunt 20-gauge needle (0.9mm diameter; BD 
Microlance™) in an RNase-free syringe (BD Plastipak™). An RNAeasy mini kit 
(Qiagen) was used to extract total RNA with the solutions supplied. EtOH (70%) was 
added to the homogenised lysate (v/v) and mixed well by pipetting. Each sample was 
then added to an RNeasy mini spin column within a 2 ml collection tube for RNA 
extraction. All samples were centrifuged for 15 sec at 8000 x g (10, 000 rpm). Each 
column was then washed with 350 μl Buffer RW1 under centrifugation for 15 sec at 
8000 x g (10, 000 rpm) to remove carbohydrates and proteins. To eliminate genomic 
DNA contamination, a DNase digestion step was performed by adding 10 μl DNase I 
stock, in 70 μl Buffer RDD (Qiagen), directly onto the spin column membrane for each 
sample. Samples were then incubated for 15 min at room temperature. Each column 
was then washed with 350 μl Buffer RW1 under centrifugation for 15 sec at 8000 x g 
(10,000 rpm). To remove residual salts, samples were washed twice with Buffer RPE 
under centrifugation at 8000 x g (10, 000 rpm) for 15 sec and 2 min, respectively. A 
final centrifugation step was performed for 1 min at full speed to eliminate any possible 
Buffer RPE carryover. RNA was eluted from the spin column membrane using 30 μl 
RNase-free H2O under centrifugation for 1 min at 8000 x g (10,000 rpm). Extracted 
RNA was stored at -80°C until further use. 
2.10.2 RNA extraction from tissue 
Placental tissue was lysed in 1ml TRI reagent® (Sigma-Aldrich) with one sterile 5 mm 
stainless steel bead (Qiagen) per Eppendorf/sample. The tissue was lysed at 25Hz 
using a Tissue Lyser II (Qiagen), 2x3 min, with tubes rotated half way through. The 
samples were then incubated for 15 min at room temperature. Following this, they 
were centrifuged at 14, 000 x g for 10 minutes at 4°C. The supernatant was then 
transferred to a 2 ml phase-lock tube (5-PRIME, Hamburg, Germany) and 200 μl of 
1-bromo-3-chloropropane (BCP; Sigma-Aldrich) were added to each sample. Samples 
were shaken for 15 sec, incubated for 10 min at room temperature and then centrifuged 
at 14, 000 x g for 15 min at 4°C. The upper aqueous phase was transferred to a new 
2ml Eppendorf and 550μl of 70% EtOH was added. Each sample was then added to 
an RNeasy mini spin column within a 2ml collection tube for RNA extraction. All 
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samples were centrifuged for 15 sec at 8000 x g (10, 000 rpm). Each column was then 
washed with 350 μl Buffer RW1 under centrifugation for 15 sec at 8000 x g (10, 000 
rpm) to remove carbohydrates and proteins. To eliminate genomic DNA 
contamination, a DNase digestion step was performed by adding 10μl DNase I stock, 
in 70 μl Buffer RDD (Qiagen), directly onto the spin column membrane for each 
sample. Samples were then incubated for 15 min at room temperature. Each column 
was then washed with 350 μl Buffer RW1 under centrifugation for 15 sec at 8000 x g 
(10,000 rpm). To remove residual salts, samples were washed twice with Buffer RPE 
under centrifugation at 8000 x g (10, 000 rpm) for 15 sec and 2 min, respectively. A 
final centrifugation step was performed for 1 minute at full speed to eliminate any 
possible Buffer RPE carryover. RNA was eluted from the spin column membrane 
using 30μl RNase-free H2O under centrifugation for 1 minute at 8000 x g (10,000 
rpm). Extracted RNA was stored at -80°C until further use. 
2.10.3 RNA quantification 
Nucleic acid concentration was quantified by measuring sample absorbance at 260nm 
on a NanoDrop ONE (ThermoFisher Scientific, Waltham, USA). RNA absorbs at 
260nm, while protein contaminants absorb closer to 280nm. RNA purity is determined 
by the 260:280 ratio. Acceptable 260:280 ratios were between 1.8 and 2.1. 
 
2.11 Reverse transcription (RT)- cDNA preparation 
2.11.1 RNA extract from cells 
Total RNA was reverse transcribed using the iScriptTM cDNA Synthesis kit (Bio Rad).  
An RT mastermix was prepared on wet ice. This included the following reagents; 5X 
iScript Reaction Mix, iScript RT enzyme and Nuclease-free H2O. RNA (300ng/μl) 
was added to the mastermix and pipetted gently to mix, then centrifuged at 10,000 rpm 
for 30 seconds to remove any air bubbles. A “no reverse transcriptase” control was 
included, omitting the enzyme, to control for genomic DNA contamination. A “no 
template” control, omitting the RNA, was included to control for general 
contamination of reagents. A G-Storm GS1 Thermal Cycler (G-Storm, Somerset, UK) 
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was set to perform the following cycles; 25°C for 5 minutes, 42°C for 30 minutes, 
85°C for 5 minutes, then held at 4°C. Samples were stored at -20°C until required for 
quantitative real time polymerase chain reaction (qRT-PCR) analysis. 
Table 2-4 Reverse transcription reagents 
Reagent Volume (μl) per sample 
for each reaction 
5x iScript Reaction Mix 4 
iScript Reverse Trascriptase 1 
Nuclease-free H2O x 
RNA template (up to 1 μg Total RNA) x 
Total Volume 20 
 
2.11.2 RNA extract from mouse tissues 
Total RNA was reverse transcribed using the High Capacity cDNA Reverse 
Transcription kit (Applied Biosystems, Life Technologies, ThermoFisher Scientific). 
A 2X RT mastermix was prepared on wet ice. This included the following reagents; 
10X RT buffer, 25X deoxyribonucleotide triphosphates (dNTPs), 10X random 
primers, RNase inhibitor, MultiScribe™ RT enzyme and RNA-free H2O. RNA (300 
ng/μl) was added to the mastermix and pipetted gently to mix, then centrifuged at 
10,000 rpm for 30 seconds to remove any air bubbles. A “no reverse transcriptase” 
control was included, omitting the enzyme, to control for genomic DNA 
contamination. A “no template” control, omitting the RNA, was included to control 
for general contamination of reagents. A G-Storm GS1 Thermal Cycler (G-Storm, 
Somerset, UK) was set to perform the following cycles; 25°C for 10 minutes, 37°C for 
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120 minutes, 85°C for 5 minutes, then held at 4°C. Samples were stored at -20°C until 
required for quantitative real time polymerase chain reaction (qRT-PCR) analysis. 
Table 2-5 Reverse transcription reagents 
Reagent Volume (μl) per sample for 
2x RT Mastermix 
10x RT Buffer 2 
25x dNTPs 0.8 
10x Random primers 2 
RNase inhibitor 1 
MultiScribeTM RT enzyme 1 
RNA-free H2O 3.2 
RNA (300ng) 10 
Total volume 20 
 
2.12 Quantitative Real-time Polymerase Chain 
Reaction (qRT-PCR) 
2.12.1 In vitro experiments 
To quantify the mRNA expression of specific genes of interest, qRT-PCR was 
performed using predesigned iTaqTM universal SYBR® Green supermix assay (Bio 
Rad). All samples and controls were added in duplicate in a 96-well PCR plate 
(Applied Biosystems). A reagent mixture was prepared with iTaqTM universal SYBR 
Green supermix, forward and reverse primers, cDNA sample and Nuclease-free H2O. 
In addition to the cDNA samples, wells containing the following controls were 
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included; “no reverse transcriptase”, “no template” and finally a H2O-only control, 
replacing cDNA, to determine any reagent contamination. Plates were sealed with 
optical adhesive film (MicroAmp®, Applied Biosystems) and then centrifuged at 500 
x g for 1 minute. All qRT-PCR analyses were performed on a CFX ConnectTM Real-
Time PCR System. The instrument was set to perform the following cycles: 95°C for 
30 seconds, then 95°C for 15 seconds and 60°C for 30 sec, repeated for 40 cycles. 
Target gene expression was normalised for RNA loading using the housekeeping gene 
GAPDH. The expression in each sample was calculated relative to a calibrator sample 
(vehicle-treated cells) using the 2−ΔΔ threshold cycle (CT) method of analysis. 
Table 2-6 iTaqTM Universal SYBR® Green assay reagents              
Reagent Volume (μl) per sample 
for each reaction 
iTaqTM Universal SYBR® Green supermix (x2) 10 
Forward and reverse primers (500 nM) x 
cDNA template (100ng) x 
Nuclease-free H2O x 
Total Volume 20 
 
Table 2-7 Primers for qRT-PCR (in vitro experiments) 







 Cervical epithelial damage and preterm birth 

















2.12.2 Mouse experiments 
To quantify the mRNA expression of specific genes of interest, qRT-PCR was 
performed using predesigned TaqMan gene expression assays from Applied 
Biosystems. All samples and controls were added in duplicate in a 384-well PCR plate 
(Applied Biosystems). A reagent mixture was prepared and 14 μl was added to each 
well, together with 1 μl of cDNA sample.  In addition to the cDNA samples, wells 
containing the following controls were included; “no reverse transcriptase”, “no 
template” and finally a H2O-only control, replacing cDNA, to determine any reagent 
contamination. Plates were sealed with optical adhesive film (MicroAmp®, Applied 
Biosystems) and then centrifuged at 500 x g for 1 min. All qRT-PCR analyses were 
performed on an Applied Biosystems 7900HT instrument set to perform the following 
cycles; 50°C held for 2 minutes, 95°C held for 10 minutes, then 95°C for 15 seconds 
and 60°C for 1 minute, repeated for 40 cycles. Target gene expression was normalised 
for RNA loading using β-actin (ACTB VIC, Mouse: 4352341E, Applied Biosystems). 
Previous studies from our laboratory found this endogenous gene to be consistent 
during late pregnancy in the mouse (170). The expression in each sample was 
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calculated relative to a calibrator sample (vehicle control) using the 2−ΔΔ threshold 
cycle (CT) method of analysis. 
Table 2-8 Taqman gene expression assay reagents (Applied Biosystems) 
Reagent Volume (μl) per sample for 
TaqMan reagent mixture 
 
TaqMan Universal Master Mix II 7.5 
Primer/probe or β-actin 0.75 
Nuclease-free H2O 5.75 
 
Table 2-9 Taqman gene expression assays 
Gene Species Code 
TNFa Mouse Mm99999068_m1 
Il1b Mouse Mm00434228_m1 
Cxcl1 Mouse Mm04207460_m1 
Cxcl2 Mouse Mm00436450_m1 
Il6 Mouse Mm00446190_m1 
Tlr1 Mouse Mm00446095_m1 
Tlr2 Mouse Mm01213946_g1 
Tlr6 Mouse Mm02529782_s1 
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Tlr9 Mouse Mm00446193_m1 
β-actin Mouse Mm00607939_s1 
UreC* Ureaplasma parvum *Provided by Dr Brad 
Spiller 
 
2.13 Experimental procedures 
2.13.1 N-9 effect on cytokine secretion by End1/E6E7 
cells 
80-90% confluent End1/E6E7 cells were put in 12-well plates (1 ml; 2 x105 cells/ml 
in Growth medium) and left to incubate for 48 h. Following this, supernatants were 
discarded and N-9 (1 ml; 4 μg/ml in Growth medium) or vehicle control was added to 
the wells and left to incubate for 2 h. After this, supernatants were discarded, cells 
were washed x2 in PBS and Lipopolysaccharide (LPS O111:B4) (1 ml; 1 μg/ml in 
Growth medium: Sigma-Aldrich, St Louis, MO, USA) or vehicle control was added 
to the cells and left to incubate for 24 h (Fig 2.2). For all experiments the E. coli LPS 
serotype O111:B4 was used in line with the in vivo experiments described below. At 
the end of this time point, supernatants were collected and stored at -20oC until further 
use and cells were frozen at -20oC. Four different independent experiments were 
performed. 
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Figure 2.2 Experimental outline. Effect of N-9 on basal and LPS-stimulated 
cytokine secretion by End1/E6E7 cells. 
 
Cytokine levels were determined using the human cytokine proteomic array and 
ELISA. Ideal N-9 concentration was decided by assessing the viability at the end of 
the experiment using MTT and LDH assays. To take the reduced cell viability in the 
N-9 treated groups into account when assessing the N-9 effect on cytokine secretion, 
the cytokine concentrations found using ELISA were normalized against the 
concentration of total secreted protein. 
2.13.2 Effect of Ureaplasma urealyticum infection on 
HeLa and HESC cells’ wound healing capacity 
Confluent HeLa and HESC were transferred to 24-well ImageLock plates (Essen 
BioSciences, Ann Arbor, MI, USA) (5x104 and 1x105 cells/ml in 500 μl of Growth 
medium per well for HeLa and HESC respectively) and allowed to set for 48 h. 
Following this, an artificial wound was created across the wells by scratching the cells 
with a pipette tip using a standardized semi-manual system (Fig 2.3). Growth medium 
was then discarded and the cells were then washed x2 with PBS. Cells were then 
treated either with Ureaplasma urealyticum (5μl/well; 5x107 CCU/ml in SP4 Broth) 
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or with vehicle control (10μl/well of SP4 Broth) and the plates were placed in an 
IncuCyte ZOOM system (Essen BioSciences) to monitor the wound closure. The 
plates were scanned every 2h for 48h. 
 
Figure 2.3 Semi-manual system used for the Wound Healing Assay 
2.13.3 Effect of N-9 on Ureaplasma parvum growth 
To examine the effect of N-9 on Ureaplasma parvum growth, the Minimum Inhibitory 
Concentration (MIC) of N-9 was determined using an adaptation of a previously 
described microdilution technique (402). MIC is the lowest concentration of an 
antimicrobial substance that will inhibit the visible growth of a microorganism after a 
given incubation time. 
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Using a 96-well plate, an N-9 gradient was created from 1024 μg/ml to 1 μg/ml across 
the plate columns, the last column being N-9 free for unrestricted growth comparison 
(180μl of each N-9 concentration/per well). 20 μl of Ureaplasma parvum from the 
overnight culture of unknown CCU was added to each well in the columns A1 to A12 
(1:10 dilution). A 10-fold dilution curve of bacteria was then titrated at 90 degrees 
across the N-9 gradient. Plates were sealed with adhesive tape and incubated at 37°C 
in a humidified cell culture incubator with ambient CO2 for 48 h, at which time color 
change within the growth control had ceased. The MIC was defined as the lowest 
concentration of antibiotic that prevented a color change after 48 h when read at 
104 CCU (relative to growth in the antibiotic-free medium). USM (with and without 
antibiotics) was also incubated in the absence of added Ureaplasma isolates to serve 
as a negative color-changing control. 
 
2.14 Animal studies 
All animal studies were performed under UK Home Office License 70/8927 (PPL) to 
Professor Jane Norman and in accordance with the UK Animals (Scientific 
Procedures) Act of 1986. All researchers that carried out procedures as part of this 
thesis were Personal License holders (PIL). Practical training was provided by the 
Establishment’s designated trainers until the PIL holder was signed off as competent 
to perform the relevant procedure unsupervised. Before each experiment, an 
Experimental Request Form (ERF) was submitted for review by the Named Veterinary 
Surgeon (NVS). ERF approval was a prerequisite for ordering mice to be used in an 
experiment. 
Virgin female C57Bl/6J mice aged 5-7 weeks were obtained from Charles Rivers 
Laboratories (Margate, UK). Mice were acclimatized for at least 7 days prior to any 
further experimental action. Upon mice arrival and until the start of each experiment, 
mice were housed in groups of 5-6 per cage and provided with food and water. Timed 
mating and vaginal copulatory plug checks of the animals were performed by the 
Animal Facility technicians, Mrs Carrie Owen and Mr Michael Dodds. During each 
 Cervical epithelial damage and preterm birth 
Materials and Methods 98 
experiment, pregnant mice were housed in individual cages and were closely 
monitored either in person at least twice a day, or by CCTV. They were checked for 
signs of delivery and severity endpoints as defined by the PPL. Temperature (19-23oC) 
and humidity (~55%) were tightly controlled, with constant 12-hour light/dark cycles. 
Animals were euthanized using methods permitted in the Schedule 1 of the UK 
Animals Scientific Procedures Act of 1986. In particular, dams were sacrificed by the 
inhalation of rising concentrations of CO2 in a sealed chamber and death was 
confirmed be cervical dislocation. Pups were sacrificed by cervical dislocation. For all 
the experiments described below, embryonic day 1 (D1) of mouse pregnancy was 
defined by the presence of a vaginal copulatory plug. 
2.14.1 Mouse model of cervical damage during 
pregnancy using N-9 
In the morning of D17 of pregnancy, mice were anaesthetized using inhalational 
isoflurane (5% for induction of anaesthesia, 2.5% for maintenance) and a pipette was 
used for intravaginal administration of either N-9 ((60 μl; 2%, 5%, 10% v/v in PBS or 
PBS (60 μl)). Mice were randomly assigned to each group. Care was taken to avoid 
spillage of treatment outside the vagina. Mice were allowed to recover from 
anaesthesia on a piece of tissue. Maintenance of treatment in the vagina after recovery 
from anaesthesia was assessed by observing potential leakage on the tissue. Only 
minor leakage incidents were observed. Following successful recovery, mice were put 
in individual cages for 8 h. During this period, they were checked in person twice per 
day for signs of potential adverse effects. At 8 h post-treatment, mice were culled by 
Schedule 1 procedures (CO2 asphyxiation followed by cervical dislocation) for tissue 
collection (Fig 2.4). Pups were culled by Schedule 1 (cervical dislocation followed by 
decapitation). 
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Figure 2.4 Mouse model of cervical damage assessment experimental outline. 
Pregnant C57Bl/6 mice were administered 60 μl of 2%, 5%, 10% N-9 or PBS control 
intravaginally in the morning of D17 of gestation. 8 h post-administration, mice were 
sacrificed for tissue collections to assess the effect of N-9-induced damage. 
Tissue collection and processing 
The vagina, the cervix and part of the uterus were collected as a single tube-like 
tissue and, after the surrounding fat was trimmed off, it was immediately transferred 
to 4% v/v Paraformaldehyde (polymeric formaldehyde) (PFA) for fixation. Tissue 
samples were fixed overnight in 4% PFA overnight (ON). Following fixation, tissue 
samples were stored in 70% v/v Ethanol. Samples were then made into paraffin 
blocks by a specialist technician, Mr Garry Menzies.  
2.14.2 Mouse model of cervical damage using N-9 and 
vaginal inflammation using LPS 
In the morning of D17 of pregnancy, mice were anaesthetized using inhalational 
isoflurane (5% for induction of anaesthesia, 2.5% for maintenance) and a pipette was 
used for intravaginal administration of either N-9 and Lipopolysaccharide (LPS) ((60 
μl; 10% v/v N-9 and 100 μg LPS O111:B4 (Sigma-Aldrich) in sterile PBS) or N-9 
alone (60 μl; 10% v/v N-9 in sterile PBS) or LPS alone (60 μl; 100μg in sterile PBS) 
or 60 μl sterile PBS alone. For all experiments the E. coli LPS serotype O111:B4 was 
used. This was recently showed to be the most potent in inducing preterm birth in mice 
when administered intrauterine (403). Mice were randomly assigned to each group. 
Care was taken to avoid spillage of treatment outside the vagina. Mice were allowed 
to recover from anaesthesia on a piece of tissue. Maintenance of treatment in the vagina 
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after recovery from anaesthesia was assessed by observing potential leakage on the 
tissue. Only minor leakage incidents were observed. Following successful recovery, 
mice were put in individual cages to monitor the time to delivery. During this period, 
they were checked in person twice per day for signs of potential adverse effects.  
In a different set of experiments, in the afternoon of D16 of pregnancy, mice were 
anaesthetized using inhalational isoflurane (5% for induction of anaesthesia, 2.5% for 
maintenance) and a pipette was used for intravaginal administration of either N-9 (60 
μl; 10% v/v N-9 in sterile PBS) or 60 μl sterile PBS alone. Mice were randomly 
assigned to each group. 16 h later, in the morning of D17, mice were anaesthetized 
using inhalational isoflurane (5% for induction of anaesthesia, 2.5% for maintenance) 
and a pipette was used for intravaginal administration of either LPS O11:B4 (1 mg in 
60 μl sterile PBS) or 60 μl sterile PBS alone. Following successful recovery from 
anaesthesia, mice were put in individual cages to monitor the time to delivery. During 




Figure 2.5 Effect of N-9-induced cervical damage and vaginal LPS on timing of 
delivery. Pregnant C57Bl/6 mice were administered 60 μl of a solution containing 
10% N-9 and 100 μg of LPS, or10% N-9 alone or 100 μg LPS or PBS control 
intravaginally in the morning of D17 of gestation (A). Alternatively, mice were 
administered 60 μl of a solution containing 10% N-9 or PBS control intravaginally in 
the afternoon of D16 of gestation and this was followed by intravaginal administration 
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of 60 μl of either 1mg LPS or PBS control 16h later, in the morning of D17 of gestation 
(B). Timing of delivery after the above treatment schemes was monitored using CCTV 
cameras.  
 
2.14.3 Mouse model of cervical damage-mediated 
ascending infection with Ureaplasma parvum 
To assess the effect of N-9-induced cervical damage on facilitating ascending vaginal 
infection with Ureaplasma parvum, in vivo bioluminescence imaging and amniotic 
fluid cultures for the presence of Ureaplasma parvum were performed. 
Bioluminescence imaging allows for optical detection and quantification of the 
Nanoluc-expressing bacteria after administration of the Nanoluc substrate, 
Furimazine, in a highly specific and non-invasive manner. Amniotic fluid cultures for 
the presence of Ureaplasma parvum allow for the detection and quantification of live 
and growing bacteria within the amniotic fluid. 
In the afternoon of D16 of pregnancy, mice were anaesthetized using inhalational 
isoflurane (5% for induction of anaesthesia, 2.5% for maintenance) and a pipette was 
used for intravaginal administration of either N-9 (60 μl; 10% v/v N-9 in sterile PBS) 
or 60 μl sterile PBS alone. Mice were randomly assigned to each group. 16 h later, in 
the morning of D17, mice were anaesthetized using inhalational isoflurane (5% for 
induction of anaesthesia, 2.5% for maintenance) and a pipette was used for intravaginal 
administration of either Ureaplasma parvum (108 CCU/ml in 40 μl of USM) or 40μl 
USM alone. Following successful recovery from anaesthesia, mice were put in 
individual cages. During this period, they were checked in person twice per day for 
signs of potential adverse effects. 24 h later, in the morning of d18, mice were 
anaesthetized to undergo in vivo bioluminescence imaging. After imaging was 
complete, a Norwegian Formula Deep Moisture Body Lotion was applied to the 
shaved abdomen to allow for quicker wound healing (Neutrogena, Los Angeles, USA). 
Following successful recovery from anaesthesia, mice were put in individual cages to 
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monitor the time to delivery. During this period, they were checked in person twice 
per day for signs of potential adverse effects. 
Mice that had not delivered any of their pups 48 h after the administration of either 
Ureaplasma parvum or vehicle control, in the morning of D19, were deemed term and 
were sacrificed for tissue collections using Schedule 1 methods (CO2 asphyxiation 
followed by cervical dislocation). Term pups that were culled by cervical dislocation 
followed by decapitation. Mice that had delivered at least 1 of their pups before 48 h 
after the d17 administration, were deemed preterm. Preterm mice were culled using 
Schedule 1 methods (CO2 asphyxiation followed by cervical dislocation). Preterm 
pups were culled by cervical dislocation followed by decapitation. 
 
Figure 2.6 Effect of N-9-induced cervical damage on ascending infection with 
Ureaplasma parvum during pregnancy. Pregnant C57Bl/6 mice were administered 
60 μl of 10% N-9 or PBS control intravaginally in the afternoon of D16 of gestation. 
This was then followed by intravaginal administration of 40 μl of Ureaplasma parvum 
in Ureaplasma medium (USM) or USM alone 16 h later, in the morning of D17. Mice 
underwent in vivo bioluminescence imaging 24 h later, in the morning of D18. Mice 
that had not delivered by the morning of D19 were sacrificed for tissue collections. 
Tissue collection and processing 
The following tissues were collected and snap-frozen in dry ice from all term dams: 
vaginal flush (60 μl of PBS were flushed into the vagina right after the mouse was 
culled) and cervix. 4 pups were chosen for tissue collections from each term dam, 2 
from each horn: the one closest to the cervix (proximal) and the one furthest from the 
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cervix (distal). The following tissues were collected and snap-frozen in dry ice from 
all term pups: amniotic fluid, placenta, uterus, fetal membranes, and fetal lung. Unless 
used immediately, tissues were stored in -80oC. 
 
Figure 2.7 Tissue collection strategy. From each term mouse, tissues were collected 
from 4 different pups: The ones in both horns that were closest to the cervix (Proximal) 
and the ones in either horn than were furthest from the cervix (Distal). 
2.14.4 Time to delivery 
Following recovery from anaesthesia, individual cameras were placed at each cage and 
mice were recorded using a digital video recorder. Time to delivery was calculated as 
the number of hours from the time of intravaginal administration until delivery of the 
first pup. 
2.14.5 Proportion of live-born pups 
Following delivery of the first pup and after recording the timing of delivery, mice 
were left in the cage for a further 24 h to deliver the rest of the pups. The proportion 
of live pups was then calculated for each mouse by dividing the number of live pups 
by the total number of pups and being presented as a percentage. Any live pups still 
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within the uterine horns 24 h after the first pup was delivered were not considered as 
live-born, as they had not been through labour. 
2.15 In vivo Bioluminescence imaging 
Mice were anaesthetized using inhalational isoflurane (2.5% for induction of 
anaesthesia, 2.5% for maintenance). To minimize signal interference through 
absorbance, scattering or diffraction of light by the mouse fur, mice abdomens were 
shaved before imaging. 100 μl of the Nanoluc substrate Furimazine (Nano-Glo Live 
Cell Assay System) were injected intraperitoneally (Promega, Madison, WI, USA). 
Mice were placed in a PhotonIMAGERTM OPTIMA for optical imaging (Biospace 
Lab, Nesles-la-Vallee, France). The PhotonIMAGERTM OPTIMA uses a photon 
counting technology based on intensified Charge-Coupled Devices (CCDs). This 
allows real-time display of the bioluminescence signal and recording of kinetics 
information. 
Imaging started right after Furimazine administration. The following imaging 
parameters have been used: 
Table 2-10 Parameters for in vivo bioluminescence imaging 
Software Photo Acquisition (Biospace Lab, Nesles-la-Vallee, 
France) 
Cryostat temperature -25oC 
Stage temperature 37oC 
Aperture 50mm f/1.2 
Stage height 560mm 
Field of view 210x158mm 
Image size 313.40371875 x 234.546203125 mm 
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Pixel size 169.133145574744 x 168.616968457944 µm 
Acquisition mode BLI Bioluminescence (61 ms per frame) 
Illumination power 10-20% 
Acquisition time 10:00 min 
Quantification Units ph/s/cm2/sr 
 
2.15.1 Imaging analysis 
Imaging analysis was performed using the M3 Vision software (Biospace Lab, Nesles-
la-Vallee, France). The same elliptical ROI was drawn around the area that 
corresponded to each mouse’s abdomen, including the lower abdomen and the cervix. 
Since the Photo Acquisition software allows the display of signal kinetics, 
quantification analysis was performed during a time frame where the signal intensity 
was in the plateau phase for each of the ROIs on display. 
Quantification unit was photons per second per centimeter square per steradian 
(ph/s/cm2/sr). This unit normalizes for differences in the mice size and position on the 
stage as well as the time frame used for the quantification analysis.  
 
2.16 Amniotic fluid cultures 
Detection and quantification of Ureaplasma parvum in amniotic fluid samples from 
D19 of pregnancy followed the principles described earlier. 
Using a 96-well plate, 15μl of amniotic fluid were added to 135μl of USM in the top 
well of a given column. The rest of the wells in that column were filled with 135μl of 
USM each. 10-fold serial dilutions of the 1st well’s bacterial concentration were 
created across the column by transferring 15μl from the 1st well to the 2nd, from the 2nd 
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to the 3rd etc. Plates were sealed with adhesive tape and incubated at 37°C in a 
humidified cell culture incubator with ambient CO2 overnight. After 48 h, the last well 
from each column showing pH change consistent with the threshold of detection based 
on colour change (dark pink) represented 1 Colour Changing Unit (CCU). As this well 
was a 10-fold dilution of the previous one, the previous well represented 10 CCU. 
Consequently, if n number of wells in the column showed pH change consistent with 
the threshold of detection based on colour change (dark pink) and the last well 
represented 1 CCU, the top well containing 15μl of amniotic fluid of unknown 
Ureaplasma parvum concentration represents 10n-1 CCU.  
2.17 Cervical damage assessment 
To assess tissue damage, the following tissue processing and analysis strategy was 
decided (Fig 2.8): For each mouse, 3 consecutive longitudinal 5μm-thick sections from 
3 different levels (L1, L2, L3) would be used for morphological damage, inflammatory 
infiltrations and mitotic activity analysis respectively. Each level would be 50μm 
deeper than the preceding one. This strategy allows for potential differences in the 
damage severity across different parts of the vagina and the cervix to be taken into 
account.     
 
Figure 2.8 Tissue processing and analysis strategy for the cervical damage model. 
At each of the 3 levels (L1, L2, and L3) one section would be used for morphological 
damage analysis, one for inflammatory infiltrations analysis and one for mitotic 
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activity analysis. L2 would be 50μm deeper than L1 and L3 would be 50μm deeper 
than L2. 
 
2.18 Alcian Blue/Periodic Acid Schiff (AB/PAS) 
staining 
AB/PAS special staining was used to stain the mucus-producing epithelial cells of the 
mouse vagina and cervix. This would allow to identify subtle changes in the integrity 
of the epithelial layers of both tissues. Alcian Blue pH 2.5 imparts a blue colour to the 
acidic mucins and other carboxylated or weakly sulphated acid mucosubstances. The 
periodic acid Schiff (PAS) reaction is then used to stain basement membranes, 
glycogen and neutral mucosubstances pink to red. Mixtures of neutral and acidic 
mucosubstances will appear purple due to positive 
reactions with both Alcian Blue and PAS. The AB/PAS special stain was performed 
by the Shared University Research Facilities (SuRF) team of the University of 
Edinburgh according to their standard protocols. 
2.18.1 Deparaffinisation and rehydration 
For deparaffinization, slides were immersed 2x5 min in Xylene (Cell Path Ltd, 
Newtown, UK). This was followed by progressive rehydration of the samples through 
a sequential immersion in 100%, 95%, 80%, 70% Ethanol, for 20 sec each.  
2.18.2 Staining 
Following rehydration, slides were immersed in 1% Alcian Blue for 10 min. Slides 
were then washed under running cold tap water for 10 min. Following this, slides were 
rinsed in deionized H2O and were then oxidized in an acquous solution of 0.5% 
periodic acid for 10-20 min. Slides were then washed under running cold tap water for 
the same length of time. After a rinse in deionized H2O, slides were treated with 
Schiff’s reagent for the same length of time. Slides were then washed under running 
cold tap water for the same length of time. 
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2.18.3 Counterstain 
Slides were immersed in Harris’ Haematoxylin for 30 sec. After a 5-min wash under 
running tap water, slides were placed in Scott’s Tap Water Substitute until sections 
were blue. Slides were then dehydrated through a sequential immersion in 70%, 80%, 
95%, 100% Ethanol followed by 2x5 min in Xylene. Mounting media (ThermoFischer 
Scientific, UK) mounting medium was added to the slides. All slides were sealed with 
cover slips. 
2.19 Immunohistochemistry 
Immunohistochemistry was used to localize polymorphonuclear neutrophils in the 
epithelium and stroma of the cervix and vagina. It was also used to localize 
proliferating cells, being in the active phases of the cell cycle, within the cervix 
basement membrane. 
2.19.1 Deparaffinisation and rehydration 
For deparaffinization, slides were immersed 2x5 min in Xylene (Cell Path Ltd, 
Newtown, UK). This was followed by progressive rehydration of the samples through 
a sequential immersion in 100%, 95%, 80%, 70% Ethanol, for 20 sec each. Slides were 
then left for 5 min under running tap water to further remove residual ethanol. 
2.19.2 Antigen retrieval 
For antigen unmasking, Heat-Induced Epitope Retrieval (HIER) using a Pressure 
Cooker was performed. Slides were put in a plastic slide holder containing 300 ml of 
Sodium Citrate Buffer (10mM Sodium Citrate, pH 6.0 in distilled H2O, Sigma-
Aldrich, St Louis, USA). The slide holder was then placed in an InstantPot IP-LUX60 
6L/6.33Qt Pressure Cooker containing 500ml of distilled H2O (InstantPot, Ottawa, 
Canada). The slides were left in the Pressure Cooker for approximately 20 min until 
boiling temperature was reached, the pressure was then released and the slides were 
left for a further 20 min to cool down. 
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Upon return of the samples temperature to room temperature, slides were washed 1x5 
min in distilled H2O on a rocker platform at 35 revolutions/min. This was followed by 
1x5 min wash in 1% Tris-buffered saline (TBS) on a rocker platform at 35 
revolutions/min (Sigma-Aldrich, St Louis, USA).  
2.19.3 Blocking 
On every slide, a circle was drown around each tissue section using a 5mm 
hydrophobic PAP pen for immunostaining (Sigma-Aldrich, St Louis, USA), to confine 
reagent incubation around the tissue. 
To block the endogenous peroxidase activity of the samples, slides were immersed in 
300ml of a Hydrogen Peroxide (H2O2) blocking solution and left to incubate for 30 
min on a rocker platform at 35 revolutions/min (10% H2O2 in methanol). This was then 
followed by 2x5 min washes in TBS on a rocker platform. 
To prevent non-specific binding of antibodies to tissue or to Fc receptors, 100 μl of a 
blocking solution was applied on each sample. The blocking solution was a 20% v/v 
non-immune normal goat serum (NGS) (primary antibodies were raised in different 
species) and 5% w/v Bovine Serum Albumin (BSA) in PBS (Sigma-Aldrich, St Louis, 
USA). Samples were left to incubate in a dark humidified chamber to minimize reagent 
evaporation. 
2.19.4 Primary antibodies incubation 
To identify polymorphonuclear neutrophils, the following primary antibody 
preparation was used: Purified rat anti-mouse Ly-6G (Lymphocyte antigen 6 complex, 
locus G) (1:500 in blocking solution, Biolegend, San Diego, USA). To identify 
proliferating cells, 100 μl of the following primary antibody preparation was applied 
on a different set of slides: rabbit anti-Ki67 (ab15580, 1:1000 in blocking solution, 
Abcam, Cambridge, UK). One section per slide was used as negative control, where 
blocking solution alone was applied. Samples were left to incubate overnight in a dark 
humidified chamber at 4oC. After overnight incubation, slides were washed 1x5 min 
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in TBS-Tween (0.05% v/v Tween in TBS, Sigma-Aldrich, St Louis, USA) and 2x5 
min in TBS on a rocker platform. 
In slides where an anti-Ly-6G primary antibody was applied, 100 μl of the following 
Horseradish Peroxidase (HRP)-conjugated secondary antibody preparation was 
applied: ImmPRESS HRP Anti-Rat IgG (Vector Laboratories, Burlington, USA). In 
slides where an anti-Ki67 primary antibody was applied, 100 μl of the following 
Horseradish Peroxidase (HRP)-conjugated secondary antibody preparation was 
applied: ImmPRESS HRP Anti-Rabbit IgG (Vector Laboratories, Burlington, USA). 
Slides were left to incubate with the above-mentioned secondary antibody preparations 
for 1 h. This was then followed by slides being washed 1x5 min in TBS-Tween and 
2x5 min in TBS on a rocker platform.  
2.19.5 Chromogenic detection 
As the secondary antibody used was conjugated with the enzyme HRP, the substrate 
used was 3,3’- diaminobenzidine (DAB). DAB is a soluble organic substrate that is 
converted by HRP to an insoluble brown product, localized at the sites of epitope 
expression.  Slides were incubated with 100 μl of DAB solution until brown colour 
development for a maximum of 2 min. Colour development was stopped by placing 
the slides in deionized H2O. 
2.19.6 Counterstain 
Slides were immersed in Harris’ Haematoxylin (Cell Path Ltd, Newtown, UK) for 5 
min. Slides were then washed under running cold tap water and put in 0.3% acid 
alcohol (Cell Path Ltd, Newtown, UK) for 2-3 sec to differentiate. After another wash 
slides were put in Scott’s tap water (Cell Path Ltd, Newtown, UK) for 30 sec to stop 
differentiation. Slides were then dehydrated through a sequential immersion in 70%, 
80%, 95%, 100% Ethanol followed by 2x5 min in Xylene. Mounting media 
(ThermoFischer Scientific, UK) mounting medium was added to the slides. All slides 
were sealed with cover slips (Cell Path Ltd, Newtown, UK). 
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2.20 Light microscopy imaging 
Imaging of the samples was performed using a Zeiss Axio Scan.Z1 Slide Scanner (Carl 
Zeiss AG, Oberkochen, Germany). Imaging analysis was performed using Zeiss ZEN 
Blue software (Carl Zeiss AG, Oberkochen, Germany). 
2.21 Statistical analysis 
All statistical analyses were performed using GraphPad Prism version 7 (GraphPad, 
San Diego, CA, USA). Data in graphs are presented as dot plots. Error bars represent 
standard deviation (SD). Data in text are presented as mean± standard error of the 
mean (SEM). Observation of data points and D’ Agostino- Pearson omnibus normality 
test were used to assess normality of the sample distributions. For normally distributed 
groups the following tests were used:  Unpaired or paired Student’s t test was used to 
compare means of two groups. One way analysis of variance (ANOVA) was used to 
compare more than two groups. Dunnett’s post hoc test was used to compare multiple 
groups to a control group. Holm-Sidak test was used to analyse sets of P values 
between multiple groups. For groups that did not follow a Gaussian distribution the 
following tests were used: Mann-Whitney test to compare the means of two groups. 
Kruskal-Wallis test to compare the means between 3 or more groups. Percentages were 
compared by Fisher’s exact test. Inter-rater reliability was assessed using weighted 
Cohen’s kappa.  
Gene expression analysis was performed on DDCt values. Two way ANOVA was 
used to determine statistical significance in the presence of two variables. This was 
followed by post hoc Dunnett’s test in cases where statistically significant results were 
yielded for the particular variable. Spearman’s correlation coefficient was used to 
determine correlation in gene expression studies. A P-value less than 0.05 was 
considered statistically significant.
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Chapter 3 Effects of Nonoxynol-9 and 
Ureaplasma spp on cervical 
epithelial cells in vitro 
 
3.1 Introduction 
The uterine cervix has a key role in maintaining a healthy pregnancy. It provides 
structural support to the uterine content throughout gestation and at the same time 
undergoes progressive remodelling to acquire the necessary distensibility that will 
allow safe passage of the fetus during labour. Importantly, it forms a physical and 
functional barrier to protect the fetus from external insults, such as a bacterial 
infection. This is particularly important given that an ascending infection of vaginal 
bacteria through the cervix is the most common precursor of preterm birth, the leading 
cause of neonatal mortality and morbidity worldwide (3) (16).  
The cervical epithelium is an important component of the barrier function of the cervix 
during pregnancy. In humans, the cervical epithelium consists of two parts: the 
endocervical single-layer columnar epithelium which is proximal to the uterus and the 
ectocervical multi-layered squamous epithelium that is proximal to the vagina. To 
maintain an effective physical barrier, the cervical epithelium strictly regulates the 
temporal expression of tight and gap junction proteins (269) and desmosomes (268). 
This ensures selective pericellular epithelial permeability of useful substances such as 
nutrients while excluding harmful bacteria. In addition, the cervical epithelium forms 
a functional immunological barrier against infection. Cervical epithelial cells express 
Toll-like receptors and are thus able to sense a microbial challenge (268). Upon 
pathogen recognition, the epithelium can stimulate the innate and adaptive immune 
response by secreting proinflammatory cytokines and chemokines (282). Epithelial 
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cells also participate in the effector mechanisms of the adaptive immunity by secreting 
antimicrobial peptides such as SLPI (288), Elafin (284) and LL-37 (285). The 
importance of a healthy cervical epithelium could be clinically demonstrated by the 
fact that excisional procedures for the treatment of CIN like cone biopsy or LLETZ, 
that remove part of the epithelium and the underlying stroma, significantly increase 
the risk for preterm delivery (304) (305). However, the underlying mechanisms remain 
elusive. 
Nonoxynol-9 is a non-ionic surfactant that has been extensively used as a component 
of spermicides due to its ability to solubilize and disrupt the plasma membrane of 
spermatozoa (404) (405). However, it is also highly cytotoxic for epithelial cells of the 
reproductive tract (406). Although it has been shown to cause significant epithelial 
damage in vivo (407) (408) (409), its effects during pregnancy have not been studied 
yet. 
Among the bacteria that have been associated with preterm birth, the most common 
ones belong to the Ureaplasma spp, namely U. parvum and U. urealyticum (410). 
These bacteria have been shown to cause chorioamnionitis that predisposes to PTB 
(253). In addition, they can cause significant fetal injury with disruption of the fetal 
brain development (411). As Ureaplasmas are considered commensals of the vagina, 
they need to break through the cervical barrier to cause an intrauterine infection. 
However, whether the cervical epithelium can mount an effective immune response 
against Ureaplasmas is not known. 
The work described in this chapter investigated the effects of Nonoxynol-9 on cervical 
epithelial cells in vitro. We hypothesized that N-9 treatment could compromise both 
the physical and the functional barrier function of the cervical epithelium. 
Furthermore, we assessed the capacity of cervical epithelial cells to sense an infection 
with U. urealyticum and respond by producing proinflammatory cytokines and 
chemokines. The hypothesis was that cervical epithelial cells could recognize U. 
urealyticum through TLRs and that this recognition could only cause a mild 
inflammatory response.  
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3.2 Results 
3.2.1 N-9 reduces the viability of endocervical End1/E6E7 
epithelial cells 
To assess the effect of N-9 on the viability of endocervical End1/E6E7 cells, a 
metabolic activity assay using MTT assay was performed. MTT assesses the metabolic 
activity of the cells which directly proportionate to the cell viability. Different doses 
of N-9 were used (0, 2, 4, 8, 16, 32, 64, 128, 256, 512 µg/ml in Cell Culture Medium-
CCM) and for different time points (30 min, 1, 2, 4, 24 h). At the end of each incubation 
period, MTT assays were performed. The metabolic activity for each group of cells 
was expressed as a percentage of the metabolic activity of the untreated cells. 
A clear trend was identified (Fig 3.1). The low doses of N-9 (2, 3, 8 µg/ml) had only 
minimal effects on the endocervical cells’ viability, as they resulted in the cells 
demonstrating 80-90% of the metabolic activity of the vehicle-treated cells for all 
incubation times (Fig 3.1). 
Similarly, the high N-9 doses (128, 256, 512 µg/ml) almost completely abolished the 
cells’ metabolic activity to less than 20% of the vehicle-treated cells for all time points 
(Fig 3.1). 
The medium N-9 doses of 16 µg/ml and more so 32 and 64 µg/ml exhibited time-
dependent trends (Fig 3.1). The 16 µg/ml dose started with 81.15±3.18% metabolic 
activity of the vehicle-treated cells after 30 min incubation, to drop to 68.35±6.4% at 
24 h. More dramatic were the changes with the other two dosages. At 32 µg/ml, N-9 
resulted in the metabolic activity being 81.2±7.34% of the vehicle-treated after 30 min 
which gradually dropped to only 12.05±1.69% at 24 h. The 64 µg/ml dose leads to a 
metabolic activity of 66.28±8.8% of vehicle-treated cells at 30 min but then follows a 
steep drop to 26.88±3.26% at 1 h and below 20% for all incubation times after this 
(Fig 3.1). 
 Cervical epithelial damage and preterm birth 
Effects of Nonoxynol-9 and Ureaplasma spp on cervical epithelial cells in vitro 116 
  
Figure 3.1 Treatment of endocervical cells (End1/E6E7) with N-9 results in 
decreased cell metabolic activity in a dose- and time-dependent manner. 
End1/E6E7 cells were incubated with various N-9 concentrations (0, 2, 4, 8, 16, 32, 
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64, 128, 256 and 512 μg/ml) for 30min, 1h, 2h, 4h and 24h. Metabolic activity 
indicating cell viability was determined by an MTT assay and is expressed relative to 
that of the untreated cells. Four independent experiments were conducted. Error bars 
indicate SD. 
 
3.2.2 N-9 compromises the physical barrier function of an 
endocervical End1/E6E7 monolayer 
To assess whether N-9 treatment could compromise the physical barrier function of 
the cervical epithelium, an in vitro permeability assay was performed on a monolayer 
of End1/E6E7 cells. After different N-9 treatments (0, 3, 10, 30, 100 µg/ml) for 2 h, a 
FITC-Dextran solution was administered and the fluorescence intensity (F. I.) was 
measured at the other side of the monolayer (receiver well) (Fig 3.2). 
The low doses of N-9 (3, 10 µg/ml) had no effect on the epithelial barrier function as 
they resulted in practically the same F. I. values (412.2±41.27 units and 452.1±26.44 
units respectively) as the vehicle-treated cells (441.8±48.5 units). They also had no 
effect on the monolayer confluence as observed by microscopy (Fig 3.2). 
The medium (30 µg/ml) and high (100 µg/ml) doses compromised the epithelial barrier 
function as they significantly increased the F. I. in the receiver well compared to both 
the untreated cells and the ones treated with the low doses. The medium dose increased 
the F. I to 968.9±139.3 units (P<0.05 for 30 µg/ml vs 0, 3 and 10 µg/ml). The high 
dose increased the F. I. to 1424±207.1 units (P<0.001 for 100 µg/ml vs 0, 3 and 10 
µg/ml). Under the microscope, both treatments disrupted the continuity of the 
epithelial cell monolayer (Fig 3.2). 
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Figure 3.2 Medium and high doses of N-9 result in compromised epithelial barrier 
function of endocervical (End1/E6E7) cells. Confluent End1/E6E7 cells were seeded 
at 500,000 cells per insert for 72 hours in growth medium. Following this period, the 
monolayers were treated with different concentrations of N-9 diluted in growth 
medium (0 μg/ml, 3 μg/ml, 10 μg/ml, 30 μg/ml and 100 μg/ml) for 2 hours. A FITC-
Dextran solution was added to the inserts for 1 hour and the fluorescence intensity (F. 
I.) of the receiver wells was measured using CLARIOstar multimode microplate 
reader. High N-9 concentrations (30 and 100 μg/ml) resulted in higher F. I. of the 
respective receiver wells compared to low N-9 concentrations (0, 3 and 10 μg/ml), 
indicating increased epithelial permeability. Five independent experiments were 
conducted. Error bars indicate SD. Statistical significance was assessed using 1-way 
ANOVA with Dunnett’s multiple comparisons test against the 0 μg/ml group (*P<0.05 
for 30 μg/ml vs. 0, 3 and 10 μg/ml, ***P<0.001 for 100 μg/ml vs. 0, 3, and 10 μg/ml). 
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3.2.3 N-9 has no effect on the ability of endocervical 
End1/E6E7 cells to secrete proinflammatory cytokines 
and chemokines 
To assess whether N-9 could compromise the functional epithelial barrier to infection 
by disrupting the ability of the epithelial cells to secrete proinflammatory cytokines 
basally and upon LPS-stimulation, End1/E6E7 cells were pre-treated with N-9 for 2 h 
and then treated with Growth medium (CCM) or LPS only.  
Identification of the proper N-9 dose 
As shown in Chapter 3.2.1 (Fig 3.1), after 2 h of N-9 treatment, the N-9 dose that 
results in an acceptable 50% cytotoxicity is 40 μg/ml. For this experiment, after the 2-
hour N-9 treatment, a 24-hour treatment with either CCM or LPS followed. To take 
into account the possibility of a prolonged N-9 effect even after it is removed from the 
treatment, we tried two lower doses of N-9 as well (0.4 and 4 μg/ml). At, the end of 
each experiment, the cell viability was assessed by MTT assay and the findings were 
validated with a cytotoxicity LDH assay.  
The high pre-treatment dose of 40 μg/ml N-9 followed by either CCM or LPS led to 
extremely low viability (2.09±0.32% and 2.44±0.53% respectively) relative to the 
control treatment as assessed by the MTT assay (Fig 3.3A). Similar were the 
cytotoxicity findings of the LDH assay (Fig 3.3B).  
The low pre-treatment dose of 0.4 μg/ml N-9 followed by either CCM or LPS led to a 
viability of 91.89±1.71% and 88.15±1.89% relative to the control treatment 
respectively, using the MTT assay (Fig 3.3A). The cytotoxicity levels of the above 
treatments in the LDH assay mirrored the MTT findings. This dose of N-9 followed 
by CCM resulted in 9.23±3.1% cytotoxicity and the N-9 followed by LPS to 
3.87±0.95% cytotoxicity relative to cytotoxicity of the highest dose of N-9 (Fig 3.3B). 
Finally, the medium dose of 4 μg/ml N-9 followed by either CCM or LPS led to a 
viability of 74.2±4.02% and 75.48±3.88% of the control treatment respectively, using 
the MTT assay (Fig 3.3A). Again the cytotoxicity findings mirrored the viability ones 
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with 23.94±9.52% and 20.62±10.07% of the highest dose of N-9 respectively (Fig 
3.3B). 
As the highest dose of N-9 was proven very toxic and the lowest dose had only a 
minimal effect, the dose of 4 μg/ml was chosen for subsequent experiments. 
Another important finding is that LPS itself does not reduce cell viability as confirmed 
by both the MTT and the LDH assay (Fig 3.3A, B).   
  
Figure 3.3 N-9 pre-treatment at 4 μg/ml for 2 h affects the viability of End1/E6E7 
cells but without exceeding the 50% cytotoxicity limit. Confluent End1/E6E7 cells 
were seeded at 200,000 cells per well for 48 hours in growth medium. Following this, 
cells were treated with 3 doses of N-9 diluted in Cell Culture Medium (CCM) (0.4 
μg/ml, 4 μg/ml and 40 μg/ml) for 2 hours followed by a further 24 h either with 1 
μg/ml LPS in CCM or CCM alone. N-9 at 0.4 μg/ml has no effect on End1/E6E7 cells’ 
viability and at 40 μg/ml results in acceptably low levels of viability as assessed by 
metabolic activity (A) and cytotoxicity (B) levels, relative to those of untreated cells 
(CCM alone). N-9 at 4 μg/ml affects viability but without exceeding the 50% 
cytotoxicity limit. 
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Protein analysis 
To identify proinflammatory cytokines and chemokines secreted by the End1/E6E7 
cells that could have been affected by the treatments, a human cytokine proteomic 
array was performed on pooled cell culture supernatants from experimental repeats. 
The array identified that the following cytokines and chemokines are secreted: IL-6, 
IL-8, CXCL-1 and CXCL-10. All of them are upregulated with LPS treatment 
compared to CCM treatment (Fig 3.4A). 
To examine whether 4 μg/ml N-9 pre-treatment could affect the ability of the 
End1/E6E7 cells to secrete cytokines, ELISA was performed on cell culture 
supernatants from the same experiments. IL-6 and IL-8 were chosen for further 
investigation.   
Pre-treatment with N-9 did not change the levels of basal IL-6 secretion by End1/E6E7 
cells after 24 hours in CCM (374.9±68.68 and 394.5±56.53 pg/ml without and with 
pre-treatment respectively). Similarly, N-9 pre-treatment had no effect in the LPS-
stimulated secretion of IL-6 either (286.3±18.73 and 239.1±34.71 pg/ml without and 
with pre-treatment respectively) (Fig 3.4B). 
The same results were also found for the levels of IL-8. No difference by N-9 pre-
treatment was noticed at a basal level (374.9±68.68 and 394.5±56.53 pg/ml without 
and with pre-treatment respectively) or after LPS stimulation (4,243±260.6 and 
4,050±309.7 pg/ml without and with pre-treatment respectively) (Fig 3.4D). 
To take into account the N-9-induced cytotoxicity that resulted in smaller population 
of cells, the amount of total protein concentration in the cell culture supernatants was 
determined using a protein assay. The levels of IL-6 and IL-8 determined by ELISA 
were subsequently expressed and graphed as a percentage of the total protein produced 
by each group of cells. Similar to the previous findings, no change in the expression 
levels of IL-6 (Fig 3.4C, E) and IL-8 was noticed, either basally or after LPS 
stimulation. 
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Figure 3.4 N-9 pre-treatment has no effect on the ability of End1/E6E7 cells to 
secrete proinflammatory cytokines basally and after LPS stimulation. Confluent 
End1/E6E7 cells were seeded at 200,000 cells per well for 48 hours in growth medium. 
Following this, cells were treated with 4 μg/ml N-9 in CCM or CCM alone for 2 h and 
then with CCM alone or 1 μg/ml LPS in CCM. No effect on IL-6, IL-8, CXCL-1 and 
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CXCL-10 levels was found as assessed using a cytokine array (A). No effect was found 
on IL-6 and IL-8 absolute levels as assessed by ELISA (B, D respectively) or levels 
relative to total protein as assessed by ELISA and total protein assay (C, E 
respectively) (Unpaired t-test with Welch’s correction). 
 
3.2.4 Ureaplasma urealyticum effect on TLR gene expression 
on HeLa cells 
While ascending to the uterus, the bacteria most commonly associated with PTB first 
come in contact with the cervical epithelium. To identify whether an infection with 
Ureaplasma urealyticum could result in upregulation of TLRs by cervical epithelial 
cells, HeLa cells were treated with 107 CCU/ml U. urealyticum for 24 h. The gene 
expression of TLR1, TLR2, TLR3, TLR4, TLR6, TLR7 and TLR9 relative to the 
vehicle-treated cells were analysed by qPCR. 
The expression of the TLRs examined did not demonstrate any statistically significant 
changes between cells treated with U. urealyticum and those treated with the vehicle 
control USM (Fig 3.5). 
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Figure 3.5 Ureaplasma urealyticum infection of HeLa cells does not result in 
significant changes of TLRs mRNA levels. Confluent HeLa cells were seeded at 
100,000 cells per well for 48 hours in growth medium. Following this, cells were 
treated either with Ureaplasma urealyticum (107 CCU/ml in USM) or with vehicle 
control (USM alone) for 24 h. Quantitative Real-Time PCR showed no changes in the 
mRNA expression of TLRs in cells infected with Ureaplasma urealyticum. Error bars 
represent SD. Statistical significance was determined using the Holm-Sidak method 
on DDCt values.  
               
3.2.5 Ureaplasma urealyticum effect on cytokine and 
chemokine secretion on HeLa cells 
To assess whether HeLa cells could respond to an infection with U. urealyticum by 
secreting proinflammatory cytokines and chemokines, a Luminex multiplex assay on 
cell culture supernatants after 24-h treatment with with 107 CCU/ml U. urealyticum or 
USM was performed. A panel of 17 cytokines and chemokines was examined. 
Luminex assay revealed 9 of these cytokines (IL-6, IL-8, GM-CSF, INFγ, IP-10, MCP-
1, MIP-1b, RANTES and TNFa) are secreted by the HeLa cells but their levels are not 
altered in the presence of an infection with U. urealyticum (Fig 3.6). 
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Figure 3.6 Ureaplasma urealyticum infection of HeLa cells has no effect on the 
levels of secreted proinflammatory cytokines. Confluent HeLa cells were seeded at 
100,000 cells per well for 48 hours in growth medium. Following this, cells were 
treated either with Ureaplasma urealyticum (107 CCU/ml in USM) or with vehicle 
control (USM alone) for 24 h. A Luminex assay showed no difference in the levels of 
secreted proinflammatory cytokines with Ureaplasma urealyticum infection. 
Statistical significance was determined using the Holm-Sidak method. 
 
3.2.6 Ureaplasma urealyticum effect on TLR gene expression 
on HESC cells 
If the physical epithelial barrier is compromised, the bacteria can then be exposed to 
the underlying stroma. To identify whether an infection with Ureaplasma urealyticum 
could result in upregulation of TLRs by endometrial stromal cells that closely resemble 
cervical stromal cells, HESC cells were treated with 107 CCU/ml U. urealyticum for 
24 h. The gene expression of TLR1, TLR2, TLR3, TLR4, TLR6, TLR7 and TLR9 
relative to the vehicle-treated cells were analysed by qPCR. 
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No significant changes were found in the gene expression of TLRs following treatment 
with U. urealyticum (Fig 3.7). 
 
Figure 3.7 Ureaplasma urealyticum infection of HESC cells does not result in 
significant changes of TLRs mRNA levels. Confluent HeLa cells were seeded at 
100,000 cells per well for 48 hours in growth medium. Following this, cells were 
treated either with Ureaplasma urealyticum (107 CCU/ml in USM) or with vehicle 
control (USM alone) for 24 h. Quantitative Real-Time PCR showed no changes in the 
mRNA expression of TLRs in cells infected with Ureaplasma urealyticum. Error bars 
represent SD. Statistical significance was determined using the Holm-Sidak method 
on DDCt values.                
 
3.2.7 Ureaplasma urealyticum effect on cytokine and 
chemokine secretion on HESC cells 
To assess whether HESC cells could respond to an infection with U. urealyticum by 
secreting proinflammatory cytokines and chemokines, a Luminex multiplex assay on 
cell culture supernatants after 24-h treatment with with 107 CCU/ml U. urealyticum or 
USM was performed. A panel of 17 cytokines and chemokines was examined. 
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Luminex assay revealed 8 of these cytokines (GROa, IL-8, G-CSF, GM-CSF, INFγ, 
MCP-1, MIP-1b and TNFa) are secreted by the HeLa cells but their levels are not 
altered in the presence of an infection with U. urealyticum (Fig 3.8). 
 
Figure 3.8 Ureaplasma urealyticum infection of HESC cells has no effect on the 
levels of secreted proinflammatory cytokines. Confluent HeLa cells were seeded at 
200,000 cells per well for 48 hours in growth medium. Following this, cells were 
treated either with Ureaplasma urealyticum (107 CCU/ml in USM) or with vehicle 
control (USM alone) for 24 h. A Luminex assay showed no difference in the levels of 
secreted proinflammatory cytokines with Ureaplasma urealyticum infection. 
Statistical significance was determined using the Holm-Sidak method. 
 
3.2.8 Ureaplasma urealyticum effect on wound healing 
capacity of HeLa cells 
It is the hypothesis of this thesis that cervical damage predisposes to ascending 
infection. In the case of cervical damage, vaginal bacteria ascending to the uterus will 
encounter a damaged cervical epithelium. To assess the effect of U. urealyticum on 
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the wound healing capacity of cervical epithelial cells, an artificial wound was created 
on a HeLa cells’ monolayer and wound closure efficiency was examined in the 
presence of infection for 48 h. 
24 h after the wound was created the cell density in the wound area relative to the cell 
density outside the wound are was significantly lower for the cells that were infected 
with U. urealyticum (24.02±3.47% for Ureaplasma vs 29.42±2.84% for vehicle, 
P=0.0135). Similar were the findings 48 h after the wound was created (25.68±3.62% 
for Ureaplasma vs 31.95±3.099% for vehicle, P=0.0111) (Fig 3.9A, B). 
During the whole 48 h, the relative wound density of the Ureaplasma-treated cells was 
consistently lower than the vehicle-treated cells (Fig 3.9C). 
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Figure 3.9 Ureaplasma urealyticum infection diminishes the wound healing 
capacity of HeLa cells. Confluent HeLa cells were seeded at 50,000 cells per well for 
48 hours in growth medium. Following this, an artificial wound was created using a 
10μl pipette tip (A, yellow). Cells were treated either with Ureaplasma urealyticum 
(107 CCU/ml in USM) or with vehicle control (USM alone) and the closure of the 
artificial wound (A, blue) was monitored every 2 h using the IncuCyte Zoom system. 
Ureaplasma urealyticum infection results in a significantly decreased relative wound 
density compared to vehicle control at 24 and 48 h (B). Curves comprising all time 
points for Vehicle and Ureaplasma (C) (each data point is an average of n=4 
experimental repeats).  Error bars represent SD. Statistical significance was determined 
using a paired t-test (*P<0.05 for Ureaplasma vs. vehicle at 24 and 48 h). 
 
3.2.9 Ureaplasma urealyticum effect on wound healing 
capacity of HESC cells 
In the case of cervical damage, vaginal bacteria ascending to the uterus will encounter 
an underlying cervical stroma as well. To assess the effect of U. urealyticum on the 
wound healing capacity of stromal cells, an artificial wound was created on a HESC 
cells’ monolayer and wound closure efficiency was examined in the presence of 
infection for 48 h. 
24 h after the wound was created there was no difference in the relative wound density 
between infected and uninfected cells (28.35±3.18% for Ureaplasma vs 30.8±3.15% 
for vehicle). However, at 48 h, the Ureaplasma-infected cells had a significantly lower 
relative wound density compared to the vehicle-treated cells (44.94±2.22% for 
Ureaplasma vs 51.49±3.32% for vehicle, P=0.012) (Fig 3.10A, B). 
During the 48 h-monitoring of the wound, the relative wound density of the 
Ureaplasma-treated cells was similar to that of the vehicle-treated cells for the first 28 
h. After this, infected cells had a consistently lower relative wound density compared 
to the uninfected ones (Fig 3.10C). 
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Figure 3.10 Ureaplasma urealyticum infection diminishes the wound healing 
capacity of HESC cells. Confluent HESC cells were seeded at 50,000 cells per well 
for 48 hours in growth medium. Following this, an artificial wound was created using 
a 10μl pipette tip (A, yellow). Cells were treated either with Ureaplasma urealyticum 
(107 CCU/ml in USM) or with vehicle control (USM alone) and the closure of the 
artificial wound (A, blue) was monitored every 2 h using the IncuCyte Zoom system. 
Ureaplasma urealyticum infection results in a significantly decreased relative wound 
density compared to vehicle control at 48 h (B). Curves comprising all time points for 
Vehicle and Ureaplasma (C) (each data point is an average of n=4 experimental 
repeats).  Error bars represent SD. Statistical significance was determined using a 
paired t-test (*P=0.012 for Ureaplasma vs. vehicle at 48 h). 
 
3.2.10 Ureaplasma urealyticum effect on TLR gene 
expression on Swan 71 cells 
The Ureaplasma spp have been associated with histological chorioamnionitis with 
placental lesions. To identify whether an infection with Ureaplasma urealyticum could 
result in upregulation of TLRs by trophoblast cells, Swan 71 cells were treated with 
107 CCU/ml U. urealyticum for 24 h. The gene expression of TLR1, TLR2, TLR3, 
TLR4, TLR6, TLR7 and TLR9 relative to the vehicle-treated cells were analysed by 
qPCR. 
Among the TLRs that were examined, TLR9 demonstrated a statistically significant 
increase in its gene expression levels relative to the cells treated with the vehicle USM. 
In particular, TLR9 expression increased by 1.8±0.05-fold relative to USM (P=0.049 
for Ureaplasma vs vehicle) (Fig 3.11).  
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Figure 3.11 Ureaplasma urealyticum infection of Swan 71 cells results in a 
significant up-regulation of TLR9 mRNA levels. Confluent Swan 71 cells were 
seeded at 100,000 cells per well for 48 hours in growth medium. Following this, cells 
were treated either with Ureaplasma urealyticum (107 CCU/ml in USM) or with 
vehicle control (USM alone) for 24 h. Quantitative Real-Time PCR revealed a 
statistically significant increase in the mRNA expression of TLR9 in cells infected 
with Ureaplasma urealyticum. Error bars represent SD. Statistical significance was 
determined using the Holm-Sidak method on DDCt values (adjusted P=0.049 for 
TLR9). 
 
3.2.11 Ureaplasma urealyticum effect on cytokine and 
chemokine secretion on Swan 71 cells 
To assess whether Swan 71 cells could respond to an infection with U. urealyticum by 
secreting proinflammatory cytokines and chemokines, a Luminex multiplex assay on 
cell culture supernatants after 24-h treatment with with 107 CCU/ml U. urealyticum or 
USM was performed. A panel of 17 cytokines and chemokines was examined. 
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Luminex assay revealed 9 of these cytokines (GROa, IL-6, IL-8, G-CSF, GM-CSF, 
INFγ, IP-10, MCP-1, MIP-1a, MIP-1b, RANTES and TNFa) are secreted by the HeLa 
cells but their levels are not altered in the presence of an infection with U. urealyticum 
(Fig 3.12). 
 
Figure 3.12 Ureaplasma urealyticum infection of Swan 71 cells has no effect on the 
levels of secreted proinflammatory cytokines. Confluent HeLa cells were seeded at 
100,000 cells per well for 48 hours in growth medium. Following this, cells were 
treated either with Ureaplasma urealyticum (107 CCU/ml in USM) or with vehicle 
control (USM alone) for 24 h. A Luminex assay showed no difference in the levels of 
secreted proinflammatory cytokines with Ureaplasma urealyticum infection. 
Statistical significance was determined using the Holm-Sidak method. 
 
3.3 Discussion 
The cervical epithelium is key for the barrier function of the cervix during pregnancy 
as it protects from ascending infection with vaginal bacteria. Cervical epithelial injury 
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increases the risk for preterm delivery. The surfactant N-9 has been shown to cause 
epithelial damage in the lower reproductive tract, however its effects during pregnancy 
have not been studied. In the first part of this chapter we examined whether N-9 could 
disrupt the physical and functional epithelial barrier against infection by endocervical 
cells in vitro. 
Firstly, we assessed the effect of N-9 on the endocervical cells’ viability. Using a 
metabolic activity MTT assay, we found that N-9 decreased the cells’ viability in dose- 
and time-dependent manner. The low N-9 doses (below 10 µg/ml) had no effect on the 
cells’ viability while the high doses (above 100 µg/ml) practically resulted in killing 
all the cells. The intermediate doses of 16, 32 and 64 µg/ml had an effect that was 
intensified with increased incubation times. These findings are in complete agreement 
with two previous studies. At first, D’Cruz et al. used the same assay to find a very 
similar viability trendline after 24-hours treatments with N-9 (412). Shortly after, 
Fichorova et al. found using the closely related MTS (3-(4,5-dimethylthiazol-2-yl)-5-
(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) assay that N-9 
cytotoxicity levels for End1/E6E7 cells start at 8 µg/ml (413). These results helped 
define the cytotoxicity thresholds that were crucial for the design of subsequent 
experiments. 
To assess the effect of N-9 on the physical barrier function of the cervical epithelium, 
we used an in vitro permeability assay. This assay provides a direct indication of 
permeability by quantifying the movement of FITC-Dextrans through a monolayer. 
We found that high (100 µg/ml) and medium (30 µg/ml) doses of N-9 are able to 
disrupt the continuity of an endocervical cells’ monolayer and thus increase their 
epithelial permeability. This is in agreement with in vivo studies in the rat (387) and 
the rabbit (409) showing an increase in the permeability of the vaginal epithelium after 
N-9 application. In humans, N-9 was also shown to increase the permeability of the 
vaginal (414) as well as the rectal epithelium (415). Low doses of N-9 (3 and 10 µg/ml) 
did not have the same effect. In these cases, the monolayer was intact and the 
permeability remained unchanged. Therefore, the permeability was increased only 
after disruption of the continuity of the monolayer as a result of administering 
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cytotoxic N-9 doses. This suggests that N-9 can compromise the barrier function of 
the cervical epithelium only in doses that are high enough to mediate epithelial 
cytotoxicity. Since N-9 can integrate in the cell membranes due to its characteristic 
chemical structure as a surfactant, it is plausible to assume that it could also increase 
the permeability even without demonstrating its cytotoxic effect. However, N-9 has 
probably no effect in the cell adhesion properties of endocervical cells. This is because 
when the monolayer was intact, even in the presence of low doses of N-9, the 
permeability was stable.   
Next, we investigated the effect of N-9 on the functional barrier of the cervical 
epithelium by assessing whether it could disrupt the ability of endocervical cells to 
secrete proinflammatory cytokines and chemokines basally and upon 24 h LPS 
stimulation.  Using further viability and cytotoxicity assays, we determined that a low 
dose of 4 µg/ml N-9 was ideal for a 2 h pre-treatment of the cells before administering 
growth medium or LPS for a further 24 h. This treatment scheme resulted in around 
75% viability at the end of the experiment, indicating that it did have an effect on the 
cells which was totally attributable to N-9 as LPS alone resulted in practically 100% 
viability. An intermediate dose of 40 µg/ml N-9 resulted in 0% viability at the end of 
the treatment scheme. Our previous results using the same dose for 2 h without an 
extra 24 h of further non-cytotoxic treatments showed a viability of around 75%. Taken 
together, these findings suggest that N-9 has a prolonging cytotoxic effect that 
continues even after its removal from the culture medium. 
Using a cytokine proteomic array, we found no effect of 4 µg/ml N-9 pre-treatment in 
the levels of IL-6, IL-8, CXCL-1 and CXCL-10 after 24 h of treatment either with 
culture medium only or with LPS. The findings for IL-6 and IL-8 were also confirmed 
using ELISA. Since the N-9 pre-treatment at this dose results in about 25% 
cytotoxicity, we quantified the total protein using a protein assay and expressed the 
levels of IL-6 and IL-8 as a percentage of this. As the total secreted protein is directly 
proportional to the amount of viable cells in each well, this allowed us to normalise 
for the cytotoxic effect of N-9. After normalisation, the levels of IL-6 and IL-8 were 
almost identical between samples pre-treated with 4 µg/ml N-9 and those treated with 
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vehicle. Therefore, N-9 had no effect on the ability of these cells to secrete cytokines 
and chemokines. N-9 itself has been shown to increase the secretion of IL-1a, IL-1b 
and IL-8 (413). However, in our experiments we tried to assess the N-9 potential as a 
damage inducer that could predispose to infection. This is why the cells were pre-
treated with N-9 and then, after removal of the medium, treated with LPS. In 
conclusion, we found that the functional barrier of the cervical epithelium against 
infection is not compromised by N-9. 
Ascending infection with vaginal bacteria is the most common cause of preterm birth 
(113). Among the bacteria implicated in preterm birth, the most common ones belong 
to the Ureaplasma spp (410). In the second part of this chapter, we assessed whether 
Ureaplasma urealyticum could stimulate cervical cells to initiate an inflammatory 
response. This set of experiments were performed during the visit of the author of this 
thesis at Yale University School of Medicine. Initial attempts to grow End1/E6E7 cells 
were proven unsuccessful. Given the time constraints, the use of HeLa cells was 
decided instead. HeLa cells are derived from an epidermoid carcinoma of the cervix 
(397) and therefore less representative of the normal cervical epithelial physiology 
compared to End1/E6E7 cells who were isolated from a healthy cervix (393). 
However, they both come from the same tissue and they both avoid cell senescence, 
HeLa being naturally immortal and End1/E6E7 being immortalised by transfection 
with the Human Papilloma Virus 16 (HPV16) oncogenes E6 and E7. 
During ascending infection the first cells that come in contact with Ureaplasma spp 
are the cervical epithelial cells. We infected HeLa cells with U. urealyticum and 
assessed potential changes in the expression of TLRs at the mRNA level. TLR1, TLR2, 
TLR6 and TLR9 have been implicated in the mechanism of entry of the U. parvum in 
amniotic epithelial cells (223) (224). However, here we found no statistically 
significant changes. In addition, we found that there was no difference in the levels of 
an array of secreted cytokines and chemokines in the supernatant of infected and 
uninfected cells, as assessed by a Luminex assay. This suggests that TLR pathways 
were not stimulated by the infection and there was no overall inflammatory response. 
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The working hypothesis of this thesis is that cervical epithelial damage predisposes to 
ascending infection with Ureaplasma spp. Upon epithelial injury, the cervical stroma 
gets exposed to the infectious stimuli. As a cervical stromal cell line is not readily 
available, we used the closely related endometrial stromal cell line HESC to assess if 
these cells can react to an infection with U. urealyticum by stimulating inflammation. 
Similar to the HeLa cells we found no changes in TLRs gene expression and no effect 
on cytokine secretion after a 24 h-infection, indicating an absence of an inflammatory 
response. 
Ureaplasma spp have been described as causative agents of chorioamnionitis that can 
cause placental lesions (416). Here we tested whether an infection with U. urealyticum 
could result in an inflammatory response by the trophoblast cell line Swan 71. A 
minimal yet statistically significant 2-fold upregulation was noticed only for TLR9, 
with no significant changes in the gene expression of the other TLRs. Taking into 
account the minimal effect along with the absence of any effect on cytokine secretion, 
it is most likely that this observation does not represent a result of biological 
significance. Still, there was again no effect on the levels of secreted cytokines. 
Taken together, data on TLR gene expression and secreted cytokine protein levels 
suggest that U. urealyticum does not stimulate an inflammatory response by these 
cells. This can be explained by both the low virulence of the microorganism and the 
limited capacity of these cells to acquire a strong inflammatory phenotype compared 
to immune cells. 
To simulate cervical damage in vitro, we created an artificial wound at the bottom of 
a well containing HeLa or HESC cells. We found using a wound healing assay that 
infection with U. urealyticum diminishes the wound healing capacity of both HeLa 
and HESC cells. This is a reasonable finding as infection of a wound is known to 
prolong the wound closure or maintain chronicity of the damage (417). However, this 
is the first time such a report is made about the Ureaplasma spp. This is particularly 
important and could have implications on preterm birth mechanisms as cervical 
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damage is associated with PTB and Ureaplasma spp are the most common bacteria 
isolated from the amniotic fluid of preterm deliveries. 
In summary, the results from the first part of this chapter demonstrate the capacity of 
N-9 to compromise the barrier function of the cervical epithelium due to its 
cytotoxicity against cervical epithelial cells. We therefore describe an in vitro model 
of cervical epithelial damage and identify N-9 as a solid damage inducer that could be 
tested in vivo to generate our proposed model of cervical damage during pregnancy. 
This is the focus of the next chapter. Data from the second part suggest that U. 
urealyticum does not stimulate a robust inflammatory response by non-immune cells 
from the reproductive tissues. However, it can negatively affect the ability of epithelial 
and stromal cells to close the wound, as in the event of cervical damage.  
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Chapter 4 Generation and characterisation of a 
new mouse model of cervical 




The mouse represents a valuable model for the study of preterm birth mechanisms. In 
parturition research, mouse models of PTB have been extensively used since their 
establishment. Various models have been described including PTB induced in the 
absence of inflammation, by sterile inflammation or by infections/inflammatory 
stimuli. Representative examples of the above models include the progesterone 
receptor antagonist RU486 (372), the DAMP HMGB1 (379) and the gram (-) bacterial 
product LPS (364). Most models use the administration of LPS. 
Cervical damage has also been associated with PTB. Specifically, excisional 
procedures that remove part of the cervical epithelium and the underlying stroma 
significantly increase the risk for preterm delivery by at least 100% (304) (305). 
However, this association has not been studied in experimental models. To our 
knowledge, no model of cervical damage during pregnancy to study its role in PTB 
has been described so far. 
The surfactant N-9 has been used as a spermicidal component for decades. It was also 
considered a potential topical microbicide against sexually transmitted diseases 
(STDs) (406). After a large Randomised Clinical Trial (RCT) found that N-9 actually 
increased the risk for HIV transmission (418), its safety profile has been evaluated in 
preclinical animal models. 
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Experiments in these models revealed significant irritation of the cervical and vaginal 
mucosa in non-pregnant rabbits and rats (419). Other studies reported an important 
disruption of the continuity of the epithelial layers with a significant submucosal 
oedema (420). Acute inflammation was also described in the rats (407).    
In non-pregnant mice, a single application of N-9 was also found to cause disruption 
of the cervical and vaginal epithelium, resulting in complete sloughing of the former 
8 h post-administration (391). Single N-9 administration for consecutive days was 
shown to diminish the cervical toxicity observed compared to a single administration 
of like duration (392).  
Studies in non-human primates that more closely resemble the human anatomy and 
physiology yielded similar results. Using colposcopy, the examination of the lower 
genital tract in this species revealed significant irritation with signs of acute 
inflammation (390). This involved the presence of neutrophils and macrophages (389). 
Epithelial disruption was made apparent through the presence of whole sheets of 
epithelial cells in the vaginal fluid (389). 
In humans, erythematous irritation after vaginal application of N-9 is observed, both 
in the vagina and the cervix (421). Once-daily applications for a few days result in 
significant irritation and inflammation but not in epithelial disruption (422). After 
multiple daily applications, cervical and vaginal epithelial disruption was observed by 
colposcopy in a significant percentage of women (423). These abnormalities have been 
shown to be dose-dependent (424). 
Findings from preclinical and clinical models agree that N-9 can cause significant 
damage in the lower reproductive tract. However, its effects during pregnancy have 
not been studied yet.  
The work described in the first part of the previous chapter found that N-9 can 
compromise the barrier function of endocervical cells in vitro. These data, along with 
data from non-pregnant animals and humans described above, suggest that N-9 could 
be used to establish a mouse model of cervical damage during pregnancy.  The aim of 
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this chapter is to develop and characterise this model using N-9 and then assess its 
effects on timing of delivery and pup survival. 
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4.2 Results 
To generate a mouse model of cervical damage during pregnancy, timed pregnant mice 
were treated on D17 with 3 different doses of N-9 (2%, 5% and 10% v/v in PBS) for 
8 h. Tissues were collected to be analysed for signs of damage using histological 
methods. 
4.2.1 Effect of vaginal N-9 on cervical epithelial morphology 
during pregnancy 
To assess the effect of N-9 on cervical epithelial tissue integrity, AB/PAS staining was 
used to identify the epithelial cells of the cervix based on their ability to produce 
mucins. 
To quantify the disruptions of the epithelial morphology caused by N-9, a new 
histopathological epithelial injury score was developed. This involved two different 
features: Epithelial morphology and area involved. Three different morphologies were 
described and scored: Intact morphology was given 1 point, Disturbance was given 2 
points and Sloughing was given 3 points. Representative images can be seen (Fig 
4.1A). For Disturbance and Sloughing only, the area involved was also described and 
scored: less than 10% of the total surface area was given 0 points, 10% to 50% of the 
total surface was given 1 point and more than 50% was given 2 points (Fig 4.1A). The 
total score for each section was Morphology+ Area involved. 
All three N-9 doses resulted in a significantly increased epithelial injury score. The 
2% N-9 was scored at 4.033±0.36 (P=0.0043), the 5% N-9 at 3.89±0.29 (P=0.0265) 
and the 10% N-9 at 4.42±0.48 (P=0.0033) compared to 1.54±0.36 for the PBS control 
(Fig 4.1B). 
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Figure 4.1 Intra-vaginal N-9 disrupts cervical epithelial morphology during 
pregnancy in a mouse model. In the morning of D17 of gestation, mice received 
either N-9 (2%, 5% or 10% in PBS) or PBS control via intravaginal inoculation. 8 h 
later mice were sacrificed for tissue collections. Cervical tissue sections were stained 
with AB/PAS and a morphological damage scoring system was used to assess 
epithelial damage (A). N-9 significantly damages the morphology of the cervical 
epithelium during pregnancy (B). Error bars indicate SD. Statistical significance was 
assessed using 1-way ANOVA with Dunnett’s multiple comparisons test against PBS 
group (**P<0.005 for 2% N-9 and 10% N-9 vs. PBS, *P<0.05 for 5% N-9 vs. PBS). 
 
All samples were assessed by two independent assessors who were blinded to 
treatment allocation. Inter-observer reliability was calculated (Weighted Cohen’s 
kappa=0.952) (Table 4-1). 
Table 4-1 Inter-rater reliability for the assessment of Morphological epithelial 
damage in the cervix. Numbers in bold represent the scores given by the assessors. 
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4.2.2 Effect of vaginal N-9 on vaginal epithelial morphology 
during pregnancy 
The same epithelial injury score was also utilised to assess the effect of N-9 in the 
vaginal epithelial integrity. Representative images of Intact morphology, Disturbance 
and Sloughing for the vaginal epithelium can be seen in Fig 4.2A. 
As in the cervix, all three N-9 doses resulted in a significantly increased epithelial 
injury score. The 2% N-9 was scored at 4.08±0.37 (P=0.0075), the 5% N-9 at 
3.56±0.95 (P=0.0434) and the 10% N-9 at 4.42±0.37 (P=0.0033) compared to 
1.54±0.36 for the PBS control (Fig 4.2B). 
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Figure 4.2 Intra-vaginal N-9 disrupts the vaginal epithelial morphology during 
pregnancy in a mouse model. In the morning of D17 of gestation, mice received 
either N-9 (2%, 5% or 10% in PBS) or PBS control via intravaginal inoculation. 8 h 
later mice were sacrificed for tissue collections. Vaginal tissue sections were stained 
with AB/PAS and a morphological damage scoring system was used to assess 
epithelial damage (A). N-9 significantly damages the morphology of the vaginal 
epithelium during pregnancy (B). Error bars indicate SD. Statistical significance was 
assessed using 1-way ANOVA with Dunnett’s multiple comparisons test against PBS 
group (**P<0.005 for 2% N-9 and 10% N-9 vs. PBS, *P<0.05 for 5% N-9 vs. PBS). 
All samples were assessed by two independent assessors who were blinded to 
treatment allocation. Inter-observer reliability was calculated (Weighted Cohen’s 
kappa=0.774) (Table 4-1). 
Table 4-2 Inter-rater reliability for the assessment of Morphological epithelial 
damage in the vagina. Numbers in bold represent the scores given by the 
assessors. The other numbers represent the amount of samples that were given 
each score combination. 
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4.2.3 Cervical infiltration of polymorphonuclear neutrophils 
after vaginal N-9 administration during pregnancy 
Upon tissue injury as the one described in the previous section, an inflammatory 
response is initiated and neutrophils are among the first immune cells to arrive on site. 
To assess neutrophil infiltrations following N-9 administration, Ly6G 
immunohistochemistry on tissue sections was performed. 
To allow for accurate quantification of these infiltrations, a new neutrophil infiltration 
score assessing both the epithelium and the sub-epithelial stroma was described. For 
the epithelium: No epithelial infiltrations were given 0 points, infiltrated area 0% to 
10% of the total surface area was given 1 points, infiltrated area 10% to 50% of the 
total surface area was given 2 points and more than 50% was given 3 points (Fig 4.3A). 
For the sub-epithelial stroma: An average of 0-1 neutrophils per field of interest (FOI) 
was given 1 point, an average of 1-3 neutrophils per FOI was given 2 points and more 
than 3 neutrophils per FOI were given 3 points (Fig 4.3B). Representative images can 
be seen (Fig 4.3A, B). The total score for each section was Epithelium+ Sub-epithelial 
stroma. 
The highest dose of 10% N-9 resulted in a significantly increased neutrophil 
infiltration score in the cervix of pregnant mice (3.75±0.75, P=0.0147) compared to 
PBS control (1±0) (Fig 4.3C). The 2% N-9 (2.75±0.75, P=0.1234) and the 5% N-9 
(1.33±0.33, P=0.962) doses did not demonstrate statistically significant differences 
compared to the control group (Fig 4.3C). 
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Figure 4.3 Intra-vaginal N-9 results in polymorphonuclear neutrophils 
infiltrations in the cervix during pregnancy in a mouse model. In the morning of 
D17 of gestation, mice received either N-9 (2%, 5% or 10% in PBS) or PBS control 
via intravaginal inoculation. 8 h later mice were sacrificed for tissue collections. Anti-
Ly6G immunohistochemistry on cervical tissue sections was used to assess the 
presence of neutrophils. A neutrophil infiltration scoring system was used to quantify 
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the presence of neutrophils in the cervical epithelium (A) and stroma (B), the total 
score being the sum of the two. 10% N-9 significantly increased the neutrophil 
infiltrations in the cervix (C). Arrowheads indicate positively stained cells. Error bars 
indicate SD. Statistical significance was assessed using 1-way ANOVA with Dunnett’s 
multiple comparisons test against PBS group (*P<0.05 for 10% N-9 vs. PBS). 
All samples were assessed by two independent assessors who were blinded to 
treatment allocation. Inter-observer reliability was calculated (Weighted Cohen’s 
kappa=0.874) (Table 4-3). 
Table 4-3 Inter-rater reliability for the assessment of neutrophil infiltrations in 
the cervix. Numbers in bold represent the scores given by the assessors. The other 
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4.2.4 Vaginal infiltration of polymorphonuclear neutrophils 
after vaginal N-9 administration during pregnancy 
The same neutrophil infiltrations score was also utilised to assess the effect of N-9 in 
the vaginal tissue. Representative images of all conditions for the vaginal epithelium 
and sub-epithelial stroma can be seen in Fig 4.4A, B. 
Similar to the finding in the cervix, the highest dose of 10% N-9 resulted in a 
significantly increased neutrophil infiltration score in the vagina of pregnant mice 
(5.5±0.5, P=0.0032) compared to PBS control (1.25±0.25) (Fig 4.4C). In addition, the 
dose of 2% N-9 resulted in a significantly increased score as well when compared to 
PBS control (4.75±0.63, P=0.0115) (Fig 4.4C). The 5% N-9 (3.67±1.45, P=0.1046) 
dose showed no statistically significant changes (Fig 4.4C). 
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Figure 4.4 Intra-vaginal N-9 results in polymorphonuclear neutrophils 
infiltrations in the vagina during pregnancy in a mouse model. In the morning of 
D17 of gestation, mice received either N-9 (2%, 5% or 10% in PBS) or PBS control 
via intravaginal inoculation. 8 h later mice were sacrificed for tissue collections. Anti-
Ly6G immunohistochemistry on vaginal tissue sections was used to assess the 
presence of neutrophils. A neutrophil infiltration scoring system was used to quantify 
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the presence of neutrophils in the vaginal epithelium (A) and stroma (B), the total score 
being the sum of the two. N-9 significantly increased the neutrophil infiltrations in the 
vagina (C). Error bars indicate SD. Statistical significance was assessed using 1-way 
ANOVA with Dunnett’s multiple comparisons test against PBS group (**P<0.005 for 
10% N-9 vs. PBS, *P<0.05 for 2% N-9 vs. PBS). 
All samples were assessed by two independent assessors who were blinded to 
treatment allocation. Inter-observer reliability was calculated (Weighted Cohen’s 
kappa=0.849) (Table 4-4). 
Table 4-4 Inter-rater reliability for the assessment of neutrophil infiltrations in 
the vagina. Numbers in bold represent the scores given by the assessors. The other 
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4.2.5 Increased proliferation of the basal cells of the cervical 
epithelium during pregnancy after vaginal N-9 
administration 
As a response to tissue injury, an epithelial regeneration process is initiated, 
characterised by increased proliferation of the basal cells. To assess whether N-9 
treatment resulted in increased epithelial regeneration as an indirect indication of 
epithelial damage, Ki67 immunohistochemistry was performed on cervical tissues. 
The percentage of proliferating cells at the basal layer of at least 1mm of the cervical 
epithelium was quantified. Representative images are shown on Fig 4.5A. 
All three doses of N-9 significantly increased the percentage of proliferating cells at 
the basal layer of the cervical epithelium compared to PBS control. The 2% N-9 dose 
resulted in 42.21±2.96% of the cells being positively stained (P=0.0437); the 5% N-9 
dose resulted in 43.94±2.66% being positively stained (P=0.0298); and the 10% N-9 
dose resulted in 50.46±3.47% being positively stained (P=0.0011), whereas the 
percentage of proliferating cells for the PBS control was 31.73±1.2% (Fig 4.5B).   
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Figure 4.5 Intra-vaginal N-9 results in increased proliferation of the basal cells of 
the cervical epithelium during pregnancy in a mouse model. In the morning of D17 
of gestation, mice received either N-9 (2%, 5% or 10% in PBS) or PBS control via 
intravaginal inoculation. 8 h later mice were sacrificed for tissue collections. Anti-
Ki67 immunohistochemistry on cervical tissue sections was used to assess cellular 
proliferation at the basal layer of the cervical epithelium. Representative images are 
shown (A). The percentage of Ki-67 positive cells was calculated across an area 
covering at least 1mm of the basal layer. N-9 significantly increases cellular 
proliferation at the cervix basal layer (B). Error bars indicate SD. Statistical 
significance was assessed using 1-way ANOVA with Dunnett’s multiple comparisons 
test against PBS group (**P<0.005 for 10% N-9 vs. PBS, *P<0.05 for 2% N-9 and 5% 
N-9 vs. PBS). 
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4.2.6 No change on cell proliferation at the basal layer of the 
vaginal epithelium during pregnancy after vaginal N-9 
administration 
In the vagina, the percentage of proliferating cells at the basal layer of at least 1mm of 
the epithelium was quantified. Representative images are shown on Fig 4.6A. 
None of the three doses of N-9 significantly increased the percentage of proliferating 
cells at the basal layer of the vaginal epithelium compared to PBS control-treated 
animals. The percentage of proliferating cells in the basal layer was 85.31±2.16% for 
mice treated with 2% N-9, 84.56±4.17 for mice treated with 5% N-9 and 86.08±2.64 
for mice treated with 10% N-9 (Fig 4.6B). In PBS-treated animals, the respective 
proportion was79.58±1.9%.  
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Figure 4.6 Intra-vaginal N-9 has no effect on cell proliferation of the basal cells 
of the vaginal epithelium during pregnancy in a mouse model. In the morning of 
D17 of gestation, mice received either N-9 (2%, 5% or 10% in PBS) or PBS control 
via intravaginal inoculation. 8 h later mice were sacrificed for tissue collections. Anti-
Ki67 immunohistochemistry on vaginal tissue sections was used to assess cellular 
proliferation at the basal layer of the vaginal epithelium. Representative images are 
shown (A). The percentage of Ki-67 positive cells was calculated across an area 
covering at least 1mm of the basal layer. N-9 has no effect on cellular proliferation at 
the vaginal basal layer (B). Error bars indicate SD. Statistical significance was assessed 
using 1-way ANOVA with Dunnett’s multiple comparisons test against PBS group. 
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4.2.7 The effects of N-9-induced epithelial damage on timing 
of delivery and pup survival  
To assess whether N-9-induced cervicovaginal epithelial damage could result in 
preterm delivery and whether there would be any effect on pup survival, a time-to-
delivery experiment was conducted. On D17 of pregnancy, timed pregnant mice were 
given an intravaginal inoculation of the three N-9 doses that were used for generating 
and characterising the model as shown before. A further dose of 40% v/v N-9 was also 
used to generate a dose response. Timing of delivery of the first pup post-
administration was monitored using CCTV. The percentage of pups born alive was 
calculated for each mouse. 
None of the administered doses had any effect on timing of delivery. Mice treated with 
PBS delivered at an average of 57.93±2 hours post-administration. Mice treated with 
2% N-9 delivered 60.05±4.97 hours post-administration. Those treated with 5% N-9 
delivered 58.1±3.58 hours post-administration. The ones that received 10% N-9 
delivered 64.34±4.18 hours post-administration. Finally, mice treated with the highest 
dose of 40% N-9 delivered 68.3±3.66 hours post-administration (Fig 4.7A).  
There was also no effect on the percentage of live born pups for any of the N-9 groups. 
As expected, the average percentage of live born pups for all mice treated with PBS 
98±2%. The percentages for the N-9 treated mice were 97.8±2.2%, 98±2%, 
96.75±2.14% and 90.6±6.49 for 2% N-9, 5% N-9, 10% N-9 and 40% N-9 respectively 
(Fig 4.7B). 
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Figure 4.7 Cervical damage caused by intra-vaginal N-9 does not affect timing of 
delivery and pup survival in a mouse model of cervical damage during pregnancy. 
In the morning of D17 of gestation, mice received either N-9 (2%, 5%, 10% or 40% 
in PBS) or PBS control via intravaginal inoculation. Time to delivery was calculated 
from the moment of intravaginal inoculation until the delivery of the first pup. N-9 had 
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no effect on timing of delivery (1-way ANOVA with Dunnett’s multiple comparisons 
test against 0% N-9) (A).  Percentage of live born pups for each mouse was calculated 
by dividing the number of live pups delivered by the total number of pups. N-9 had no 
effect on pup survival (1-way ANOVA with Dunnett’s multiple comparisons test after 
arcsine transformation of proportions against 0% N-9) (B). Error bars represent SD. 
 
4.3 Discussion 
Cervical epithelial damage has been shown to increase the risk for preterm delivery in 
humans (304). However, no mechanisms underpinning this association have been 
suggested.  It is our hypothesis that cervical epithelial damage predisposes to 
ascending infection with vaginal bacteria. To address this hypothesis, the aim of 
creating a mouse model of cervical epithelial damage during pregnancy was set. In the 
previous chapter, we identified the surfactant N-9 to be a potent inducer of cervical 
epithelial damage in vitro. The work in this chapter describes the establishment and 
characterisation of a new mouse model of cervical epithelial damage during pregnancy 
using N-9. 
N-9 was administered intravaginally in day 17 of the mouse gestation. N-9 has been 
used as a spermicidal component for female-controlled contraception for decades. The 
N-9 doses that we tried in this mouse model (2%, 5%, 10% v/v) represent the whole 
pharmacological spectrum that has been applied in humans (2-12%).  To quantify the 
extent of damage, we described a new scoring system. This system took into account 
the morphology of the epithelium after N-9 application and the extent of the damaged 
area. We found that N-9 caused a significant disruption of the cervical epithelial 
morphology 8 hours post-administration with all three doses. This disruption involved 
the presence of extensive areas of disturbance and complete sloughing of the epithelial 
layers. This findings are in agreement with reports from non-pregnant animal models 
and humans. Significant damage in the lower reproductive tract with epithelial 
disruption and shedding after vaginal application of N-9 has been found in mice (391), 
rats (407), rabbits (425) and non-human primates (390). In addition, the detrimental 
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effects of N-9 appear to extend outside the epithelium of the lower reproductive tract. 
Specifically, it has been shown to cause exfoliation of the rectal epithelium with 
exposure of the underlying stroma in mice (426) (427), rhesus monkeys (390) and 
humans (428). 
A significant disruption with all three doses of N-9 was also found in the vaginal 
epithelium of pregnant mice. The extent of damage was similar to that found in the 
cervical epithelium. Catalone et al. and Lozenski et al. reported that the damage in the 
vagina was minimal compared to the cervix (391) (392). Data from rabbits also suggest 
that the cervical epithelium is more susceptible to N-9-induced damage (420). 
However, the explanation for rabbits lies in the fact that, similar to humans, the vaginal 
epithelium consists of multiple layers of squamous cells, whereas the cervical canal 
only has a simple columnar epithelium (429). Columnar cells have been shown to be 
more susceptible to the N-9 cytotoxicity (409).  Therefore, the vaginal epithelium is 
more protected compared to the cervical. In mice though, the epithelium of the lower 
reproductive tract is continuous from the vagina to the uterus and consists of multiple 
layers of squamous cells (430). More layers are seen in the vaginal epithelium, which 
might explain the differences observed in other non-pregnant mouse models. 
Progesterone treatment has been shown to induce a columnar mucus-producing 
phenotype in the entire cervicovaginal epithelium (406). The very high pregnancy 
levels of progesterone during the course of pregnancy, as in our model, ensure this 
phenotype is consistent across the vaginal and cervical epithelium. Our AB/PAS 
staining confirms the abundance of mucins within the epithelial cells of both the cervix 
and the vagina. Thus, both epithelia are susceptible to N-9 cytotoxicity.  
Using immunohistochemistry, we found that N-9 treatment also leads to 
polymorphonuclear neutrophil populations infiltrating the epithelium and the sub-
epithelial stroma in both the cervix and the vagina. To quantify the extent of the 
infiltrations, we developed another scoring system. This system systematically 
assessed the presence of neutrophils in both the epithelium and the sub-epithelial 
stroma. The effect was stronger with the highest N-9 dose of 10% v/v. This was in fact 
the only dose that yielded statistically significant results both in the cervix and the 
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vagina using our scoring system. However, the clear effect of the highest dose was 
enough proof of the inflammatory infiltrations not to require an increase in sample 
size.   
These findings are consistent with an early immune response to tissue injury as 
neutrophils are among the first immune populations to arrive on site. Therefore, these 
data constitute a further indication of the extent of damage caused by N-9 in our model. 
They are also in line with other histological findings in mice (391). Apart from 
infiltrating the epithelial tissue, high levels of neutrophils after N-9 application have 
also been detected in vaginal secretions from mice (389) and pigtailed macaques (388). 
In addition to confirming the extent of N-9-induced damage, the finding that N-9 can 
cause neutrophil recruitment in the cervix is important. This could have implications 
in cervical damage-induced preterm birth mechanisms as the influx of neutrophils into 
the cervix secondary to intrauterine LPS administration can induce premature cervical 
ripening in mice (431). 
To further investigate the functional effects of N-9-mediated damage in the cervix and 
the vagina, we used immunohistochemistry to determine the percentage of 
proliferating cells across the basement membrane of the cervix. All three doses of N-
9 resulted in a statistically significant increase in the proportion of proliferating cells. 
This increased proliferation of the cells in the basement membrane is characteristic of 
an epithelial regeneration process as a response to acute tissue injury. Catalone et al. 
reported that the epithelium of the cervix in non-pregnant mice is completely 
regenerated within 24 hours of the original insult (391). In our model, this seems 
unlikely given the extent of damage observed 8 hours post-application. However, it 
does suggest that an epithelial regeneration process is in place in response to the 
damage exerted by N-9. In addition, it provides further evidence that validates our 
mouse model and confirms the suitability of N-9 as an epithelial damage inducer.  
In the vaginal epithelium, we found no increase in the percentage of proliferating cells 
in the basement membrane. The vast majority of the cells were proliferating in all 
groups including mice that only received the vehicle treatment. The proportion for the 
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control group in the vagina was around 80% as opposed to 30% in the cervix. As the 
vaginal epithelium has substantially more epithelial layers, it is likely that in any given 
time more cells in the basement membrane are proliferating in order for the cells in the 
apical part to be promptly replaced. High rates of proliferating cells in the basal layer 
of the vaginal epithelium late during the mouse pregnancy have been reported before 
(432). Estrogen is known to stimulate this proliferation in non-pregnant mice and the 
increased levels of estrogen during late pregnancy could have accounted for our 
observation (433). Another factor implicated in increasing vaginal cell proliferation is 
relaxin, the secretion of which by the corpus luteum is also increased during late 
pregnancy in the mouse (434). This means that even if there would have been increases 
in the proliferation of basal cells due to tissue injury, these would not be identified 
because of the high percentage of the cells that are already proliferating.   
Collectively, these experiments confirmed that N-9 significantly damages the 
cervicovaginal epithelium during pregnancy. From the features of damage that we 
assessed, morphological damage and neutrophil infiltrations could have resulted in 
preterm delivery. However, we found no effect of N-9-induced damage on the timing 
of delivery or pup survival. An even higher dose of 40% N-9 was used in these 
experiments to ensure coverage of the whole spectrum, even outside the 
pharmacological limits. Akgul et al. found that loss of Hyaluronic acid (HA) in the 
cervix results in epithelial disorganisation (280). This is not sufficient to cause preterm 
birth on its own (280). It rather predisposes to preterm delivery induced by E. coli 
(280). This is in line with our finding that N-9-induced morphological damage does 
not cause PTB. In addition, we found that the neutrophil infiltrations induced by N-9 
are again not sufficient to cause PTB. Timmons et al. suggested that neutrophils are 
not necessary for cervical ripening to occur in the mouse and are physiologically 
recruited on site in preparation for postpartum repair (435). Still, the activation of 
immune pathways appears to be sufficient to induce preterm cervical ripening in mice 
(436). In our damage model, the neutrophils recruited are targeting the epithelium as 
part of the tissue repair process secondary to N-9 application. Hence, they have no 
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effect on the main bulk of the stroma and are therefore incapable of inducing premature 
cervical ripening and a subsequent preterm birth. 
In summary, data from this chapter reveal that N-9 causes significant damage in the 
morphology of the cervicovaginal epithelium. This initiates a tissue repair process that 
is characterised by neutrophil infiltrations and increased proliferation in the basement 
membrane of the epithelium. However, this damage is not sufficient to cause preterm 
delivery and has no effect on pup survival. Overall, we describe and characterise for 
the first time a mouse model of cervical epithelial damage during pregnancy using N-
9.   
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Chapter 5 The effect of cervical epithelial 




Preterm birth is a syndrome that has been associated with a diverse range of etiologies 
(56). Among them, the most common one affecting at least 25-40% of pregnancies is 
infection (437). In addition, intrauterine infection is the only condition for which a 
causality link has been established and the underlying pathophysiology is well studied. 
There are several routes through which microorganisms can access the uterine cavity 
and cause an intrauterine infection. By ascending from the vagina and through the 
cervix; by disseminating haematogenously and through the placenta; by retrograde 
spread from the abdominal cavity and through the fallopian tubes; or by accidental 
dissemination during invasive medical procedures (196). The bacteria most commonly 
isolated from the amniotic fluid of women delivering preterm are are common to those 
which are also present in the vagina. Therefore, the most common route of intrauterine 
infection is believed to be the ascending pathway of vaginal bacteria through the 
cervix. 
Ureaplasmas are the bacteria most frequently associated with preterm birth, and are 
commonly present in the amniotic fluid of preterm deliveries, as they can be detected 
in more than 40% of patients with preterm labour or PPROM (438). In addition, they 
are associated with potential adverse pregnancy outcomes in the absence of preterm 
delivery. These adverse outcomes include chorioamnionitis (416), fetal brain injury 
(411) and pulmonary disease (439) (440). Ureaplasmas are divided into two species: 
U. urealyticum and U. parvum. The latter is considered to be the more prevalent of the 
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two in the case of PTB, and is considered to be an independent risk factor for PTB 
(231). Despite the rate of around 40% of Ureaplasma infection in early preterm birth 
studies, a causal link is hard establish in humans, as a significant number of women 
with positive Ureaplasma cultures have normal pregnancy outcomes (242). One 
potential explanation is the low virulence of these bacteria. Further evidence on the 
mechanisms of infection during pregnancy is needed to establish the role of 
Ureaplasma spp as PTB-triggering microorgnanisms. 
The cervical epithelium has a pivotal role in protecting against ascending infection 
during pregnancy (282). It has been shown that excisional procedures that damage the 
cervix by removing part of the epithelium and the underlying stroma significantly 
increase the risk for preterm delivery (304) (305), but the association has not been 
explained yet. A potential explanation could involve a compromise of the barrier 
function after cervical damage that could increase the risk for an ascending infection. 
In the previous chapter, we established and characterised a new mouse model of 
cervical epithelial damage during pregnancy using the surfactant Nonoxynol-9. We 
also found that N-9-induced cervical damage per se does not cause preterm birth. Thus, 
the aim of the work described in this chapter is to address whether cervical damage 
could predispose to ascending inflammation and/or infection.  
Intra-vaginal administration of LPS has previously been shown to induce preterm 
delivery (365). However, it is not clear if this is achieved by LPS only causing 
intrauterine inflammation or by causing vaginal inflammation that propagates to reach 
the intrauterine compartment. In addition, our group did not manage to replicate this 
finding before, with mice delivering normally at term after vaginal LPS administration 
(170). Therefore, we hypothesized that N-9-induced cervical epithelial damage and 
inflammation would boost LPS-induced inflammation in the vagina to induce preterm 
birth after co-administration of both substances. We also tested the hypothesis that loss 
of the epithelial barrier function by N-9 pre-treatment would facilitate preterm birth 
induced by a subsequent LPS intra-vaginal administration.    
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Ureaplasma parvum, the most clinically relevant bacteria for preterm birth, was also 
used to model ascending infection. We hypothesized that N-9-induced cervical 
epithelial damage would facilitate ascending infection with U. parvum. We also sought 
to investigate the capacity of U. parvum to mount an inflammatory response in fetal 
and maternal tissues.  
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5.2 Results 
In the previous chapter, the establishment and characterisation of a mouse model of 
cervical damage using N-9 was described. Among the three different doses of N-9 that 
were tested, the one resulting in statistically significant epithelial injury as assessed by 
our scoring systems was the 10% N-9 v/v. Therefore, this was the dose of choice used 
in all subsequent experiments.  
5.2.1 Co-administration of N-9 and LPS has no effect on timing 
of delivery or pup survival 
To assess whether the added inflammatory effects induced by co-treatment of N-9 and 
LPS could result in preterm delivery and whether there would be any effect on pup 
survival, a time-to-delivery experiment was conducted. On D17 of pregnancy, timed 
pregnant mice were given an intravaginal inoculation of a formulation of N-9 and LPS. 
Timing of delivery of the first pup post-administration was monitored using CCTV. 
The percentage of pups born alive was calculated for each mouse. The experimental 
outline can be seen in Materials and Methods (Fig 2.5A). 
Co-treatment with N-9 and LPS had no effect on timing of delivery. Mice treated with 
it delivered at an average of 70±6.06 hours post-administration compared to the ones 
treated with PBS control who delivered at 56.5±1.22 hours post-administration 
(P=0.0636). There was also no effect on timing of delivery for mice treated with either 
N-9 or LPS only, compared with PBS vehicle control only. Mice treated with N-9 
alone or LPS alone delivered at 64.34±4.18 and 65.25±2.85 hours post-administration 
respectively (Fig 5.1A). 
Co-administration of N-9 and LPS had also no effect on the pup survival. Mice in this 
group exhibited an average pup survival of 93.4±6.6% compared to 98±2% for mice 
treated with PBS control. Again, there was also no effect on pup survival for mice 
treated with N-9 or LPS alone. The former had an average pup survival of 
96.75±2.14% while the latter had an average pup survival of 94.33±3.81% (Fig 5.1B). 
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Figure 5.1 The combination of intra-vaginal N-9 with LPS does not affect timing 
of delivery and pup survival in a mouse model of cervical damage during 
pregnancy. In the morning of D17 of gestation, mice received either 10% N-9 in PBS 
or 100 μg/ml LPS in PBS or 10% N-9 and 100 μg/ml LPS in PBS or PBS control via 
intravaginal inoculation. Time to delivery was calculated from the moment of 
intravaginal inoculation until the delivery of the first pup. N-9 and LPS either alone or 
combined had no effect on timing of delivery (A).  Percentage of live born pups for 
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each mouse was calculated by dividing the number of live pups delivered by the total 
number of pups. N-9 and LPS either alone or combined had no effect on pup survival 
(B). Statistical significance was assessed using 2-way ANOVA. Error bars represent 
SD. 
 
5.2.2 N-9 pretreatment induced cervical damage does not 
facilitate vaginal LPS-induced preterm delivery and has 
no effect on pup survival 
To investigate whether cervical damage induced by pretreatment with N-9-induced 
could facilitate vaginal LPS-induced preterm birth, another time-to delivery 
experiment was performed. In the afternoon of D16 of pregnancy, timed pregnant mice 
were given an intravaginal inoculation of N-9 and 16 hours later they were 
administered with vaginal LPS. Timing of delivery of the first pup post-administration 
was monitored using CCTV. The percentage of pups born alive was calculated for 
each mouse. The experimental outline can be seen in Materials and Methods (Fig 
2.5B). 
The administration of N-9 followed by LPS had no effect on timing of delivery. Mice 
treated with this scheme delivered at an average of 64.34±4.18 hours post-
administration compared to the ones treated with PBS control who delivered at 
57.93±2 hours post-administration. There was also no effect on timing of delivery for 
mice treated with either N-9 followed by PBS control or PBS control followed by LPS. 
Mice treated with the former combination delivered at 60.05±4.97 hours post-
administration. Mice treated with the latter delivered at and 58.1±3.58 hours post-
administration (Fig 5.2A). 
N-9 followed by LPS had also no effect on the pup survival. Mice in this group had an 
average pup survival of 66.45±14.59% compared to 87.5±10.03% for mice treated 
with PBS controls only. Again, there was also no effect on pup survival for mice 
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treated with N-9 or LPS alone. The former had an average pup survival of 95.6±2.36% 
while the latter had an average pup survival of 75.21±9.9% (Fig 5.2B). 
 
Figure 5.2 Cervical damage caused by intra-vaginal N-9 does not facilitate intra-
vaginal LPS-induced preterm birth and has no effect on pup survival. In the 
afternoon of D16 of gestation, mice received either 10% N-9 in PBS or PBS control 
via intravaginal inoculation. 16 h later, in the morning of D17 of gestation, mice 
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received either 1 mg/ml LPS in PBS or PBS control via intravaginal inoculation. Time 
to delivery was calculated from the moment of intravaginal inoculation until the 
delivery of the first pup. N-9 and LPS either alone or combined had no effect on timing 
of delivery (A).  Percentage of live born pups for each mouse was calculated by 
dividing the number of live pups delivered by the total number of pups. N-9 and LPS 
either alone or combined had no effect on pup survival (B). Statistical significance was 
assessed using 2-way ANOVA.  Error bars represent SD. 
 
5.2.3 N-9 is more cytotoxic against endocervical cells than 
against Ureaplasma parvum 
N-9 has been shown to be cytotoxic against a wide range of bacteria (441) (442) (443) 
(444) and against epithelial cells (413). Our in vivo experimental design to test the 
hypothesis that cervical epithelial damage predisposes to ascending infection with U. 
parvum involved the sequential administration of N-9 followed by U. parvum 16 h 
later. First, we sought to determine the relative cytotoxicity of N-9 against cervical 
epithelial cells and U. parvum.  To assess whether N-9 is more cytotoxic against 
endocervical cells or against U. parvum, both of them were treated with various N-9 
concentrations for 48 hours and their ability to survive and grow was assessed by an 
MTT assay and colour changing assessment respectively. 
Determination of the minimum N-9 cytotoxic dose against End1/E6E7 
An MTT assay after 48 h of treatment with various doses of N-9 (0, 1, 2, 4, 8, 16, 32, 
64, 128, 256, 512, 1024 µg/ml in Growth medium) revealed that the dose of 32 µg/ml 
was the minimum dose that completely abolished the cells’ metabolic activity (Fig 
5.3). 
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Figure 5.3 Determination of minimum N-9 concentration that stops endocervical 
End1/E6E7 cells’ growth after 48 hours. End1/E6E7 cells were incubated with 
various N-9 concentrations (0, 2, 4, 8, 16, 32, 64, 128, 256 and 512 μg/ml) for 48h. 
Metabolic activity indicating cell viability was determined by an MTT assay and is 
expressed relative to that of the untreated cells. The minimum N-9 concentration that 
stops End1/E6E7 growth is 32 μg/ml. Error bars indicate SD. 
 
Determination of the minimum N-9 cytotoxic dose against Ureaplasma 
parvum 
U. parvum bacteria were allowed to grow in the presence of various doses of N-9 (0, 
1, 2, 4, 8, 16, 32, 64, 128, 256, 512, 1024 µg/ml in Ureaplasma selective medium) and 
the microplate assay based on colour change indicative of bacterial growth was used 
to determine the lowest dose of N-9 that inhibited U. parvum growth. The minimum 
cytotoxic dose was found to be 128 µg/ml (Fig 5.4). 
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Figure 5.4 Determination of minimum N-9 concentration that stops Ureaplasma 
parvum growth after 48 hours. The 96-well plate contains an N-9 gradient from 1024 
μg/ml to 1 μg/ml. Pink wells indicate growth and yellow wells indicate no growth of 
Ureaplasma parvum (UP) after 48 h. The minimum N-9 concentration that stops UP 
growth is 128 μg/ml. 
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5.2.4 N-9-induced cervical damage facilitates ascending 
infection with Ureaplasma parvum during pregnancy 
To investigate whether N-9-induced cervical damage could facilitate ascending 
infection with U. parvum, a bioluminescent strain of the bacteria was used. In the 
afternoon of D16 of pregnancy, timed pregnant mice were given an intravaginal 
inoculation of 10% N-9 or PBS control. Sixteen hours later they were vaginally 
administered with U. parvum or Ureaplasma selective medium (USM) control. 
Twenty-four hours later, in the morning of D18, optical in vivo bioluminescence 
imaging was performed to assess the presence of U. parvum in the upper reproductive 
tract. The experimental outline can be seen in Materials and Methods (Fig 2.6). 
Bioluminescence signal (BLI) was quantified in pre-drawn regions of interest (ROI) 
that covered the whole mouse abdomen. A representative image is shown (Fig 5.5A). 
Mice treated with control treatments (PBS+USM) exhibited only background levels of 
BLI (706±48 counts). Such was the case for that received the cervical damage 
treatment but were not administered with U. parvum (N-9+USM) (734±55 counts) 
(Fig 5.5B). 
N-9 induced cervical damage facilitated ascending infection with U. parvum. Among 
mice that were given U. parvum, those that were previously treated with N-9 (N-9+UP) 
exhibited a significantly higher BLI signal (61,2x103±25,7x103 counts; P=0.0245) 
compared to those that received a control treatment for cervical damage (PBS+UP) 
(9,5x103±7,4x103 counts) (Fig 5.5B). 
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Figure 5.5 Cervical damage caused by N-9 results in increased bioluminescence 
signal in the upper reproductive tract after vaginal infection with luciferase-
expressing Ureaplasma parvum during pregnancy. In the afternoon of D16 of 
gestation, mice received either 10% N-9 in PBS or PBS control via intravaginal 
inoculation. 16 h later, in the morning of D17 of gestation, mice received either 
luciferease-expressing Ureaplasma parvum (UP) in Ureaplasma Selective Medium 
(USM) or USM control via intravaginal inoculation. 24h later, in the morning of D18, 
the luciferase substrate Furimazine was injected intraperitoneally to allow UP 
localisation. A representative image is shown (A). Bioluminescence signal was 
quantified in a region of interest (ROI) covering each mouse’s abdomen. 
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Bioluminescence signal coming from luciferase-expressing UP was significantly 
increased in mice that have been pre-treated with N-9 compared to PBS controls (B). 
No difference was found between bioluminescence signal on mice that delivered 
preterm compared to those that delivered at term (C). Error bars indicate SD. Statistical 
significance was assessed using a non-parametric Mann-Whitney test for PBS+UP vs. 
N-9+UP (*P=0.0245) and Term vs. Preterm (P=0.115). 
 
5.2.5 N-9 pre-treatment results in higher Ureaplasma parvum 
titres in the amniotic fluid 
To assess the capacity of Ureaplasma parvum to establish an infection at the 
administration site and whether this is affected by pre-treatment of the site with N-9, 
vaginal flushes with PBS were performed 48 hours post-administration. U. parvum 
titres were quantified in the returned solution. To further investigate the level to which 
cervical epithelial damage facilitates ascending infection, Ureaplasma parvum titres 
were measured in the amniotic fluid from sites located both proximally and distally to 
the cervix 48 hours post-administration of Ureaplasma parvum. 
Ureaplasma parvum can grow in the vagina of pregnant mice either pre-treated with 
N-9 (N-9+UP) or not (PBS+UP). The bacterial titres in the vaginal flushes for the 2 
groups were similar (1.3x106±7x105 CCU/15ul of vaginal flush for PBS+UP; 
1.1x106±7x105 CCU/15ul of vaginal flush for N-9+UP) (Fig 5.6).  
Pre-treatment with N-9 was again shown to facilitate ascending infection with U. 
parvum. At a site proximal to the cervix, Ureaplasma parvum titres were statistically 
significantly higher in the amniotic fluid of mice pre-treated with N-9 (2.2x106±7x105 
CCU/15ul of amniotic fluid; P=0.0356) compared to those pre-treated with PBS 
control (7.2x104±3.7x104 CCU/15ul of amniotic fluid) (Fig 5.6).  
Similarly, the same statistically significant trend was noticed at a site distal to the 
cervix with higher bacterial titres in the amniotic fluid of N-9 pre-treated mice 
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(2.2x106±8.105 CCU/15ul amniotic fluid; P=0.0466) compared to the PBS control pre-
treated ones (3.7x103±2.8x103 CCU/15ul of amniotic fluid) (Fig 5.6). 
 
Figure 5.6 Cervical damage caused by N-9 results in higher Ureaplasma parvum 
titres in the amniotic fluid of pregnant mice after vaginal U. parvum 
administration. In the afternoon of D16 of gestation, mice received either 10% N-9 
in PBS or PBS control via intravaginal inoculation. 16 h later, in the morning of D17 
of gestation, mice received either Ureaplasma parvum (UP) in Ureaplasma Selective 
Medium (USM) or USM control via intravaginal inoculation.  48 h after U. parvum 
administration, vaginal flushes and amniotic fluid (AF) from proximal and distal sites 
were cultured in USM and Ureaplasma parvum titres were calculated using the 
microplate method. There was a significant increase in UP titres at the proximal sites 
and a trend increase at the distal sites in the amniotic fluid of mice pre-treated with N-
9. For AF proximal and distal, each dot in the dot plot represents the average of left 
and right horn for each mouse at either site. Error bars indicate SD. Statistical 
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significance was assessed using unpaired t-test with Welch’s correction on the log-
transformed values of Ureaplasma parvum titres for PBS+UP vs. N-9+UP at all three 
sites (*P<0.05; P=0.0356 for Amniotic Fluid proximal, P=0.0466 for Amniotic Fluid 
distal). 
5.2.6 N-9 pre-treatment results in a higher copy number of the 
U. parvum gene Urease C in the upper reproductive 
tract 
To assess whether cervical damage could facilitate ascending infection with U. parvum 
that results in tissue invasion and/or colonisation, the copy number of the U. parvum-
derived gene Urease C was quantified in the placenta, uterus, fetal membranes and 
fetal lung 48 hours after administration using qPCR. 
Once again, results consistently supported that cervical damage facilitated ascending 
infection. Pre-treatment with N-9 followed by U. parvum administration resulted in a 
significantly higher UreC copy number in the placenta (29,490±5,037 copies) and the 
fetal membranes (48,270±7,716 copies) at a site proximal to the cervix compared to 
pre-treatment with PBS control (10,386±2,862 copies for placenta; 22,602±8,623 
copies for fetal membranes) (P=0.0093 for placenta; P=0.048 for fetal membranes). 
The same trend was noticed in these two tissues at the distal site (12,894±4,420 vs 
4,820±871 for placenta; 43,253±12,036 vs 14,522±6,725 for fetal membranes), 
although statistical significance was not reached (Fig 5.7A, C). 
Similarly, the N-9+UP group demonstrated a higher UreC copy number in the uterus 
both proximally (6,382±1,785 copies) and distally (5,566±2,402 copies) to the cervix 
compared to the PBS+UP group (3,857±1,646 copies for proximal; 3,129±1,384 
copies for distal). The differences observed were not statistically significant (Fig 
5.7B). 
The same trend for UreC gene copy number was followed in the fetal lung at the 
proximal site, albeit at a much lower copy number (333.8±190.1 copies for N-9+UP 
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vs 218.8±108.2 copies for PBS+UP). No difference was observed at the distal site (Fig 
5.7D). 
  
Figure 5.7 Cervical damage caused by N-9 results in a higher copy number of the 
Ureaplasma parvum-derived gene Urease C in the placenta, uterus and fetal 
membranes after vaginal U. parvum administration. In the afternoon of D16 of 
gestation, mice received either 10% N-9 in PBS or PBS control via intravaginal 
inoculation. 16 h later, in the morning of D17 of gestation, mice received either 
Ureaplasma parvum (UP) in Ureaplasma Selective Medium (USM) or USM control 
via intravaginal inoculation. 48 h after U. parvum administration, tissues were 
collected and gene expression of UreC was analysed using qPCR. In mice pre-treated 
with N-9, there was a significant increase in UreC copy number at the proximal sites 
of the placenta and the fetal membranes and a trend increase in all other tissues and 
sites. No difference was observed at the distal site of the fetal lung. Each dot in the dot 
plot represents the average of left and right horn for each mouse at either site. Error 
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bars indicate SD. Statistical significance was assessed using unpaired t-test for 
PBS+UP vs. N-9+UP in all 4 tissues and at both sites (*P=0.048 for N-9+UP vs 
PBS+UP at the fetal membranes’ proximal site, **P=0.0093 for N-9+UP vs PBS+UP 
at the placental proximal site). 
 
5.2.7 Increased preterm birth rates in mice treated with N-9 
followed by ascending infection with Ureaplasma 
parvum 
C57Bl/6 mice normally deliver at around 60 hours after the morning of D17 of 
gestation. Timings of delivery of all control mice that were used in previous 
experiments is shown on Fig 5.8. Delivery occurs 60.45±1.76 hours post-
administration, 95% Confidence Intervals (CI) [56.81, 64.08] (Fig 5.8). No mice 
delivered before 48 hours post-administration. 
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Figure 5.8 C57Bl/6 mice normally deliver at around 60 hours after the morning 
of D17 of gestation. Data from all experiments conducted in the previous chapters 
using control-treated animals (A). No mice delivered before 48 hours post-
administration (A). Timing of delivery of mice that delivered preterm using the 48-
hour threshold in subsequent experiments are also depicted (B). 
 
To assess whether ascending infection with U. parvum facilated by N-9-induced 
cervical damage can cause PTB, a time threshold at 48 hours post U. parvum 
administration was set up. Delivery of the first pup before 48 hours after U. parvum 
administration deemed the respective pregnancy to be called preterm. 
N-9 pre-treatment followed by U. parvum administration (N-9+UP) resulted in 
significantly increased PTB rates. 10/36 (28%) mice in this group delivered 
prematurely (P=0.0104) as opposed to 0/19 (0%) in the group that received control 
treatments only (PBS+USM) (Fig 5.9). Only 1/16 (6%) of mice treated with N-9 but 
without Ureaplasma parvum (N-9+USM) delivered preterm (P=0.4571). Mice that 
were infected with U. parvum but without prior N-9 treatment (PBS+UP) exhibited a 
13% preterm birth rate (4/31; P=0.1476). None of these groups differed significantly 
from the group that received the control treatments only (Fig 5.9). Total numbers and 
percentages can be seen on Table 5-1. 
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Figure 5.9 Cervical damage caused by N-9 facilitates a significant increase in 
preterm birth rates after vaginal infection with Ureaplasma parvum. In the 
afternoon of D16 of gestation, mice received either 10% N-9 in PBS or PBS control 
via intravaginal inoculation. 16 h later, in the morning of D17 of gestation, mice 
received either Ureaplasma parvum (UP) in Ureaplasma Selective Medium (USM) or 
USM control via intravaginal inoculation. Preterm birth was defined as delivery of the 
first pup before 48 completed hours from the moment of the D17 inoculation. The 
combination of N-9-induced cervical damage and Ureaplasma parvum infection 
resulted in a significant increase in preterm birth rates compared to controls. Statistical 
significance was assessed using Fisher’s exact test (*P=0.0104 for PBS+USM vs. 
N9+UP). 
Table 5-1 Preterm birth rates in mice after cervical damage and/or vaginal 
infection with Ureaplasma parvum. 
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5.2.8 Inflammatory gene response in the placenta following 
vaginal infection with Ureaplasma parvum 
To assess whether ascending infection with U. parvum facilitated by cervical damage 
could mount an inflammatory response in the reproductive tract during pregnancy, 
maternal and fetal tissues from the previous experiment were collected 48 h after 
vaginal U. parvum administration that was preceded by cervical damage or control. As 
defined in the previous section, these mice were deemed term. Changes in the gene 
expression of proinflammatory cytokines and TLRs were examined using RT-qPCR. 
The analysis was performed both at the proximal and at the distal site. 
Proinflammatory cytokine gene expression in the placenta 
Infection with U. parvum but not damage with N-9 was a statistically significant source 
of variation in the expression of Tnfa (P<0.0001 for proximal, P=0.0141 for distal), 
Il1b (P<0.0001 for proximal and distal), Cxcl1 (P<0.0001 for proximal, P=0.0004 for 
distal) and Cxcl2 (P<0.0001 for proximal and distal) both at the proximal and at the 
distal site. No interaction between the two independent variables was detected. No 
differences were found for Il-6. 
At the proximal site, the genes Tnfa, Il1b, Cxcl1and Cxcl2 were significantly 
upregulated in the two groups infected with U. parvum (N-9+UP, PBS+UP) compared 
to the vehicle-treated group (PBS+USM). For the N-9+UP group, TNFa expression 
increased by 2.35±0.3-fold, Il1b increased 10.71±2.59-fold, Cxcl1 increased 
3.82±0.48-fold and Cxcl-2 increased 61.3±12.26-fold. For the PBS+UP group, TNFa 
expression increased by 1.85±0.32-fold, Il1b increased 7.27±1.56-fold, Cxcl1 
increased 3.26±0.57-fold and Cxcl2 increased 39.01±12.83-fold. Il6 levels did not 
change. No differences were found for the group that received N-9 but not U. parvum 
(N-9+USM). All changes can be seen in Table 5-2 and Fig 5.10. 
At the distal site, the genes Il1b and Cxcl2 were significantly upregulated in the two 
groups infected with U. parvum (N-9+UP, PBS+UP) compared to the vehicle-treated 
group (PBS+USM). For the N-9+UP group, Il1b increased 4.14±0.87-fold and Cxcl-2 
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increased 29.79±8.04-fold. For the PBS+UP group Il1b increased 2.64±0.39-fold and 
Cxcl-2 increased 8.51±1.41-fold. Tnfa, Cxcl1 and Il6 levels did not change. No 
differences were found for the group that received N-9 but not U. parvum (N-9+USM). 
All changes can be seen in Table 5-2 and Fig 5.10. 
The changes for Il1b, Cxcl1 and Cxcl2 were significantly higher at the proximal site 
compared to the distal. Tnfa followed the same trend without reaching statistical 
significance (Fig 5.10). 
A significant correlation was noticed between the copy number of the Urease C gene 
derived from U. parvum and the increase in the expression of Tnfa (r=0.51, P=0.0072), 
Il1b (r=0.72, P<0.0001), Cxcl1 (r=0.71, P<0.0001) and Cxcl2 (r=0.78, P<0.0001).  
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Table 5-2 Inflammatory cytokine gene changes in the placenta after vaginal 
administration of Ureaplasma parvum preceded by cervical damage or control 
treatments (*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001). 
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Figure 5.10 Ureaplasma parvum infection causes significant upregulation of 
proinflammatory genes in the placenta of pregnant mice. In the afternoon of D16 
of gestation, mice received either 10% N-9 in PBS or PBS control via intravaginal 
inoculation. 16 h later, in the morning of D17 of gestation, mice received either 
Ureaplasma parvum (UP) in Ureaplasma Selective Medium (USM) or USM control 
via intravaginal inoculation. Tissues were collected 48 h later and analysed using RT-
qPCR. Mice that were infected had an increase in the mRNA levels of Tnfa (A), Il1b 
(B), Cxcl1 (C) and Cxcl2 (D) compared to vehicle-treated controls. The effect was 
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stronger at the proximal site. Error bars indicate SD. Statistical significance of the 
treatment effect was assessed using 2-way ANOVA with post hoc Dunnett’s multiple 
comparisons test on the DDCt values against the PBS+USM group for the proximal 
and distal site. Statistical significance for the site effect was assessed unpaired t-test 
for Proximal vs Distal for each treatment group. (*P<0.05, **P<0.01, ***P<0.001, 
****P<0.0001). In collaboration with MSc student Gabriella Sammut Demarco. 
Toll-like receptors gene expression in the placenta 
Infection with U. parvum but not damage with N-9 was a statistically significant source 
of variation in the expression of Tlr1 (P=0.0336 for proximal, P=0.0346 for distal) and 
Tlr2 (P<0.0001 for proximal, P=0.0016 for distal). No interaction between the two 
independent variables was detected. No differences were found for Tlr6 and Tlr9.At 
the proximal site, Tlr2 was significantly upregulated in the two groups infected with 
U. parvum (N-9+UP, PBS+UP) compared to the vehicle-treated group (PBS+USM). 
For the N-9+UP group, Tlr2 expression increased by 2.22±0.13-fold. For the PBS+UP 
group, Tlr2 expression increased by 2.03±0.34-fold. The levels of Tlr1 also increased 
by 1.98±0.41-fold but only for the N-9+UP group. Levels of the other TLRs did not 
change. No differences were found for the group that received N-9 but not U. parvum 
(N-9+USM). All changes can be seen in Table 5-3 and Fig 5.11. 
At the distal site, Tlr2 was significantly upregulated only in the group infected with U. 
parvum and preceded by cervical damage (N-9+UP) compared to the vehicle-treated 
group (PBS+USM). In this case, Tlr2 expression increased by 1.72±0.21-fold. Levels 
of the other TLRs did not change. No differences were found for the group that 
received N-9 but not U. parvum (N-9+USM) or U. parvum but not N-9. All changes 
can be seen in Table 5-3 and Fig 5.11. 
No differences were detected between the proximal and the distal site (Fig 5.11). 
A significant correlation was noticed between the copy number of the Urease C gene 
derived from U. parvum and the increase in the expression of Tlr1 (r=0.66, P=0.0002), 
Tlr2 (r=0.70, P<0.0001), Tlr6 (r=0.45, P=0.0219) and Tlr9 (r=0.42, P=0.0323). 
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Table 5-3 TLR gene changes in the placenta after vaginal administration of 
Ureaplasma parvum preceded by cervical damage or control treatments (*P<0.05, 
***P<0.001, ****P<0.0001). 
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Figure 5.11 Ureaplasma parvum infection causes significant upregulation of TLR2 
gene expression in the placenta of pregnant mice. In the afternoon of D16 of 
gestation, mice received either 10% N-9 in PBS or PBS control via intravaginal 
inoculation. 16 h later, in the morning of D17 of gestation, mice received either 
Ureaplasma parvum (UP) in Ureaplasma Selective Medium (USM) or USM control 
via intravaginal inoculation. Tissues were collected 48 h later and analysed using RT-
qPCR. Mice that were infected had an increase in the mRNA levels of Tlr2 (B) and 
those that were pre-treated with N-9 followed by U. parvum also had an increase in 
Tlr1 (A) mRNA at the proximal site compared to vehicle-treated controls. There was 
no site effect. Error bars indicate SD. Statistical significance of the treatment effect 
was assessed using 2-way ANOVA with post hoc Dunnett’s multiple comparisons test 
on the DDCt values against the PBS+USM group for the proximal and distal site. 
Statistical significance for the site effect was assessed unpaired t-test for Proximal vs 
Distal for each treatment group. (*P<0.05, ***P<0.001, ****P<0.0001). In 
collaboration with MSc student Gabriella Sammut Demarco. 
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5.2.9 Inflammatory gene response in the uterus following 
vaginal infection with Ureaplasma parvum 
Proinflammatory cytokine gene expression in the uterus 
Infection with U. parvum but not damage with N-9 was a statistically significant source 
of variation in the expression of Tnfa (P<0.0001 for proximal, P=0.0086 for distal), 
Il1b (P<0.0001 for proximal, P=0.0042 for distal), Cxcl1 (P<0.0001 for proximal, 
P=0.002 for distal) and Cxcl2 (P<0.0001 for proximal, P=0.0017 for distal) both at the 
proximal and at the distal site. No interaction between the two independent variables 
was detected. No differences were found for Il-6. 
At the proximal site of the uterus, the genes TNFa, Il1b, Cxcl1and Cxcl2 were 
significantly upregulated in the two groups infected with U. parvum (N-9+UP, 
PBS+UP) compared to the vehicle-treated group (PBS+USM). For the N-9+UP group, 
TNFa expression increased by 6.46±0.73-fold, Il1b increased 7.2±0.98-fold, Cxcl1 
increased 9.11±1.87-fold and Cxcl-2 increased 24.32±6.19-fold. For the PBS+UP 
group, TNFa expression increased by 2.87±0.63-fold, Il1b increased 3.66±1.27-fold, 
Cxcl1 increased 7.54±2.5-fold and Cxcl-2 increased 14.46±4.88-fold. No differences 
were found for the group that received N-9 but not U. parvum (N-9+USM). All 
changes can be seen in Table 5-4 and Fig 5.12. 
At the distal site, the genes TNFa, Cxcl1and Cxcl2 were significantly upregulated in 
only in the N-9+UP compared to the vehicle-treated group (PBS+USM). For the N-
9+UP group, TNFa expression increased by 5.47±1.95-fold, Cxcl1 increased 
7.63±3.22-fold and Cxcl-2 increased 11.66±5.64 -fold. No differences were found in 
the other two groups. All changes can be seen in Table 5-4 and Fig 5.12. 
Although a trend difference was noticed when comparing the site effect, this only 
reached significance in the case of Il1b for the N-9+UP group (Fig 5.12). 
A significant correlation was noticed between the copy number of the Urease C gene 
derived from U. parvum and the increase in the expression of Tnfa (r=0.76, P<0.0001), 
Il1b (r=0.79, P<0.0001), Cxcl1 (r=0.80, P<0.0001) and Cxcl2 (r=0.84, P<0.0001). 
 Cervical epithelial damage and preterm birth 
The effect of cervical epithelial damage on ascending infection and preterm birth 195 
Table 5-4 Inflammatory cytokine gene changes in the uterus after vaginal 
administration of Ureaplasma parvum preceded by cervical damage or control 
treatments (*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001). 
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Figure 5.12 Ureaplasma parvum infection causes significant upregulation of 
proinflammatory genes in the uterus of pregnant mice. In the afternoon of D16 of 
gestation, mice received either 10% N-9 in PBS or PBS control via intravaginal 
inoculation. 16 h later, in the morning of D17 of gestation, mice received either 
Ureaplasma parvum (UP) in Ureaplasma Selective Medium (USM) or USM control 
via intravaginal inoculation. Tissues were collected 48 h later and analysed using RT-
qPCR. Mice that were infected had an increase in the mRNA levels of Tnfa (A), Il1b 
(B), Cxcl1 (C) and Cxcl2 (D) compared to vehicle-treated controls. The effect was 
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stronger at the proximal site. Error bars indicate SD. Statistical significance of the 
treatment effect was assessed using 2-way ANOVA with post hoc Dunnett’s multiple 
comparisons test on the DDCt values against the PBS+USM group for the proximal 
and distal site. Statistical significance for the site effect was assessed unpaired t-test 
for Proximal vs Distal for each treatment group. (*P<0.05, **P<0.01, ***P<0.001, 
****P<0.0001). In collaboration with MSc student Gabriella Sammut Demarco. 
Toll-like receptor gene expression in the uterus 
Infection with U. parvum but not damage with N-9 was a statistically significant source 
of variation in the expression of Tlr2 (P=0.041 for proximal, P=0.028 for distal). No 
interaction between the two independent variables was detected. No differences were 
found for Tlr1, Tlr6 and Tlr9. 
Statistically significant upregulations were only noted for the Tlr2 gene and for the 
group were U. parvum administration was preceded by N-9 administration. At the 
proximal site, Tlr2 expression increased by 2.67±0.4-fold for the N-9+UP group. 
Levels of the other TLRs did not change for this group. No changes were noticed for 
the PBS+UP group. No differences were found for the group that received N-9 but not 
U. parvum (N-9+USM). All changes can be seen in Table 5-5 and Fig 5.13. 
At the distal site, Tlr2 was significantly upregulated only in the group infected with U. 
parvum and preceded by cervical damage (N-9+UP) compared to the vehicle-treated 
group (PBS+USM). Tlr2 expression increased by 2.47±0.51-fold. Levels of the other 
TLRs did not change. No differences were found for the group that received N-9 but 
not U. parvum (N-9+USM) or U. parvum but not N-9. All changes can be seen in 
Table 5-5 and Fig 5.13. 
No differences were detected between the proximal and the distal site (Fig 5.13). 
A significant correlation was noticed between the copy number of the Urease C gene 
derived from U. parvum and the increase in the expression of Tlr2 (r=0.63, 
P<0.0001). 
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Table 5-5 TLR gene changes in the placenta after vaginal administration of 
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Figure 5.13 Ureaplasma parvum infection causes significant upregulation of TLR2 
gene expression in the uterus of pregnant mice. In the afternoon of D16 of gestation, 
mice received either 10% N-9 in PBS or PBS control via intravaginal inoculation. 16 
h later, in the morning of D17 of gestation, mice received either Ureaplasma parvum 
(UP) in Ureaplasma Selective Medium (USM) or USM control via intravaginal 
inoculation. Tissues were collected 48 h later and analysed using RT-qPCR. Mice that 
were infected with UP and had a previously damaged cervix by N-9 had an increase 
in the mRNA levels of Tlr2 (B) both at a proximal and at a distal site. There was no 
site effect. Error bars indicate SD. Statistical significance of the treatment effect was 
assessed using 2-way ANOVA with post hoc Dunnett’s multiple comparisons test on 
the DDCt values against the PBS+USM group for the proximal and distal site. 
Statistical significance for the site effect was assessed unpaired t-test for Proximal vs 
Distal for each treatment group. (*P<0.05, **P<0.01). In collaboration with MSc 
student Gabriella Sammut Demarco. 
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5.2.10 Inflammatory response in the fetal membranes 
following vaginal infection with Ureaplasma parvum 
Proinflammatory cytokine gene expression in the fetal membranes 
Infection with U. parvum but not damage with N-9 was a statistically significant source 
of variation in the expression of Tnfa (P<0.0001 for proximal, P=0.0006 for distal), 
Il1b (P<0.0001 for proximal, P=0.0134 for distal), Cxcl1 (P<0.0001 for proximal, 
P=0.0455 for distal) and Cxcl2 (P<0.0001 for proximal, P=0.0001 for distal) both at 
the proximal and at the distal site. No interaction between the two independent 
variables was detected. No differences were found for Il-6.At the proximal site of the 
membranes, the genes TNFa, Il1b, Cxcl1and Cxcl2 were significantly upregulated in 
the two groups infected with U. parvum (N-9+UP, PBS+UP) compared to the vehicle-
treated group (PBS+USM). For the N-9+UP group, TNFa expression increased by 
15.69±3.51-fold, Il1b increased 13.38±3.15-fold, Cxcl1 increased 6.49±1.77-fold and 
Cxcl2 increased 63.6±12.51-fold. For the PBS+UP group, TNFa expression increased 
by 14.67±7.99-fold, Il1b increased 10.98±3.97-fold, Cxcl1 increased 5.48±1.35-fold 
and Cxcl-2 increased 59.73±32.43-fold. No differences were found for the group that 
received N-9 but not U. parvum (N-9+USM). All changes can be seen in Table 5-6 
and Fig 5.14. 
At the distal site, the genes Cxcl2 was significantly upregulated in the two groups 
infected with U. parvum (N-9+UP, PBS+UP) compared to the vehicle-treated group 
(PBS+USM) and Tnfa and Il1b were upregulated only in the N-9+UP group. For the 
N-9+UP group, TNFa expression increased by 8.92±3.28-fold, Il1b increased 
8.6±3.25-fold and Cxcl-2 increased 28.21±12.67-fold. For the PBS+UP group, Cxcl-2 
increased 6.52±2.15-fold. No differences were found for the group that received N-9 
but not U. parvum (N-9+USM). All changes can be seen in Table 5-6 and Fig 5.14. 
Although a trend difference was noticed when comparing the site effect, this only 
reached significance in the case of Cxcl2 for the N-9+UP group (Fig 5.14). 
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A significant correlation was noticed between the copy number of the Urease C gene 
derived from U. parvum and the increase in the expression of Tnfa (r=0.84, P<0.0001), 
Il1b (r=0.78, P<0.0001), Cxcl1 (r=0.70, P<0.0001), Cxcl2 (r=0.87, P<0.0001) and Il6 
(r=0.39, P=0.0059). 
Table 5-6 Inflammatory cytokine gene changes in the fetal membranes after 
vaginal administration of Ureaplasma parvum preceded by cervical damage or 
control treatments (*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001). 
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Figure 5.14 Ureaplasma parvum infection causes significant upregulation of 
proinflammatory genes in the fetal membranes of pregnant mice. In the afternoon 
of D16 of gestation, mice received either 10% N-9 in PBS or PBS control via 
intravaginal inoculation. 16 h later, in the morning of D17 of gestation, mice received 
either Ureaplasma parvum (UP) in Ureaplasma Selective Medium (USM) or USM 
control via intravaginal inoculation. Tissues were collected 48 h later and analysed 
using RT-qPCR. Mice that were infected had an increase in the mRNA levels of Tnfa 
(A), Il1b (B), Cxcl1 (C) and Cxcl2 (D) compared to vehicle-treated controls. The effect 
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was stronger at the proximal site. Error bars indicate SD. Statistical significance of the 
treatment effect was assessed using 2-way ANOVA with post hoc Dunnett’s multiple 
comparisons test on the DDCt values against the PBS+USM group for the proximal 
and distal site. Statistical significance for the site effect was assessed unpaired t-test 
for Proximal vs Distal for each treatment group. (*P<0.05, **P<0.01, ***P<0.001, 
****P<0.0001). In collaboration with MSc student Gabriella Sammut Demarco. 
Toll-like receptor gene expression in the fetal membranes 
Infection with U. parvum but not damage with N-9 was a statistically significant source 
of variation in the expression of Tlr2 (P<0.0001 for proximal, P=0.0078 for distal). No 
interaction between the two independent variables was detected. No differences were 
found for Tlr1, Tlr6 and Tlr9. 
At the proximal site, Tlr2 was significantly upregulated in the two groups infected with 
U. parvum (N-9+UP, PBS+UP) compared to the vehicle-treated group (PBS+USM). 
Tlr1 and Tlr6 were only upregulated in the N-9+UP group. For the N-9+UP group, 
Tlr1 expression increased by 2.14±0.5-fold, Tlr2 expression increased by 5.25±1.03-
fold and Tlr6 expression increased by 1.74±0.13-fold. For the PBS+UP group, Tlr2 
expression increased by 2.91±0.65-fold. Levels of the other TLRs did not change. No 
differences were found for the group that received N-9 but not U. parvum (N-9+USM). 
All changes can be seen in Table 5-7 and Fig 5.15. 
At the distal site, Tlr2 was significantly upregulated only in the group infected with U. 
parvum and preceded by cervical damage (N-9+UP) compared to the vehicle-treated 
group (PBS+USM). In this case, Tlr2 expression increased by 3.52±0.88-fold. Levels 
of the other TLRs did not change. No differences were found for the group that 
received N-9 but not U. parvum (N-9+USM) or U. parvum but not N-9. All changes 
can be seen in Table 5-7 and Fig 5.15. 
No differences were detected between the proximal and the distal site (Fig 5.15). 
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A significant correlation was noticed between the copy number of the Urease C gene 
derived from U. parvum and the increase in the expression of Tlr1 (r=0.34, P=0.0153), 
Tlr2 (r=0.69, P<0.0001) and Tlr6 (r=0.36, P=0.0108). 
Table 5-7 TLR gene changes in the fetal membranes after vaginal administration 
of Ureaplasma parvum preceded by cervical damage or control treatments 
(*P<0.05, **P<0.01, ****P<0.0001). 
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Figure 5.15 Ureaplasma parvum infection causes significant upregulation of TLR2 
gene expression in the fetal membranes of pregnant mice. In the afternoon of D16 
of gestation, mice received either 10% N-9 in PBS or PBS control via intravaginal 
inoculation. 16 h later, in the morning of D17 of gestation, mice received either 
Ureaplasma parvum (UP) in Ureaplasma Selective Medium (USM) or USM control 
via intravaginal inoculation. Tissues were collected 48 h later and analysed using RT-
qPCR. Mice that were infected had an increase in the mRNA levels of Tlr2 (B) and 
those that were pre-treated with N-9 followed by U. parvum also had an increase in 
Tlr1 (A) and Tlr6 (C) mRNA at the proximal site compared to vehicle-treated controls. 
There was no site effect. Error bars indicate SD. Statistical significance of the 
treatment effect was assessed using 2-way ANOVA with post hoc Dunnett’s multiple 
comparisons test on the DDCt values against the PBS+USM group for the proximal 
and distal site. Statistical significance for the site effect was assessed unpaired t-test 
for Proximal vs Distal for each treatment group. (*P<0.05, ***P<0.001, 
****P<0.0001). In collaboration with MSc student Gabriella Sammut Demarco. 
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5.2.11 Inflammatory gene response in the fetal lung 
following vaginal infection with Ureaplasma parvum 
Proinflammatory cytokine gene expression in the fetal lung 
In the fetal lung, no change was noticed in the gene expression of any of the above-
mentioned cytokines with any of the treatments. Fold changes can be seen in Table 5-
8 and Fig 5.16. 
The gene copy number of Urease C did not correlate with changes in the relative 
expression of any of the proinflammatory genes. 
Table 5-8 Inflammatory cytokine gene changes in the placenta after vaginal 
administration of Ureaplasma parvum preceded by cervical damage or control 
treatments. 
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Figure 5.16 Ureaplasma parvum infection does not affect the expression of 
proinflammatory genes in the fetal lung. In the afternoon of D16 of gestation, mice 
received either 10% N-9 in PBS or PBS control via intravaginal inoculation. 16 h later, 
in the morning of D17 of gestation, mice received either Ureaplasma parvum (UP) in 
Ureaplasma Selective Medium (USM) or USM control via intravaginal inoculation. 
Tissues were collected 48 h later and analysed using RT-qPCR. No changes were 
detected between the different treatments. Error bars indicate SD. Statistical 
significance of the treatment effect was assessed using 2-way ANOVA for the 
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proximal and distal site. Statistical significance for the site effect was assessed 
unpaired t-test for Proximal vs Distal for each treatment group. (*P<0.05, **P<0.01, 
***P<0.001, ****P<0.0001). In collaboration with MSc student Gabriella Sammut 
Demarco. 
 
As no change was found in the gene expression of proinflammatory cytokines in the 
fetal lung, gene expression analysis was not performed for TLRs in this tissue. 
5.2.12 Correlations between the three methods that 
demonstrate Ureaplasma parvum ascension to the upper 
reproductive tract 
In this chapter we used three different methods to study whether vaginally 
administered U. parvum can ascend to the uterus and whether this is facilitated by prior 
cervical epithelial damage with N-9. Specifically, 24h hours after U. parvum 
administration, mice that were still pregnant underwent in vivo bioluminescence 
imaging. The following day, 48 hours after U. parvum administration, amniotic fluid 
was cultured for the presence of U. parvum and gestational tissues were analysed for 
gene expression of the U. parvum-derived gene, Urease C. 
A statistically significant moderate correlation was found between the levels of 
bioluminescence and the amniotic fluid titres the following day (r=0.59, P<0.0001). A 
further statistically significant strong correlation was found between the levels of 
bioluminescence and the gene expression of UreC in the fetal membranes only (r=0.67, 
P<0.0001). 
The amniotic fluid titres also showed statistically significant moderate correlations 
with UreC gene expression in the fetal membranes (r=0.55, P<0.0001) and the placenta 
(r=0.47, P=0.0005). 
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5.3 Discussion 
The epithelium is the first line of defence against infectious agents and the cervical 
epithelium is crucial for the barrier function of the cervix during pregnancy. As 
cervical epithelial damage has been associated with preterm birth and ascending 
infection is widely considered as the most common cause of PTB, we hypothesised 
that cervical epithelial damage predisposes to ascending infection. In the previous 
chapter we developed and characterised a mouse model of cervical damage during 
pregnancy using N-9. Here, we utilised this model to address our hypothesis. Since the 
dose of 10% v/v was consistently shown to cause more significant damage in the cervix 
compared to the other doses as assessed by our scoring systems, this was the dose of 
choice for all subsequent experiments. We found that N-9-induced cervical epithelial 
damage facilitated ascending infection with Ureaplasma parvum, leading to increased 
PTB rates. 
First, we examined whether N-9 could facilitate preterm birth induced by vaginally 
administered LPS. After administering a formulation containing both N-9 and LPS 
intravaginally, we found the combination treatment to have no effect on the timing of 
delivery or pup survival. There was also no effect on timing of delivery or pup survival 
when each of N-9 or LPS were administered alone. In all these experiments, we used 
the O111:B4 LPS, which is shown to be the most rapid inducer of PTB when 
administered intrauterine compared to other commonly used serotypes (403). LPS 
O55:B5 was reported to induce preterm birth when administered intravaginally (365). 
However, our group did not manage to reproduce this finding. This was also the case 
for LPS O111:B4 (170). Our results for LPS alone in the current experiments are in 
line with our previous findings, although they contradict Gonzalez et al (365). In 
addition, our data from the previous chapter that 10% N-9 alone does not induce PTB 
were successfully replicated here. Our group has previously used as high as 250 µg 
LPS intravaginally (170). In this case, we used 100 µg LPS, as the potential additive 
inflammatory effect of N-9 was taken into account. Failure of the co-administration 
scheme to cause PTB could potentially be due to the fact that by the time N-9 has 
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caused substantial epithelial damage, LPS might have already be metabolised to non-
toxic levels.    
To this end, we pre-treated the mice with N-9 16 hours before LPS administration to 
examine whether the inflammatory effect of LPS could benefit by being exerted on the 
ground of an already damaged cervix. Since mice in the previous experiments of co-
administration of N-9 and LPS showed no adverse effects, the LPS dose used in this 
case was very high at 1mg. Still, we found no effect on timing of delivery. The effect 
on pup survival was again not significant. However, we noticed that there were three 
mice that demonstrated 100% fetal demise despite delivering at term. This could 
potentially indicate that the combination of N-9 followed by LPS does initiate an 
inflammatory response that can propagate to reach the intrauterine compartment. In 
certain cases, this effect can be potent in inducing fetal death but is still not strong 
enough to prematurely initiate the labour cascade and this is why these mice deliver at 
term. 
Overall, N-9-induced cervical damage does not appear to promote cervicovaginal 
inflammation to an extent sufficient enough to induce preterm birth. For the next set 
of experiments, we investigated its potential to facilitate ascending infection with live 
Ureaplasma parvum bacteria. 
To compare the susceptibility of cervical epithelial cells and U. parvum to N-9 
cytotoxicity, we determined the minimum N-9 dose that resulted in 0% cell viability 
and completely inhibited bacterial growth respectively. We found N-9 to be much 
more cytotoxic against endocervical cells than against U. parvum. Specifically, the 
minimum N-9 dose was 128 µg/ml for U. parvum while only 32 µg/ml for End1/E6E7 
cells after 48 hours incubation time. Similarly, Krebs et al. found cervical HeLa cells 
to be more susceptible to N-9 toxicity compared to HIV virions by a factor of 8 (445). 
Human lymphocytes were also shown to be more susceptible than HIV virions (446).  
Our experimental design had N-9 administered 16 hours before U. parvum. When 
applied in the vagina as an aqueous solution in saline as in our case, the majority of N-
9 is absorbed by the cervicovaginal wall within 3-4 hours (447). This means that in 
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our experiment, N-9 would first induce cervical damage. Then, by the time of U. 
parvum administration, N-9 would be completely absorbed and thus it would be very 
unlikely for it to inactivate the bacteria. 
Using in vivo bioluminescence imaging we found that mice pre-treated with N-9 had 
a significantly higher BLI signal in their upper reproductive tracts 24 hours after 
vaginal administration of our NanoLuc-expressing U. parvum compared to the ones 
pre-treated with vehicle control. This finding is supportive of our hypothesis that 
cervical damage predisposes to ascending infection. Roberts et al. also found that N-9 
can facilitate a viral infection with HPV16 in non-pregnant mice by disrupting the 
cervicovaginal epithelium (448). The fact that cervical epithelial damage predisposes 
to ascending infection with the most clinically relevant bacteria suggests a potential 
mechanism underlying the higher PTB incidence among women that have undergone 
excisional treatments of the cervix. 
To provide further proof that cervical damage facilitates ascending infection in our 
model, we quantified the U. parvum titres in the amniotic fluid of mice 48 hours after 
vaginal inoculation. We found U. parvum titres to be significantly higher in mice that 
were pre-treated with N-9 compared to PBS pre-treated controls. This was the case 
both at a proximal and at a distal site to the cervix. This finding is in agreement with 
our imaging results and has significant translational importance as it shows that the 
fetus can also get exposed to infection since it swallows the amniotic fluid. In addition, 
by culturing the amniotic fluid we identify bacteria that are capable of growing and are 
therefore able to establish an active infection.  
Moreover, we detected significantly higher levels of mRNA expression of the U. 
parvum gene Urease C both in the fetal membranes and the placenta at the proximal 
site of mice pre-treated with N-9 using qPCR. The effect was similar at the distal site 
as well, although it did not manage to reach statistical significance. Higher levels of 
UreC were also found in the uterus of pre-treated mice, despite the results not being 
statistically significant. The UreC copy number in the uterus was lower than that of 
the fetal membranes or the placenta. As the whole part of the uterus surrounding each 
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mouse was analysed, it is likely that levels are artificially low since that majority of 
the bacteria would probably colonise the decidua. Racicot et al. also used qPCR to 
show that the other Ureaplasma species, U. urealyticum can ascend to the uterus after 
vaginal administration and this effect is aided by a viral infection (286). 
Furthermore, when examining the preterm birth incidence among mice that had only 
cervical damage, only infection with U. parvum, or both, we found that only the last 
group had significantly higher PTB rates compared to the group that only received 
vehicle treatments. This finding highlights the importance of a healthy cervical 
epithelium for a safe pregnancy outcome. It is also in agreement with a study from 
Akgul et al. which found that inappropriate differentiation of the cervical epithelium 
increases the risk of PTB induced by an ascending infection with E. coli (280). A viral 
infection of the cervical epithelium was also shown to increase PTB rates after E. coli 
administration (449). The preterm birth incidence in these studies was higher 
compared to what we found. This is not unexpected as E. coli is a much more virulent 
bacterium than U. parvum. Also, the PTB rate of 28% that we found is consistent with 
the finding that vaginal colonisation with U. parvum is an independent risk factor for 
PTB in humans (237). 
Since U. parvum does ascend to the upper reproductive tract and can increase the PTB 
rates, we examined its potential to stimulate an inflammatory response in fetomaternal 
tissues after vaginal administration using qPCR. We found the gene expression of the 
cytokines Tnfa and Il1b and the chemokines Cxcl1 and Cxcl2 to be significantly 
upregulated in the placenta, uterus and fetal membranes of the groups of mice infected 
with U. parvum. Tnfa and Il1b were shown to be upregulated in mouse peritoneal 
macrophages that were treated with U. parvum-derived lipoproteins, such as MBA 
(225). They also demonstrated a slight upregulation in vivo, in the placentas of mice 
where U. parvum was administered intrauterine after laparotomy (256). These findings 
are in agreement with a study from von Chamier et al. that reported a mild 
chorioamnionitis after intrauterine administration of U. parvum (222). Importantly, we 
found medium to strong correlations in the increases of these cytokines and 
chemokines with the copy number of UreC produced by U. parvum in all three of the 
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tissues. This further supports a causal role for U. parvum in this inflammatory 
response. Collectively, the gene expression changes observed after vaginal U. parvum 
administration are compatible with an inflammatory pre-labour phenotype. Of note, 
these experiments were conducted in mice that did not deliver during the 48-hour 
preterm birth window and were thus deemed term. Consequently, the levels of changes 
caused by U. parvum in these cases were not sufficient to cause PTB. 
Trend differences in the expression levels were also identified in mice pre-treated with 
N-9 compared to those pre-treated with vehicle control. These are reflective of the 
higher titres of U. parvum in the tissues of mice pre-treated with N-9, as N-9 was found 
in our previous experiments to facilitate ascending infection. 
Another important finding was that the increase in the expression of the cytokines and 
chemokines was higher at the proximal site compared to the distal. This further 
supports the notion of ascending infection. By being closer to the administration point, 
tissues at the proximal site were colonised potentially earlier than those at the distal 
site. This could have allowed more time for the bacteria to establish an infection which 
led to more significant changes in gene expression of proinflammatory molecules as 
part of the immune response.   
To gain further insights as to which pathway was stimulated by U. parvum to result in 
these proinflammatory gene expression changes, we examined the expression of TLRs 
in those tissues using qPCR. We found a mild but consistent upregulation in the 
expression of Tlr2 in all three tissues and a less consistent increase in Tlr1 and Tlr6, 
mostly in the fetal membranes. Uchida et al. have also found that the proinflammatory 
changes caused by U. parvum in macrophages are mediated by TLR2 (225). Another 
study, however, found no change in the levels of Tlr2 or Cd14 (256). In support of our 
findings, two other studies suggested a key role of TLR2, both in human amniotic cells 
(224) and in a human kidney cell line (223). Still, we cannot conclude on the role of 
TLR2 in the inflammatory response stimulated by U. parvum based solely on an 
upregulation in the gene expression. These studies also described a role for TLR6 (224) 
and TLR1 (223) respectively, something we also noticed, albeit at a lower extent. 
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Triantafyllou et al. implied that TLR9 can also participate in U. parvum recognition 
by internalising the bacterium as a whole (224). We found no changes in the expression 
of Tlr9 in any group and there was no correlation between its relative expression and 
the levels of UreC. 
Finally, we assessed whether any changes were caused by U. parvum in the fetal lung. 
No differences were found in the expression of any of the cytokines and chemokines 
that we tested and found to be increased in the other tissues between infected and sham 
mice. This is in contrast with a study that found an increase in the levels of IL-1b, IL-
6 and CXCL-2 in the fetal lungs after intra-amniotic administration of U. parvum 
(411). This study however was performed on CD-1 mice. While CD-1 fetuses have 
been shown to be susceptible to U. parvum infection, the foetuses of the C57Bl/6 strain 
that we used are considered to be resistant (222). This was in line with our findings. 
Given the high U. parvum titres that we found in the amniotic fluid, we expected high 
copy numbers of UreC to be found in the fetal lung as the fetuses swallow the amniotic 
fluid. However, we only found very low copy numbers at levels barely detectable. This 
was also the finding of von Charmier et al. who only detected the bacteria in the 
intestinal lumen and not the lungs (222). Therefore, U. parvum cannot establish an 
infection at the fetal lungs, something explaining the unchanged levels of the 
expression of proinflammatory cytokines in our model.    
In summary, using our mouse model of cervical damage during pregnancy we provide 
strong evidence that N-9-induced epithelial damage facilitates ascending infection 
with U. parvum. This leads to increased preterm birth rates. We also report that U. 
parvum can induce an inflammatory response in fetomaternal tissues with increased 
expression of proinflammatory cytokines and chemokines.  
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Chapter 6 General Discussion 
6.1 Main findings 
The cervix is key in protecting pregnancy from ascending infections that can cause 
preterm birth. The cervical epithelium, in particular, is a major contributor to the 
physical and functional barrier of the cervix to infection (282). Excisional procedures 
that damage the cervix by removing part of the epithelium and the underlying stroma 
have been associated with PTB, but no explanation of this association has been 
proposed (304) (305). The overarching hypothesis of this thesis is that cervical 
epithelial injury predisposes to ascending infection. To address this hypothesis we used 
the surfactant N-9 as an inducer of epithelial damage. N-9 has been shown to cause 
epithelial damage in the lower reproductive tract of non-pregnant animals and in 
humans (391) (392) (386) (387) (450) (388). The aims that we set were to: i) 
investigate the effect of N-9 on cervical epithelial cells in vitro, ii) to generate and 
characterise a mouse model of cervical epithelial damage during pregnancy using N-9 
and ii) to investigate the effect of cervical epithelial damage on ascending infection 
and preterm delivery. 
The main findings are summarised below: 
- N-9 is cytotoxic against cervical epithelial cells in vitro in a dose-dependent 
manner. Low doses (less than 10 µg/ml) do not have a strong effect, resulting 
in less than 20% cytotoxicity within 24 hours. High doses (more than 100 
µg/ml) rapidly exert 100% cytotoxicity. The effect of the intermediate doses is 
also time-dependent with cytotoxicity increasing with longer incubation times. 
At 32 and 64 μg/ml, N-9 cytotoxicity increases from 20% and 30% at 30 
minutes respectively, to 90% after 24-hour treatments.  
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- N-9 compromises the physical barrier function of the cervical epithelium in 
vitro by increasing its permeability through direct cell cytotoxicity. 
 
- N-9 does not affect the ability of cervical epithelial cells to secrete 
proinflammatory cytokines basally or after LPS stimulation. 
 
- The wound healing capacity of cervical epithelial cells and endometrial stromal 
cells can be diminished by a concurrent infection with Ureaplasma 
urealyticum. 
 
- N-9 causes cervical epithelial damage in pregnant mice after vaginal 
administration in late gestation. Features of this damage include severe 
disruption of the epithelial morphology and infiltrations of polymorphonuclear 
neutrophils. However, it is not sufficient to cause preterm delivery. 
 
- N-9-induced cervical epithelial damage followed by vaginal administration of 
high dose of LPS does not cause preterm birth in a mouse model 
 
- N-9-induced cervical epithelial damage facilitates ascending infection with 
Ureaplasma parvum. This is accompanied by an increase in preterm birth rates 
in a mouse model 
 
- Ureaplasma parvum is capable of ascending to the upper reproductive tract and 
colonise the fetal membranes, the placenta, the uterus and the amniotic fluid. 
In the first three tissues it can induce an inflammatory response in a mouse 
model.  
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6.2 Cervical damage facilitates ascending infection 
with Ureaplasma parvum  
We used 3 different methods to identify the presence and quantify the levels of U. 
parvum in the upper reproductive tract. The first was in vivo bioluminescence imaging 
24 hours after vaginal administration of the bacteria. The second was by collecting the 
amniotic fluid 48 hours after administration and then culturing it with Ureaplasma 
Specific Medium, to detect and quantify a population of actively growing bacteria. The 
third was by measuring the copy number of the U. parvum-derived gene Urease C in 
the fetal membranes, placenta and uterus by qPCR. Previous studies have used PCR 
(286) or culture-based methods (440) or a combination of the two (261), but this is the 
first study using three different methods to confirm the presence of U. parvum. The 
use of robust methodoly to address our main question is a strength of the current thesis.  
We could detect U. parvum in the upper reproductive tract with all three of these 
methods. Therefore, U. parvum can ascend to the uterus during mouse gestation. This 
is an interesting finding as Ureaplasmas are non-motile bacteria. Using in vivo 
imaging, we could determine the presence of U. parvum in the upper reproductive tract 
in some of the mice 24 hours after intravaginal administration. This indicates that U. 
parvum can deploy transport mechanisms that can lead to it ascending in the uterine 
compartment. These may include the bacteria itself actively moving over epithelial 
surfaces or passively being moved over. The capacity of other non-motile bacteria such 
as Staphylococcus aureus (451), Mycobacterium spp (452) and a non-motile mutant 
of Listeria monocytogenes (453) to move has also been described. Future studies could 
investigate potential mechanisms of attachment, detachment and re-attachment by U. 
parvum on epithelial cells. This will help in the design of more effective prevention 
strategies against pregnancy complications in women colonised by Ureaplasma spp.  
After quantifying the levels of U. parvum, a consistent pattern was identified with all 
three methods: U. parvum was more abundant in the upper reproductive tract of mice 
that have been pre-treated with N-9. In Chapter 4, we characterised the damage that 
N-9 causes to the cervical epithelium, which involves significant disturbance and 
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sloughing. Consequently, these lesions can compromise the barrier function of the 
cervix to facilitate ascending infection. This finding is supportive of our hypothesis 
and could represent a potential pathway explaining the increased risk for preterm 
delivery among women that were treated with excisional procedures. 
Different potential mechanisms have been proposed in an effort to explain the 
epidemiological association between cervical damage-inducing procedures and 
preterm delivery. These can be broadly divided into three different etiologic factors: 
impairment of mechanical support (454), decreased protection against infection (455) 
or both (456). The former is mainly supported by studies reporting that while minimal 
excisions confer no increased risk of preterm birth, with larger excisions the risk 
almost doubles (457). The bigger the thickness and the overall volume of cervical 
tissue excised, the higher the incidence of a subsequent preterm delivery (458). 
Importantly, this is independent of the interval time between the procedure and 
conception (457) (459). Current evidence is limited to retrospective cohort studies and 
as such the validity of these claims is hard to be confirmed. To our knowledge, no 
studies have been conducted to evaluate whether damage to the cervical epithelium 
can increase susceptibility to ascending infection. 
Our findings support the fact that cervical epithelial injury compromises the barrier 
function of the cervix to render the uterine content more susceptible to ascending 
infection with the most clinically relevant bacteria. This suggests a potential 
mechanism explaining the observation that women with a damaged cervical 
epithelium are at increased risk for preterm delivery. Our model assesses the effect of 
the acute phase of cervical epithelial damage characterised by areas of complete 
epithelial sloughing. As such, the only group of women directly comparable to this 
scenario would be the ones that conceive very soon after the cervical intervention, a 
practice that is discouraged by obstetricians. However, our data also have indirect 
implications for all pregnancies following excisional procedures. A mature cervical 
epithelium can take up to 7 weeks to cover the affected area (460). This is sufficient 
time to allow for ascending infection and colonisation of the upper reproductive tract, 
which can lead to an increased risk of intrauterine infection should a pregnancy occur. 
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Even after epithelial regeneration, the development of scar tissue has been reported 
(454). A scarred surface conveying limited protection compared to a healthy 
epithelium as a result of an excisional treatment could account for an increased risk of 
ascending infection during pregnancy. Overall, our findings highlight the importance 
of a healthy epithelium in the protection against microbial invasion.    
Apart from the cervical epithelium, the lower reproductive tract has other barriers 
against infection that could lead to an adverse pregnancy outcome. A beneficial 
composition of the vaginal microbiome is important in preventing proliferation of 
potentially pathogenic vaginal microorganisms. A dysbiotic state, as in bacterial 
vaginosis, has been shown to increase the risk for preterm delivery (461) (462) (463). 
Another important barrier is the cervical mucus which forms the mucus plug. Mucus 
from women at high-risk for preterm birth can have altered biophysical properties 
leading to a reduced capacity to form strong gels (464). It would be interesting for 
future studies to assess whether disruption of these barriers could also predispose to 
ascending infection with Ureaplasma spp and compare the respective findings with 
the effect of cervical epithelial damage. This will help for future risk stratification 
strategies.   
6.3 Ascending infection pathway 
An interesting observation regarding the pathway of ascending infection can be made 
when considering the levels of U. parvum as assessed by culture and qPCR. At first, 
bacterial cultures revealed very high titres of U. parvum in the amniotic fluid, in a 
magnitude of about 107-108 CCU/ml. Next, using qPCR, we found the UreC copy 
number, which is indicative of the U. parvum presence, to be higher in the fetal 
membranes compared to the placenta or the uterus. These apparent higher levels might 
reflect a pattern that is consistent with the following pathway of ascending infection: 
From the vagina where it is administered, U. parvum passes through the cervix. This 
is aided by cervical epithelial damage. From there, the bacteria invade the amniotic 
cavity through a certain region of the fetal membranes. In the amniotic fluid they 
proliferate rapidly before colonising the fetal membranes and then reaching the 
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placenta and uterus. This potential pathway of ascending infection was first proposed 
back in 1961 (465) and is further supported by a human study from Kim et al (201). 
Using qPCR and culture-based methods for general bacterial populations, they found 
the bacteria to be more abundant on the amniotic fluid than in the fetal membranes 
(201). Then the genomic DNA copy number was greater in the amnion than in the 
chorion (201). Thus, bacterial proliferation in the amniotic fluid is likely to precede 
colonisation of the fetal membranes and subsequent chorioamnionitis. Using detection 
systems specific for U. parvum, we found this to be the case in our study as well. Based 
on this model of ascending infection, it is likely that U. parvum can induce preterm 
delivery by leading to premature activation and rupture of the fetal membranes. The 
potential of U. parvum to drive PPROM can be studied by assessing its ability to 
upregulate the expression of prostaglandins and MMPs in the fetal membranes. The 
other Ureaplasma species, U. urealyticum was reported to increase the production of 
PGE2 by human choriodecidual explants in vitro (466). In addition, a recent study 
found that U. parvum could stimulate an upregulation in the expression of MMP-9 by 
both maternal and fetal human monocytes in vitro (467). Expanding these findings in 
an in vivo setting will provide further evidence about U. parvum pathogenicity with 
regards to pregnancy complications. The activation status of the MMPs can be 
examined using zymography. Alternatively, preterm birth induced by U. parvum could 
have premature myometrial contractions as its main feature. Our group has extensive 
experience using gel contraction assays to examine the pro-contractile potential of 
different agents. These could be deployed to assess the potency of U. parvum as a 
contraction stimulator. 
The much higher U. parvum titres in the amniotic fluid compared to the tissues could 
also be reflective of the composition of the amniotic fluid. The concentration of urea 
significantly increases in the amniotic fluid during late gestation in the mouse, 
potentially due to an increase in the fetal urine output (468). Ureaplasmas hydrolyse 
urea to generate virtually 100% of its energy requirements (469). They appear to be 
the sole bacteria capable of producing ATP via this mechanism. Therefore, the 
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amniotic fluid late during mouse pregnancy represents an environment that favours the 
growth of U. parvum.                     
6.4 Inflammatory changes after Ureaplasma infection 
Inflammatory cytokines are central to the mechanisms of infection/inflammation-
induced preterm birth. Levels of several key cytokines and chemokines, such as IL-1b 
(149), IL-6 (158), IL-8 (161) and TNFa (163) increase in the amniotic fluid after 
microbial invasion of the amniotic cavity (MIAC) and they can also be used as 
predictors of intra-amniotic infection (160). In our study, we found U. parvum to 
invade the amniotic cavity after vaginal administration. As the amount of amniotic 
fluid rapidly decreases during late gestation (470) and our samples were collected on 
D19, we used all of it for culture-based detection of U. parvum. Therefore, we 
examined the in situ gene expression of the cytokines of interest in the fetal 
membranes, placenta and uterus. We noticed a mild inflammatory response with 
increases in the gene expression levels of TNFa, IL-1b, CXCL-1 and CXCL-2 
correlating with the gene copy number of the U. parvum-derived gene Urease C in the 
respective tissues. Previous studies using intrauterine administration of U. parvum 
have reported similar results (222) (256) (225). In vitro stimulation of human 
monocytes by U. parvum was also found to cause an increased expression of TNFa, 
IL-1b and IL-8, the human ortholog of CXCL-1 and CXCL-2 (471). Importantly, our 
experiments were conducted in term mice, as they had not delivered by the morning 
of D19 and consequently their tissues were available antenatally. Given the strong 
correlation between the levels of U. parvum and the increase in inflammatory gene 
expression in these tissues, it can be postulated that in mice that did deliver preterm, 
higher bacterial levels in the reproductive tissues resulted in a stronger inflammatory 
response that was potent in inducing preterm delivery. This could be the pathway of 
U. parvum-induced PTB, as these cytokines are known stimulators of the labour-
associated prostaglandins E2 and F2a and their synthesising enzyme COX-2 (181) (174) 
(175). They can also induce several MMPs (186) (188).  Nevertheless, this hypothesis 
is not backed up by our in vivo imaging data as there was no difference in the levels of 
bioluminescence of mice that ended up delivering preterm compared to those that 
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delivered at term. However, BLI imaging was performed on D18 so these results are 
not directly comparable to the qPCR and culture results from D19.  
Importantly, by using qPCR, we assessed changes at the gene expression level. This 
does not necessarily mean that there is an inflammatory response in those tissues. 
Further studies are required to determine changes of the above-mentioned cytokines at 
the protein level. This will validate our findings and solidify the role of U. parvum as 
a trigger for preterm birth. In addition, future studies could also assess whether 
immune cells are recruited in the reproductive tissues after infection with U. parvum 
and determine their activation status. This will provide further information regarding 
the magnitude of the inflammatory response induced by U. parvum in the reproductive 
tissues and will be important for designing potential etiological treatment strategies.  
6.5 Pathway of Ureaplasma-induced inflammation 
Since we found U. parvum to increase the expression of proinflammatory cytokines 
and chemokines, we sought to identify Pathogen Recognition Receptors (PRRs) that 
are involved in triggering this response. Using qPCR, we found a significant 
upregulation in TLR2 gene expression across all tissues where an inflammatory 
response has been observed, namely the fetal membranes, placenta and uterus. Trend 
increases were also noticed in the gene expression of TLR1 and TLR6, more so in the 
fetal membranes. This findings are in agreement with a previous study in mice 
identifying TLR2 as the receptor activated by MBA (225), the Ureaplasma main 
virulence factor. In addition, studies in human cell lines suggested that TLR1/TL2 
(223) and TLR2/TLR6 (224) dimers are involved in the cytokine responses stimulated 
by U. parvum. Activation of TLR2 in mouse macrophages has been shown to elicit a 
mild inflammatory response (472). This is consistent with our findings that do not 
represent a robust inflammatory reaction. It is also consistent with the pregnancy 
outcome in these mice, as none of them delivered preterm.   
However, our findings on TLR2 expression are at the gene expression level. Further 
studies evaluating changes at the protein level are needed to evaluate the role of this 
receptor in the Ureaplasma-induced inflammation in the reproductive tissues during 
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pregnancy. Future experiments using TLR2 KO mice could identify whether this 
receptor is necessary for the induction of an inflammatory response by U. parvum.  
At a molecular level, the key transcriptional events leading to the increased expression 
of cytokines after U. parvum infection should also be assessed. Previous studies have 
demonstrated that U. parvum-derived products can lead to increased cytokine secretion 
by activating the NFĸB pathway via TLR2 (225). NFĸB is an important regulator of 
the inflammatory and pro-contractile pathways leading to preterm birth (473). In 
addition, the transcription factor Activator ptotein-1 (AP-1) has also been suggested 
as a key driver of the inflammatory events preceding the onset of labour and a 
sufficient inducer of preterm labour (474). It would be interesting for future studies to 
assess whether an infection with U. parvum could also activate AP-1 during pregnancy 
to stimulate the expression of labour-associated genes. Phosphorylation of the AP-1 
sub-unit c-Jun results to activation and nuclear translocation of the complex (475). 
Measuring the levels and localisation of phosphorylated c-Jun after U. parvum 
infection in the uterus by Western blot and immunofluorescence will provide an 
indication on the activation status of this transcription factor. Chromatin 
immunoprecipitation (ChIP) in combination with high-throughput sequencing will 
allow the identification of specific genes (476) stimulated by these transcription factors 
during pregnancy in relation to U. parvum infection. This will help identify potential 
targets for therapeutic interventions. 
6.6 Ureaplasma virulence 
As we identified that U. parvum is able to elicit an inflammatory response in 
reproductive tissues, it is important to determine its specific virulence factors that 
could contribute to an adverse pregnancy outcome. In our study, we found the gene 
copy number of Urease C to have a strong positive correlation with the increase in the 
gene expression of TNFa, IL-1b, CXCL-1, CXCL-2 and TLR2 in the fetal membranes, 
placenta and uterus. A study by Ligon et al found that intravenous administration of 
Ureaplasmas can kill mice within 5 min of the injection (477). This lethal effect can 
be rescued by administering a urease inhibitor (477). In humans, Ureaplasma-derived 
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urease causes increased precipitation of minerals leading to increased formation of 
urinary struvite stones and urolithiasis (478). During sheep pregnancy, it has been 
shown to increase the pH of the amniotic fluid due to increased production of ammonia 
as part of the urea hydrolysis process (479). This can lead to significant damage in the 
fetal lung (479). Therefore, urease has the potential to cause adverse pregnancy 
outcomes. 
The Ureaplasma multiple-banded antigen (MBA) is also considered a major virulence 
factor of Ureaplsama spp. It can stimulate dimers between TLR2 and TLR1 or TLR6 
to activate NFĸB leading to the production of proinflammatory cytokines (223) (225). 
Phospholipase A and phospholipase C have also been suggested as virulence factors, 
as they can cleave and destabilise the cell membrane phospholipids of the host cells 
(480). Immunoglobulin A (IgA) protease is also pivotal for Ureaplasma spp survival 
and can contribute to the disease pathogenesis by helping the bacteria escape the 
mucosal immune surveillance (481) (482) (483). Future studies should focus on 
identifying the relative contribution of these factors to an adverse pregnancy outcome. 
One way through which this can be achieved is by genetic manipulation of 
Ureaplasma strains that will elucidate a definitive role for its virulence factors by 
examining the relative pathogenicity of mutant strains. This will determine candidate 
molecules that could be targeted for preventing and treating infections with 
Ureaplasma spp that could lead to adverse pregnancy outcomes. 
6.7 Summary and conclusions 
In conclusion, the findings of this thesis highlight the importance of a healthy cervical 
epithelium for a healthy pregnancy. We confirmed the potential of the surfactant N-9 
as a damage-inducing agent capable of compromising the barrier function of the 
cervical epithelium in vitro. We then used N-9 to establish the first mouse model of 
cervical epithelial damage during pregnancy that has been described. To quantify the 
extent of damage caused by N-9 in the epithelial surfaces of the lower reproductive 
tract, we developed a robust epithelial injury scoring system. This model could be 
broadly used to study the barrier function of the cervical epithelium.  
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Finally, using this model we showed that cervical epithelial damage predisposes to 
ascending infection with Ureaplasma parvum from the vagina to the uterus. This 
causes a mild inflammatory response in the upper reproductive tract and increases 
preterm birth rates among these mice. We provide evidence that the most clinically 
relevant bacteria for preterm birth in humans are also capable of causing adverse 
pregnancy outcomes in the mouse. Further studies are needed to decipher the 
pathogenetic mechanisms of Ureaplasma spp-induced preterm delivery. This will 
have broad implication in the prevention, proper identification of at-risk individuals 
and treatment of a series of pregnancy complications.  
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